{"users":[{"id":"2301781832","username":"maheih","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"M Heikkilä-Hoikka","description":"","protected":false,"created_at":"2014-01-20T17:47:17.000Z","public_metrics":{"followers_count":4,"following_count":16,"tweet_count":1,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"116716199","username":"EMA_News","profile_image_url":"https://pbs.twimg.com/profile_images/855440526195261440/DLfsCtAz_normal.jpg","verified":true,"name":"EU Medicines Agency","description":"Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.","protected":false,"created_at":"2010-02-23T11:05:21.000Z","public_metrics":{"followers_count":113072,"following_count":325,"tweet_count":21178,"listed_count":1738},"url":"http://t.co/wld9xoWe8y","location":"Amsterdam, Nederland","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wld9xoWe8y","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497166321901056009"},{"id":"524685920","username":"Viglya","profile_image_url":"https://pbs.twimg.com/profile_images/478601163596517377/AIyCCYdr_normal.jpeg","verified":false,"name":"Viglya","description":"Regulatory Affairs and Pharmacovigilance services through drug development and post-autorization for the biopharmaceutucial industry","protected":false,"created_at":"2012-03-14T20:09:29.000Z","public_metrics":{"followers_count":294,"following_count":453,"tweet_count":7636,"listed_count":0},"url":"http://t.co/Qjd4D5gb7s","location":"Barcelona - Spain","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Qjd4D5gb7s","expanded_url":"http://www.viglya.com","display_url":"viglya.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"69232855","username":"myESMO","profile_image_url":"https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_normal.jpeg","verified":false,"name":"ESMO - Eur. Oncology","description":"The European Society for Medical Oncology (ESMO) supports oncology professionals in providing cancer patients  with the most effective treatment and care.","protected":false,"created_at":"2009-08-27T07:45:16.000Z","public_metrics":{"followers_count":56949,"following_count":734,"tweet_count":14993,"listed_count":700},"url":"http://t.co/d58pSFlZZR","location":"Lugano - Switzerland","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/d58pSFlZZR","expanded_url":"http://www.esmo.org","display_url":"esmo.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1492227448372703234"},{"id":"113148426","username":"Martinharvey100","profile_image_url":"https://pbs.twimg.com/profile_images/1135188412301041665/s4E2JTb3_normal.png","verified":false,"name":"Martin Harvey","description":"Head of International Affairs at @EMA_News. Tweets reflect my interests & what catches my eye, ≠ official views of EMA. MCIPR FDIA","protected":false,"created_at":"2010-02-10T21:32:44.000Z","public_metrics":{"followers_count":695,"following_count":321,"tweet_count":546,"listed_count":32},"url":"https://t.co/0Q7qKxb8LI","location":"Amsterdam, The Netherlands","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0Q7qKxb8LI","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"mentions":[{"start":33,"end":42,"username":"EMA_News"}],"hashtags":{},"urls":{}}}},{"id":"308356449","username":"pisanie7","profile_image_url":"https://pbs.twimg.com/profile_images/881054953220997120/97x4vUTu_normal.jpg","verified":false,"name":"Eduardo Pisani","description":"Connecting dots to achieve shared goals. CEO @AllCanGroup Working on #health, #biopharma policy and law for #GlobalHealth solutions. Music passionate","protected":false,"created_at":"2011-05-31T08:15:34.000Z","public_metrics":{"followers_count":1049,"following_count":935,"tweet_count":7349,"listed_count":68},"url":"","location":"Brussels","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":45,"end":57,"username":"AllCanGroup"}],"hashtags":[{"start":69,"end":76,"tag":"health"},{"start":78,"end":88,"tag":"biopharma"},{"start":108,"end":121,"tag":"GlobalHealth"}],"urls":{}}},"pinned_tweet_id":"1495020867813879816"},{"id":"134450541","username":"EVEPIE","profile_image_url":"https://pbs.twimg.com/profile_images/1454948330522480640/ii7TRvF2_normal.jpg","verified":false,"name":"EVELYNE 에블린 PIERRON #BlacklivesMatter","description":"#Docteure en médecine #SantePublique #produitsdesante #signal #vigilancessanitaires #pharmacovigilance #gestiondurisque  Compte personnel","protected":false,"created_at":"2010-04-18T13:07:28.000Z","public_metrics":{"followers_count":5639,"following_count":3927,"tweet_count":41462,"listed_count":372},"url":"https://t.co/QOQcnlZxmC","location":"Paris ","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/QOQcnlZxmC","expanded_url":"http://linkedin.com/in/evelynepierron","display_url":"linkedin.com/in/evelynepier…"}]},"description":{"mentions":{},"hashtags":[{"start":0,"end":9,"tag":"Docteure"},{"start":22,"end":36,"tag":"SantePublique"},{"start":37,"end":53,"tag":"produitsdesante"},{"start":54,"end":61,"tag":"signal"},{"start":62,"end":83,"tag":"vigilancessanitaires"},{"start":84,"end":102,"tag":"pharmacovigilance"},{"start":103,"end":119,"tag":"gestiondurisque"}],"urls":{}}},"pinned_tweet_id":"1385581239260876808"},{"id":"67413545","username":"FirstlinePR","profile_image_url":"https://pbs.twimg.com/profile_images/1387801073218465793/zIctXtcR_normal.jpg","verified":false,"name":"Firstline Media","description":"Firstline is a broadcast public relations firm with the media savvy to know what decision makers at networks and major market tv and radio stations want.","protected":false,"created_at":"2009-08-20T20:21:25.000Z","public_metrics":{"followers_count":192,"following_count":452,"tweet_count":882,"listed_count":4},"url":"http://t.co/QvlFxmy7PV","location":"Atlanta (Headquarters)","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/QvlFxmy7PV","expanded_url":"http://www.firstlinemedia.com","display_url":"firstlinemedia.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"964487156","username":"TAPBiosystems","profile_image_url":"https://pbs.twimg.com/profile_images/1230886883816886272/NooP5fm3_normal.jpg","verified":false,"name":"SartoriusRoyston","description":"Leading supplier of innovative cell culture systems and consumables for life science applications.","protected":false,"created_at":"2012-11-22T15:48:00.000Z","public_metrics":{"followers_count":1552,"following_count":1208,"tweet_count":6825,"listed_count":50},"url":"https://t.co/i7KtIB4qGI","location":"Cambridge, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/i7KtIB4qGI","expanded_url":"https://www.sartorius-stedim-tap.com/tap/news/pages/curr_news.asp?show=current","display_url":"sartorius-stedim-tap.com/tap/news/pages…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"469324230","username":"isciencewriter","profile_image_url":"https://pbs.twimg.com/profile_images/743735975478595584/E_dCeJAo_normal.jpg","verified":false,"name":"IScienceWriter","description":"International Science Writer (ISW) creating and sharing up-to-the-minute  news about #lifescience, #biotech and #pharma industries.","protected":false,"created_at":"2012-01-20T13:39:56.000Z","public_metrics":{"followers_count":5766,"following_count":3862,"tweet_count":18720,"listed_count":166},"url":"http://t.co/MNLk1KNsZY","location":"Hitchin, UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/MNLk1KNsZY","expanded_url":"http://www.internationalsciencewriter.com","display_url":"internationalsciencewriter.com"}]},"description":{"mentions":{},"hashtags":[{"start":85,"end":97,"tag":"lifescience"},{"start":99,"end":107,"tag":"biotech"},{"start":112,"end":119,"tag":"pharma"}],"urls":{}}}},{"id":"45537659","username":"DrSuePearson","profile_image_url":"https://pbs.twimg.com/profile_images/748424176147566592/hmXmodzY_normal.jpg","verified":false,"name":"Sue Pearson","description":"Writer for @GENBio, @ISciencewriter, presenter @CambridgeTVnews and weight loss #blogger. Tweets about #stemcells #biotech #health and #menopause","protected":false,"created_at":"2009-06-08T10:19:29.000Z","public_metrics":{"followers_count":1328,"following_count":761,"tweet_count":11537,"listed_count":89},"url":"https://t.co/bLSgCbBCr5","location":"Hitchin","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/bLSgCbBCr5","expanded_url":"http://www.drsuepearson.blog","display_url":"drsuepearson.blog"}]},"description":{"mentions":[{"start":11,"end":18,"username":"GENBio"},{"start":20,"end":35,"username":"ISciencewriter"},{"start":47,"end":63,"username":"CambridgeTVnews"}],"hashtags":[{"start":80,"end":88,"tag":"blogger"},{"start":103,"end":113,"tag":"stemcells"},{"start":114,"end":122,"tag":"biotech"},{"start":123,"end":130,"tag":"health"},{"start":135,"end":145,"tag":"menopause"}],"urls":{}}}},{"id":"341251022","username":"RebelMouse","profile_image_url":"https://pbs.twimg.com/profile_images/1346111538751549440/F_jITuyi_normal.png","verified":false,"name":"RebelMouse","description":"The fastest sites on the web. ✌️","protected":false,"created_at":"2011-07-24T02:13:40.000Z","public_metrics":{"followers_count":90016,"following_count":14496,"tweet_count":36667,"listed_count":1791},"url":"https://t.co/hGbU4stnQG","location":"Global","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hGbU4stnQG","expanded_url":"http://rbl.ms/2qNoORC","display_url":"rbl.ms/2qNoORC"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484602957840666626"},{"id":"376804644","username":"KathrinLudwig","profile_image_url":"https://pbs.twimg.com/profile_images/1201421198925746176/qyQkpQ4o_normal.jpg","verified":false,"name":"Kathrin Ludwig","description":"Passionate about public health & healthcare | travel | our planet & sustainable lifestyle | scuba diving || views are my own","protected":false,"created_at":"2011-09-20T14:36:25.000Z","public_metrics":{"followers_count":716,"following_count":993,"tweet_count":933,"listed_count":37},"url":"","location":"European Union / BRX","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"552617924","username":"ScripRegMaureen","profile_image_url":"https://pbs.twimg.com/profile_images/775989970913886208/aYt8PC5S_normal.jpg","verified":false,"name":"Maureen Kenny","description":"Executive editor at Informa Pharma Intelligence (Pink Sheet). All opinions are my own.","protected":false,"created_at":"2012-04-13T11:25:36.000Z","public_metrics":{"followers_count":1131,"following_count":579,"tweet_count":2222,"listed_count":48},"url":"https://t.co/TZvOK1sijS","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TZvOK1sijS","expanded_url":"https://pink.pharmamedtechbi.com/","display_url":"pink.pharmamedtechbi.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"31353538","username":"michelerhee","profile_image_url":"https://pbs.twimg.com/profile_images/1100194074043301888/wH4ddZkC_normal.jpg","verified":false,"name":"Michele Rhee","description":"#RareDisease & #AYACSM / #AYA Cancer #PatientAdvocate| Board of @CostsOfCare | #Sambassador for @TheSamfund | Overall enthusiastic person! | Tweets are my own.","protected":false,"created_at":"2009-04-15T06:01:33.000Z","public_metrics":{"followers_count":1769,"following_count":349,"tweet_count":10253,"listed_count":82},"url":"","location":"Boston, MA","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":64,"end":76,"username":"CostsOfCare"},{"start":96,"end":107,"username":"TheSamfund"}],"hashtags":[{"start":0,"end":12,"tag":"RareDisease"},{"start":15,"end":22,"tag":"AYACSM"},{"start":25,"end":29,"tag":"AYA"},{"start":37,"end":53,"tag":"PatientAdvocate"},{"start":79,"end":91,"tag":"Sambassador"}],"urls":{}}}},{"id":"962947430","username":"Lordsofdrinks","profile_image_url":"https://pbs.twimg.com/profile_images/413001402693079040/OQSeLWWN_normal.jpeg","verified":false,"name":"Lordsofthedrinks.com","description":"http://t.co/SrDHalgLL2 is a weblog that discusses all alcohol related stuff. THE place for people who love drinking and partying.","protected":false,"created_at":"2012-11-21T19:23:50.000Z","public_metrics":{"followers_count":595,"following_count":893,"tweet_count":3209,"listed_count":10},"url":"http://t.co/ndv3K32cpY","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/ndv3K32cpY","expanded_url":"http://lordsofthedrinks.com/","display_url":"lordsofthedrinks.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":0,"end":22,"url":"http://t.co/SrDHalgLL2","expanded_url":"http://lordsofthedrinks.com","display_url":"lordsofthedrinks.com"}]}}},{"id":"441940097","username":"Aifa_ufficiale","profile_image_url":"https://pbs.twimg.com/profile_images/1410593679299911689/cV-Qg8dx_normal.jpg","verified":false,"name":"AIFA","description":"Profilo ufficiale dell'Agenzia Italiana del Farmaco | #AIFA ✉ ufficiostampaaifa@aifa.gov.it | https://t.co/gCLzpL6nAb","protected":false,"created_at":"2011-12-20T15:44:17.000Z","public_metrics":{"followers_count":37867,"following_count":1042,"tweet_count":5999,"listed_count":355},"url":"https://t.co/X8Gax5dj4o","location":"Roma","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/X8Gax5dj4o","expanded_url":"http://www.aifa.gov.it","display_url":"aifa.gov.it"}]},"description":{"mentions":{},"hashtags":[{"start":54,"end":59,"tag":"AIFA"}],"urls":[{"start":94,"end":117,"url":"https://t.co/gCLzpL6nAb","expanded_url":"http://bit.ly/AIFA-SM-Policy","display_url":"bit.ly/AIFA-SM-Policy"}]}}},{"id":"1017044760","username":"animalhealthEU","profile_image_url":"https://pbs.twimg.com/profile_images/1468217923617673216/oHA98tT4_normal.png","verified":false,"name":"AnimalhealthEurope","description":"AnimalhealthEurope represents manufacturers of animal health products and services in Europe #AnimalHealthMatters #MorethanMedicine","protected":false,"created_at":"2012-12-17T09:14:15.000Z","public_metrics":{"followers_count":6925,"following_count":1002,"tweet_count":7582,"listed_count":87},"url":"https://t.co/WJdV3X5glJ","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/WJdV3X5glJ","expanded_url":"http://www.animalhealtheurope.eu","display_url":"animalhealtheurope.eu"}]},"description":{"mentions":{},"hashtags":[{"start":93,"end":113,"tag":"AnimalHealthMatters"},{"start":114,"end":131,"tag":"MorethanMedicine"}],"urls":{}}},"pinned_tweet_id":"1488156259174043650"},{"id":"606325697","username":"EU_Health","profile_image_url":"https://pbs.twimg.com/profile_images/907604041215201280/IuRPoVdN_normal.jpg","verified":true,"name":"EU Health","description":"EU Commission's DG Health & Food Safety (SANTE). We are building the foundations of a stronger European #HealthUnion RT ≠ endorsement. Food tweets @Food_EU","protected":false,"created_at":"2012-06-12T13:41:08.000Z","public_metrics":{"followers_count":83156,"following_count":3182,"tweet_count":25006,"listed_count":1873},"url":"https://t.co/Xb07O4qmcC","location":"Brussels, Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xb07O4qmcC","expanded_url":"http://ec.europa.eu/health","display_url":"ec.europa.eu/health"}]},"description":{"mentions":[{"start":147,"end":155,"username":"Food_EU"}],"hashtags":[{"start":104,"end":116,"tag":"HealthUnion"}],"urls":{}}},"pinned_tweet_id":"1498207262346821632"},{"id":"156892827","username":"UnumCommunitas","profile_image_url":"https://pbs.twimg.com/profile_images/1776308080/blind_justice_33_normal.jpg","verified":false,"name":"Unum Communitas","description":"With a firm reliance on the protection of Divine Providence, we mutually pledge to each other our Lives, our Fortunes and Sacred Honor","protected":false,"created_at":"2010-06-18T06:37:01.000Z","public_metrics":{"followers_count":974,"following_count":1219,"tweet_count":64651,"listed_count":45},"url":"","location":"Undisclosed Underground Bunker","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"34732474","username":"Indiegogo","profile_image_url":"https://pbs.twimg.com/profile_images/1414958903754952705/wy4hRtad_normal.jpg","verified":true,"name":"Indiegogo Reads 📚","description":"Your go-to for all things #crowdfunding — from community stories to educational resources.💡 PSA: Crowdfunding is not shopping! It's better.","protected":false,"created_at":"2009-04-23T21:18:31.000Z","public_metrics":{"followers_count":324760,"following_count":5484,"tweet_count":29961,"listed_count":4285},"url":"https://t.co/QBfjNgdgZO","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/QBfjNgdgZO","expanded_url":"http://indiegogo.com/blog","display_url":"indiegogo.com/blog"}]},"description":{"mentions":{},"hashtags":[{"start":26,"end":39,"tag":"crowdfunding"}],"urls":{}}},"pinned_tweet_id":"1460317139454369792"},{"id":"243228907","username":"BioPharmaMike","profile_image_url":"https://pbs.twimg.com/profile_images/378800000308429980/0288ff3098daceff8672357bac3209fd_normal.jpeg","verified":false,"name":"Mike Ward","description":"Commentating on issues consequential to pharma, biotech, healthcare & medtech stakeholders","protected":false,"created_at":"2011-01-26T15:58:16.000Z","public_metrics":{"followers_count":5965,"following_count":1077,"tweet_count":13680,"listed_count":264},"url":"","location":"London, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"144624330","username":"kerfors","profile_image_url":"https://pbs.twimg.com/profile_images/775021351262363648/qeB7Z25Z_normal.jpg","verified":false,"name":"Kerstin Forsberg","description":"Lifelong Learner and Information Architect caring about clinical trial data and metadata https://t.co/0JRDBXfXVk…","protected":false,"created_at":"2010-05-16T21:20:15.000Z","public_metrics":{"followers_count":2258,"following_count":569,"tweet_count":15309,"listed_count":297},"url":"https://t.co/Fg3X3mbA44","location":"Kungälv, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Fg3X3mbA44","expanded_url":"http://kerfors.blogspot.se/","display_url":"kerfors.blogspot.se"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":89,"end":112,"url":"https://t.co/0JRDBXfXVk","expanded_url":"http://orcid.org/0000-0002-1491","display_url":"orcid.org/0000-0002-1491"}]}}},{"id":"140344419","username":"cancereu","profile_image_url":"https://pbs.twimg.com/profile_images/1367015286721957890/NBLDvvzN_normal.jpg","verified":false,"name":"ECPC","description":"We are the voice of over 450 cancer patient organisations, covering the most common to the rarest cancers.\n\nECPC is providing Secretariat for @ChallengeCAN","protected":false,"created_at":"2010-05-05T07:43:41.000Z","public_metrics":{"followers_count":6018,"following_count":1849,"tweet_count":13668,"listed_count":0},"url":"https://t.co/8PBLq9mnAU","location":"Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8PBLq9mnAU","expanded_url":"http://www.ecpc.org","display_url":"ecpc.org"}]},"description":{"mentions":[{"start":142,"end":155,"username":"ChallengeCAN"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1447517527366643712"},{"id":"18474984","username":"English_Woman","profile_image_url":"https://pbs.twimg.com/profile_images/869476696654835712/7XlX4FKZ_normal.jpg","verified":false,"name":"Sue Jameson","description":"Mum/Grandmum, Gamer, IT, Libertarian Minarchist. Indigenous Heathen.","protected":false,"created_at":"2008-12-30T11:09:12.000Z","public_metrics":{"followers_count":3729,"following_count":4355,"tweet_count":96542,"listed_count":148},"url":"https://t.co/pqkwclo60r","location":"Dunstable, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/pqkwclo60r","expanded_url":"https://www.facebook.com/sue.muffv","display_url":"facebook.com/sue.muffv"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"745006285888819200"},{"id":"556679074","username":"URPLWMiPB","profile_image_url":"https://pbs.twimg.com/profile_images/2150354867/image_normal.jpg","verified":true,"name":"URPL","description":"The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products | Urząd Rejestracji Prod. Leczniczych, Wyrobów Med. i Prod. Biobójczych","protected":false,"created_at":"2012-04-18T08:30:51.000Z","public_metrics":{"followers_count":2133,"following_count":377,"tweet_count":6710,"listed_count":23},"url":"https://t.co/yOlqIh8cmt","location":"Poland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yOlqIh8cmt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"203357203","username":"EAHPtweet","profile_image_url":"https://pbs.twimg.com/profile_images/648845031965487104/TM1cuwrq_normal.jpg","verified":false,"name":"EAHP","description":"European Association of Hospital Pharmacists","protected":false,"created_at":"2010-10-16T02:42:15.000Z","public_metrics":{"followers_count":5053,"following_count":3472,"tweet_count":8274,"listed_count":131},"url":"https://t.co/7GCosREhd5","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7GCosREhd5","expanded_url":"http://www.eahp.eu","display_url":"eahp.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"556859372","username":"GCessak","profile_image_url":"https://pbs.twimg.com/profile_images/1134087083709140993/nDgYr-uy_normal.jpg","verified":true,"name":"𝗚𝗿𝘇𝗲𝗴𝗼𝗿𝘇 𝗖𝗲𝘀𝘀𝗮𝗸","description":"President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products; Member of the EMA’s Management Board & CHMP, Ph.D.","protected":false,"created_at":"2012-04-18T13:24:10.000Z","public_metrics":{"followers_count":4971,"following_count":799,"tweet_count":12829,"listed_count":82},"url":"https://t.co/jTYELiOaYt","location":"Poland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/jTYELiOaYt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2382044864","username":"JHJournalist","profile_image_url":"https://pbs.twimg.com/profile_images/790558282503036928/RnIBmJWP_normal.jpg","verified":false,"name":"Joseph Harvey","description":"Expect tweets on #animalhealth, #biotech, #pharma, #healthcare, #onehealth, #agriculture, #investment and #foodsafety... #journalist","protected":false,"created_at":"2014-03-10T12:07:54.000Z","public_metrics":{"followers_count":2551,"following_count":250,"tweet_count":3779,"listed_count":73},"url":"https://t.co/sJKlT8OaG4","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sJKlT8OaG4","expanded_url":"http://www.animalpharmnews.com","display_url":"animalpharmnews.com"}]},"description":{"mentions":{},"hashtags":[{"start":17,"end":30,"tag":"animalhealth"},{"start":32,"end":40,"tag":"biotech"},{"start":42,"end":49,"tag":"pharma"},{"start":51,"end":62,"tag":"healthcare"},{"start":64,"end":74,"tag":"onehealth"},{"start":76,"end":88,"tag":"agriculture"},{"start":90,"end":101,"tag":"investment"},{"start":106,"end":117,"tag":"foodsafety"},{"start":121,"end":132,"tag":"journalist"}],"urls":{}}}},{"id":"35511598","username":"Kieran_Research","profile_image_url":"https://pbs.twimg.com/profile_images/835168863637495808/oPq0DFKU_normal.jpg","verified":false,"name":"Kieran Breen","description":"Head of Research and Innovation at  St Andrew’s Healthcare - all views are my own","protected":false,"created_at":"2009-04-26T17:20:58.000Z","public_metrics":{"followers_count":1019,"following_count":298,"tweet_count":6601,"listed_count":0},"url":"https://t.co/SvfdVALzti","location":"Northampton, UK.","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/SvfdVALzti","expanded_url":"http://www.linkedin.com/in/kcbreen","display_url":"linkedin.com/in/kcbreen"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"64681292","username":"worldkidneyday","profile_image_url":"https://pbs.twimg.com/profile_images/1437695843411406848/_aq89UUR_normal.jpg","verified":true,"name":"World Kidney Day","description":"World Kidney Day's objective is to raise awareness globally of the importance of Kidney Health and to increase screening for chronic kidney disease","protected":false,"created_at":"2009-08-11T10:40:45.000Z","public_metrics":{"followers_count":22188,"following_count":1125,"tweet_count":5125,"listed_count":193},"url":"https://t.co/MTsaT9TgLM","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/MTsaT9TgLM","expanded_url":"https://linktr.ee/WorldKidneyDay","display_url":"linktr.ee/WorldKidneyDay"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1438499037917827080"},{"id":"329999446","username":"gm901007","profile_image_url":"https://pbs.twimg.com/profile_images/1193161822888767490/qv_5QGKo_normal.jpg","verified":false,"name":"Georgiana","description":"This is now a personal account, which I seem to use to RT things. All views my own.","protected":false,"created_at":"2011-07-05T23:15:54.000Z","public_metrics":{"followers_count":442,"following_count":869,"tweet_count":4927,"listed_count":32},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"157981564","username":"EU_Commission","profile_image_url":"https://pbs.twimg.com/profile_images/1460560236138438659/UrnEa2g7_normal.jpg","verified":true,"name":"European Commission 🇪🇺","description":"News and information from the European Commission. Social media and data protection policy: https://t.co/S5WriNaXYZ…","protected":false,"created_at":"2010-06-21T12:28:34.000Z","public_metrics":{"followers_count":1615790,"following_count":634,"tweet_count":43353,"listed_count":13718},"url":"https://t.co/JooRnYJttM","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JooRnYJttM","expanded_url":"https://europa.eu/next-generation-eu/index_en","display_url":"europa.eu/next-generatio…"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":92,"end":115,"url":"https://t.co/S5WriNaXYZ","expanded_url":"http://ec.europa.eu/info/social-me","display_url":"ec.europa.eu/info/social-me"}]}}},{"id":"1125798749727539202","username":"GeoMurariu","profile_image_url":"https://pbs.twimg.com/profile_images/1402600640120041473/VC1sF22Z_normal.jpg","verified":false,"name":"Georgiana Murariu","description":"User researcher at @dwpdigital, background in social anthropology. Romanian in London. Views my own.","protected":false,"created_at":"2019-05-07T16:25:13.000Z","public_metrics":{"followers_count":436,"following_count":809,"tweet_count":1488,"listed_count":6},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":19,"end":30,"username":"dwpdigital"}],"hashtags":{},"urls":{}}}},{"id":"208120290","username":"US_FDA","profile_image_url":"https://pbs.twimg.com/profile_images/773141404860162061/WK4RgHMx_normal.jpg","verified":true,"name":"U.S. FDA","description":"Our tweets are FDA Approved!               Privacy Policy - https://t.co/LbTJXYRXVP","protected":false,"created_at":"2010-10-26T17:31:41.000Z","public_metrics":{"followers_count":529044,"following_count":161,"tweet_count":16596,"listed_count":4981},"url":"https://t.co/4XwENQl3Ov","location":"Silver Spring, MD","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4XwENQl3Ov","expanded_url":"https://www.fda.gov/coronavirus","display_url":"fda.gov/coronavirus"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":60,"end":83,"url":"https://t.co/LbTJXYRXVP","expanded_url":"http://go.usa.gov/xFfG8","display_url":"go.usa.gov/xFfG8"}]}}},{"id":"226603998","username":"alanROYGBIV","profile_image_url":"https://pbs.twimg.com/profile_images/2511777070/4iume3veudmj2muqx9c8_normal.jpeg","verified":false,"name":"Alan Thomas","description":"Founder of @Ataxia_and_Me  to support #Ataxia (Rare Neuro. condition) from the #patient view. PASSIONATE about Inclusion for #disabled citizens - views are mine","protected":false,"created_at":"2010-12-14T16:06:15.000Z","public_metrics":{"followers_count":3313,"following_count":2111,"tweet_count":68368,"listed_count":562},"url":"","location":"Llanboidy  West Wales","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":11,"end":25,"username":"Ataxia_and_Me"}],"hashtags":[{"start":38,"end":45,"tag":"Ataxia"},{"start":79,"end":87,"tag":"patient"},{"start":125,"end":134,"tag":"disabled"}],"urls":{}}}},{"id":"335343087","username":"Em_L_Hughes","profile_image_url":"https://pbs.twimg.com/profile_images/2676192810/a9f4ef8f6c77dd6f5942bd110194dc91_normal.png","verified":false,"name":"Emma Hughes","description":"Policy & Engagement Manager for Wales @GeneticAll_UK and @rarediseaseuk , Trustee @CHWchildren, PPI Lead @WalesGenePark","protected":false,"created_at":"2011-07-14T14:54:38.000Z","public_metrics":{"followers_count":361,"following_count":394,"tweet_count":1654,"listed_count":12},"url":"http://t.co/OtQjz52EFe","location":"Swansea, Wales","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OtQjz52EFe","expanded_url":"http://www.geneticalliance.org.uk","display_url":"geneticalliance.org.uk"}]},"description":{"mentions":[{"start":38,"end":52,"username":"GeneticAll_UK"},{"start":57,"end":71,"username":"rarediseaseuk"},{"start":82,"end":94,"username":"CHWchildren"},{"start":105,"end":119,"username":"WalesGenePark"}],"hashtags":{},"urls":{}}}},{"id":"37254356","username":"DawnieMorgan","profile_image_url":"https://pbs.twimg.com/profile_images/694515453113286657/0MjQ34DP_normal.jpg","verified":false,"name":"Dawn Morgan","description":"Hometown - St. Dogmaels, Pembs. I now live in the middle of nowhere in Wales with my Partner Alan who has Cerebellar Ataxia. Ex chocolatier","protected":false,"created_at":"2009-05-02T18:39:16.000Z","public_metrics":{"followers_count":424,"following_count":988,"tweet_count":5245,"listed_count":42},"url":"","location":"Carmarthenshire","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"21026095","username":"jccolyer","profile_image_url":"https://pbs.twimg.com/profile_images/1473663586799083522/uA_MiqBM_normal.jpg","verified":false,"name":"John JC Colyer","description":"Diagnosed with neurological disorder Cerebellar Ataxia - To Know the Joy of Giving “\nWE ARE ALL IN THIS TOGETHER","protected":false,"created_at":"2009-02-16T20:50:59.000Z","public_metrics":{"followers_count":1662,"following_count":1949,"tweet_count":189870,"listed_count":223},"url":"","location":"Seaside Heights,NJ ,USA","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497962968457297925"},{"id":"62116349","username":"PrescribingPrac","profile_image_url":"https://pbs.twimg.com/profile_images/1083042614037889024/Soi3qeoJ_normal.jpg","verified":false,"name":"Journal of Prescribing Practice","description":"The peer-reviewed, multidisciplinary journal for all non-medical prescribers","protected":false,"created_at":"2009-08-01T20:54:36.000Z","public_metrics":{"followers_count":4187,"following_count":858,"tweet_count":2137,"listed_count":48},"url":"https://t.co/TlaFCtq10i","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TlaFCtq10i","expanded_url":"https://www.prescribingpractice.com/","display_url":"prescribingpractice.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1490629165418229762"},{"id":"432519961","username":"Unclean__","profile_image_url":"https://pbs.twimg.com/profile_images/1233629037320425473/pNUyQIan_normal.jpg","verified":false,"name":"Unclean","description":"Designed to be Buried - Official Fucking Beast of @sheep_destroyer - he/him - #FriedBarry Evangelist","protected":false,"created_at":"2011-12-09T13:48:37.000Z","public_metrics":{"followers_count":648,"following_count":4192,"tweet_count":13617,"listed_count":6},"url":"https://t.co/zw7PRY0Epz","location":"Kansas","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/zw7PRY0Epz","expanded_url":"http://forums.somethingawful.com","display_url":"forums.somethingawful.com"}]},"description":{"mentions":[{"start":50,"end":66,"username":"sheep_destroyer"}],"hashtags":[{"start":78,"end":89,"tag":"FriedBarry"}],"urls":{}}}},{"id":"434758377","username":"HSVhayatsaglik","profile_image_url":"https://pbs.twimg.com/profile_images/1334567294110994448/8dB3lH9A_normal.jpg","verified":false,"name":"Hayatsağlık Dergisi","description":"Sağlık ve Sosyal Bilimler Dergisi hayatsaglikdergisi@hayatvakfi.org.tr","protected":false,"created_at":"2011-12-12T08:28:01.000Z","public_metrics":{"followers_count":736,"following_count":169,"tweet_count":762,"listed_count":4},"url":"https://t.co/0EwYinBsVp","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0EwYinBsVp","expanded_url":"http://hayatsaglik.hayatvakfi.org.tr/son-sayimiz/","display_url":"hayatsaglik.hayatvakfi.org.tr/son-sayimiz/"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1257025042040467456"},{"id":"1159798933","username":"KerryCasting","profile_image_url":"https://pbs.twimg.com/profile_images/1045608184432463872/-VXjOA_U_normal.jpg","verified":false,"name":"KerryTVProducer","description":"Casting Producer on new adult literacy programme for Shine TV.\nEmail spell@shine.tv for info","protected":false,"created_at":"2013-02-08T10:30:48.000Z","public_metrics":{"followers_count":1342,"following_count":1620,"tweet_count":5565,"listed_count":13},"url":"","location":"London, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"166942410","username":"ITVWales","profile_image_url":"https://pbs.twimg.com/profile_images/1166284135004028928/XxWv5YUy_normal.jpg","verified":true,"name":"ITV Wales News","description":"The latest news, sport & entertainment for Wales. Contact us: wales@itv.com - https://t.co/p0kGsvP13M - https://t.co/nDcD2LUq2d","protected":false,"created_at":"2010-07-15T10:59:09.000Z","public_metrics":{"followers_count":106138,"following_count":1527,"tweet_count":74952,"listed_count":679},"url":"http://t.co/CkDL0Cne9s","location":"Wales","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/CkDL0Cne9s","expanded_url":"http://itv.com/wales","display_url":"itv.com/wales"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":78,"end":101,"url":"https://t.co/p0kGsvP13M","expanded_url":"http://facebook.com/itvwales/","display_url":"facebook.com/itvwales/"},{"start":104,"end":127,"url":"https://t.co/nDcD2LUq2d","expanded_url":"http://instagram.com/itvwales","display_url":"instagram.com/itvwales"}]}}},{"id":"340331522","username":"BelenZafra","profile_image_url":"https://pbs.twimg.com/profile_images/988866272589963265/mNRgwEs__normal.jpg","verified":false,"name":"ASanfilippoBarcelona","description":"","protected":false,"created_at":"2011-07-22T14:41:39.000Z","public_metrics":{"followers_count":1044,"following_count":2636,"tweet_count":3925,"listed_count":13},"url":"https://t.co/50O0mMTj49","location":"Barcelona (Spain)","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/50O0mMTj49","expanded_url":"http://www.sanfilippobcn.es","display_url":"sanfilippobcn.es"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"318743706","username":"emilycfreeman","profile_image_url":"https://pbs.twimg.com/profile_images/1487476742373658624/RZqVRAMl_normal.jpg","verified":false,"name":"Emily Freeman, MSc, PhD 🇨🇦🇺🇸","description":"Social/behavioral scientist & meteorologist. Patient Focused Drug Development. Endometriosis Advocacy. Opinions are my own. #HailState #MissStateAlumni 🏳️‍🌈","protected":false,"created_at":"2011-06-17T00:05:59.000Z","public_metrics":{"followers_count":1100,"following_count":623,"tweet_count":16564,"listed_count":0},"url":"","location":"Carmel, IN","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":124,"end":134,"tag":"HailState"},{"start":135,"end":151,"tag":"MissStateAlumni"}],"urls":{}}}},{"id":"525474752","username":"MMGHealth","profile_image_url":"https://pbs.twimg.com/profile_images/1440331786362310656/-gfwzzjH_normal.jpg","verified":false,"name":"MMG","description":"Leaders in public health communications and clinical trial recruitment #PublicHealth #PatientRecruitment #ClinicalTrials #patientengagement","protected":false,"created_at":"2012-03-15T15:35:09.000Z","public_metrics":{"followers_count":590,"following_count":320,"tweet_count":2448,"listed_count":33},"url":"https://t.co/kbbhIigYNd","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/kbbhIigYNd","expanded_url":"http://mmgct.com","display_url":"mmgct.com"}]},"description":{"mentions":{},"hashtags":[{"start":71,"end":84,"tag":"PublicHealth"},{"start":85,"end":104,"tag":"PatientRecruitment"},{"start":105,"end":120,"tag":"ClinicalTrials"},{"start":121,"end":139,"tag":"patientengagement"}],"urls":{}}},"pinned_tweet_id":"1281586344482013185"},{"id":"261573281","username":"mmadurga","profile_image_url":"https://pbs.twimg.com/profile_images/1380151738196459528/rbFfYoWN_normal.jpg","verified":false,"name":"Mariano Madurga","description":"Sanitario, experto en farmacovigilancia, tranquilo, sencillo, amigo de sus amigos y de sus enemigos","protected":false,"created_at":"2011-03-06T06:43:34.000Z","public_metrics":{"followers_count":1566,"following_count":1822,"tweet_count":9678,"listed_count":29},"url":"","location":"Madrid, España/Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"982666808","username":"Justice4Faroque","profile_image_url":"https://pbs.twimg.com/profile_images/3021413658/9170ea506e800523fd71da125f530a4c_normal.jpeg","verified":false,"name":"Justice4DrFaroque","description":"PhD in Actuarial Science (City University), Teacher, Loving Father and Grandfather","protected":false,"created_at":"2012-12-01T14:35:26.000Z","public_metrics":{"followers_count":7,"following_count":133,"tweet_count":327,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2254792730","username":"CDeRede","profile_image_url":"https://pbs.twimg.com/profile_images/561111961971081216/0dCUBYl3_normal.jpeg","verified":false,"name":"Camille DR ϟ","description":"Communications Expert for @EU_SRB - 🇪🇺Agency. #Banking #EU #Digital #SocialMedia #Tech #Travels #Photography - Tweets are My Own (& mostly nerdy) 🇧🇪","protected":false,"created_at":"2013-12-20T10:06:32.000Z","public_metrics":{"followers_count":877,"following_count":721,"tweet_count":1792,"listed_count":22},"url":"https://t.co/RbIqg8GFJn","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RbIqg8GFJn","expanded_url":"http://www.linkedin.com/in/camillederede","display_url":"linkedin.com/in/camilledere…"}]},"description":{"mentions":[{"start":26,"end":33,"username":"EU_SRB"}],"hashtags":[{"start":46,"end":54,"tag":"Banking"},{"start":55,"end":58,"tag":"EU"},{"start":59,"end":67,"tag":"Digital"},{"start":68,"end":80,"tag":"SocialMedia"},{"start":81,"end":86,"tag":"Tech"},{"start":87,"end":95,"tag":"Travels"},{"start":96,"end":108,"tag":"Photography"}],"urls":{}}}},{"id":"19982434","username":"rarediseaseday","profile_image_url":"https://pbs.twimg.com/profile_images/1355077533553680390/MqIWPy9F_normal.png","verified":false,"name":"Rare Disease Day","description":"28 February 2022 is Rare Disease Day. Raising awareness for patients, families and carers around the world that are affected by rare diseases. #RareDiseaseDay","protected":false,"created_at":"2009-02-03T16:44:43.000Z","public_metrics":{"followers_count":39380,"following_count":3519,"tweet_count":2038,"listed_count":479},"url":"https://t.co/7Ijl6jH6gu","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7Ijl6jH6gu","expanded_url":"http://www.rarediseaseday.org","display_url":"rarediseaseday.org"}]},"description":{"mentions":{},"hashtags":[{"start":143,"end":158,"tag":"RareDiseaseDay"}],"urls":{}}}},{"id":"274030199","username":"rarediseaseuk","profile_image_url":"https://pbs.twimg.com/profile_images/1346027276346007552/DHf4Qjo2_normal.jpg","verified":false,"name":"Rare Disease UK","description":"National campaign run by @GeneticAll_UK to improve the lives of those affected by rare conditions and all who support them #RareDisease. Monitored weekdays 9-5.","protected":false,"created_at":"2011-03-29T15:57:09.000Z","public_metrics":{"followers_count":21217,"following_count":2193,"tweet_count":16498,"listed_count":306},"url":"https://t.co/0Os4YEqeWT","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0Os4YEqeWT","expanded_url":"http://www.raredisease.org.uk/","display_url":"raredisease.org.uk"}]},"description":{"mentions":[{"start":25,"end":39,"username":"GeneticAll_UK"}],"hashtags":[{"start":123,"end":135,"tag":"RareDisease"}],"urls":{}}},"pinned_tweet_id":"1498214256512315392"},{"id":"413849446","username":"GeneticAll_UK","profile_image_url":"https://pbs.twimg.com/profile_images/1346027149371834368/IbA4l8U6_normal.jpg","verified":false,"name":"Genetic Alliance UK","description":"National charity working for everyone affected by genetic, rare and undiagnosed conditions. We run the campaign @rarediseaseuk and support network @SWAN_UK.","protected":false,"created_at":"2011-11-16T10:07:51.000Z","public_metrics":{"followers_count":14774,"following_count":2182,"tweet_count":18341,"listed_count":216},"url":"https://t.co/mGSf3EEsi6","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/mGSf3EEsi6","expanded_url":"http://www.geneticalliance.org.uk","display_url":"geneticalliance.org.uk"}]},"description":{"mentions":[{"start":112,"end":126,"username":"rarediseaseuk"},{"start":147,"end":155,"username":"SWAN_UK"}],"hashtags":{},"urls":{}}}},{"id":"330993102","username":"MHRAgovuk","profile_image_url":"https://pbs.twimg.com/profile_images/1359177868870311936/ooRMF1mW_normal.jpg","verified":true,"name":"MHRAgovuk","description":"The MHRA is a global leader in protecting and improving public health and supporting innovation through scientific research and development.","protected":false,"created_at":"2011-07-07T13:47:46.000Z","public_metrics":{"followers_count":29459,"following_count":541,"tweet_count":5190,"listed_count":314},"url":"http://t.co/Ec7fWJf5Zu","location":"United Kingdom","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Ec7fWJf5Zu","expanded_url":"http://gov.uk/mhra","display_url":"gov.uk/mhra"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484528605849862146"},{"id":"250163834","username":"JanetWilliams99","profile_image_url":"https://pbs.twimg.com/profile_images/1465462297728626695/Od6MvFXJ_normal.jpg","verified":false,"name":"janet williams  INFACT","description":"Co-Founder of National Trust & Reg charity for AEDs in Pregnancy, campaigner, lobbyist, songwriter & Supermum..!! These are my personal views #valproatecrisis","protected":false,"created_at":"2011-02-10T15:10:42.000Z","public_metrics":{"followers_count":624,"following_count":1115,"tweet_count":19796,"listed_count":28},"url":"https://t.co/6akbPHWv9q","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6akbPHWv9q","expanded_url":"http://www.infactuk.com","display_url":"infactuk.com"}]},"description":{"mentions":{},"hashtags":[{"start":142,"end":158,"tag":"valproatecrisis"}],"urls":{}}},"pinned_tweet_id":"1491756309066223621"},{"id":"277466861","username":"Emma4facs","profile_image_url":"https://pbs.twimg.com/profile_images/1475965222175264777/OB0lxnGi_normal.jpg","verified":false,"name":"Emma Murphy (INFACT) ☘️💕😘🦋","description":"Official Campaign & Trust @Infactuk for AEDs in Pregnancy🤰#epilepsy Mum of 6 diagnosed with FVSD 💊 Award Winning Campaigner 🏆🏆 #Valproatecrisis","protected":false,"created_at":"2011-04-05T12:43:19.000Z","public_metrics":{"followers_count":3636,"following_count":5000,"tweet_count":114433,"listed_count":125},"url":"https://t.co/hwin8axImt","location":"Manchester/London/Worldwide ","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hwin8axImt","expanded_url":"http://www.infactuk.com","display_url":"infactuk.com"}]},"description":{"mentions":[{"start":26,"end":35,"username":"Infactuk"}],"hashtags":[{"start":58,"end":67,"tag":"epilepsy"},{"start":127,"end":143,"tag":"Valproatecrisis"}],"urls":{}}},"pinned_tweet_id":"1282265702775259138"},{"id":"51282370","username":"BioMarin","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"BioMarin","description":"","protected":false,"created_at":"2009-06-27T00:03:06.000Z","public_metrics":{"followers_count":344,"following_count":0,"tweet_count":0,"listed_count":13},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"380500399","username":"redacre","profile_image_url":"https://pbs.twimg.com/profile_images/893112881008463872/Zitiyh_B_normal.jpg","verified":false,"name":"Red Acre Investments","description":"Binary Event Specialists & Fund Managers, Macro-trend Analysis.  Get Ahead of the Curve with our Actionable Analysis: Subscribe at http://t.co/v7P2mXJP","protected":false,"created_at":"2011-09-26T19:11:09.000Z","public_metrics":{"followers_count":5852,"following_count":599,"tweet_count":21889,"listed_count":138},"url":"http://t.co/Cdv01739TD","location":"Connecticut","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Cdv01739TD","expanded_url":"http://www.redacre.com","display_url":"redacre.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":131,"end":151,"url":"http://t.co/v7P2mXJP","expanded_url":"http://www.redacre.com","display_url":"redacre.com"}]}}},{"id":"1171477128","username":"BegoLopezGo","profile_image_url":"https://pbs.twimg.com/profile_images/678334233191030784/qblkGkzf_normal.jpg","verified":false,"name":"Begoña López","description":"","protected":false,"created_at":"2013-02-12T09:54:03.000Z","public_metrics":{"followers_count":143,"following_count":228,"tweet_count":437,"listed_count":24},"url":"https://t.co/ssn4HAVvHh","location":"MADRID","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ssn4HAVvHh","expanded_url":"http://www.linkedin.com/in/begolopez1","display_url":"linkedin.com/in/begolopez1"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"224614927","username":"SusanWer","profile_image_url":"https://pbs.twimg.com/profile_images/970960336663777285/ZZZ6cadE_normal.jpg","verified":false,"name":"Susanne Karin Werner","description":"Advisor in strategic communication. Passionate about volunteering @OsloRodeKors Resource Center for Youth #Groruddalen #Fellesverket","protected":false,"created_at":"2010-12-09T12:41:28.000Z","public_metrics":{"followers_count":1209,"following_count":2436,"tweet_count":1715,"listed_count":37},"url":"https://t.co/O4BKFwU6fJ","location":"Oslo, Norway","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/O4BKFwU6fJ","expanded_url":"https://www.linkedin.com/in/susannekwerner/","display_url":"linkedin.com/in/susannekwer…"}]},"description":{"mentions":[{"start":66,"end":79,"username":"OsloRodeKors"}],"hashtags":[{"start":106,"end":118,"tag":"Groruddalen"},{"start":119,"end":132,"tag":"Fellesverket"}],"urls":{}}}},{"id":"267831890","username":"ampariu","profile_image_url":"https://pbs.twimg.com/profile_images/1870485251/359_29575888642_748548642_844337_7258_n_normal.jpg","verified":false,"name":"Amparo Iraola Lliso","description":"Castelló 1975. Médico de Familia y Oncóloga en la Fundación Instituto Valenciano de Oncologia (FIVO) Adicciones incurables: lectura/escritura/viajes","protected":false,"created_at":"2011-03-17T16:36:01.000Z","public_metrics":{"followers_count":1745,"following_count":1519,"tweet_count":12061,"listed_count":0},"url":"https://t.co/cAoEZoChS5","location":"Valencia, España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cAoEZoChS5","expanded_url":"http://wwwlabelleechape.blogspot.com/","display_url":"wwwlabelleechape.blogspot.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"555051765","username":"_SEOM","profile_image_url":"https://pbs.twimg.com/profile_images/1361302838404595716/vip6ZIWW_normal.jpg","verified":true,"name":"SEOM","description":"Somos una sociedad científica, referente en cáncer. Nuestra misión: mejorar la prevención, el diagnóstico, el tratamiento y el seguimiento del cáncer.","protected":false,"created_at":"2012-04-16T08:38:44.000Z","public_metrics":{"followers_count":29986,"following_count":2000,"tweet_count":28104,"listed_count":537},"url":"https://t.co/3CxDC5u3K9","location":"Spanje","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3CxDC5u3K9","expanded_url":"http://www.seom.org","display_url":"seom.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497131842557861912"},{"id":"1193633406","username":"CRCTU","profile_image_url":"https://pbs.twimg.com/profile_images/1489603298109890563/bcX7Ocd3_normal.jpg","verified":false,"name":"Birmingham Cancer Research UK Clinical Trials Unit","description":"@CR_UK Clinical Trials Unit @unibirmingham is one of largest UK units running phase I-III adult & paediatric trials including @Tap_Clin_Trials @impactstemcell","protected":false,"created_at":"2013-02-18T15:44:45.000Z","public_metrics":{"followers_count":1955,"following_count":625,"tweet_count":2069,"listed_count":0},"url":"https://t.co/TL3NlVuhUx","location":"University of Birmingham","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TL3NlVuhUx","expanded_url":"http://www.birmingham.ac.uk/CRCTU","display_url":"birmingham.ac.uk/CRCTU"}]},"description":{"mentions":[{"start":0,"end":6,"username":"CR_UK"},{"start":28,"end":42,"username":"unibirmingham"},{"start":126,"end":142,"username":"Tap_Clin_Trials"},{"start":143,"end":158,"username":"impactstemcell"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1489552533731389441"},{"id":"53023973","username":"uicc","profile_image_url":"https://pbs.twimg.com/profile_images/1116646002763665408/uYP9DxpE_normal.png","verified":false,"name":"Union for International Cancer Control","description":"Uniting the cancer community to reduce the #globalcancer burden, promote #equity, & ensure #cancercontrol remains a priority in the #health & dev agenda","protected":false,"created_at":"2009-07-02T10:06:16.000Z","public_metrics":{"followers_count":19033,"following_count":1922,"tweet_count":12292,"listed_count":297},"url":"https://t.co/8Hx4YxDGgT","location":"Geneva, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8Hx4YxDGgT","expanded_url":"http://www.uicc.org","display_url":"uicc.org"}]},"description":{"mentions":{},"hashtags":[{"start":43,"end":56,"tag":"globalcancer"},{"start":73,"end":80,"tag":"equity"},{"start":91,"end":105,"tag":"cancercontrol"},{"start":132,"end":139,"tag":"health"}],"urls":{}}}},{"id":"1030110686","username":"docjavip","profile_image_url":"https://pbs.twimg.com/profile_images/1201576694743781380/Jcw-XGqw_normal.jpg","verified":false,"name":"Javier Puente","description":"Medical oncologist. Clinical researcher focused in GU tumors. Director Institute of Oncology. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain","protected":false,"created_at":"2012-12-23T08:00:23.000Z","public_metrics":{"followers_count":2852,"following_count":848,"tweet_count":4668,"listed_count":68},"url":"","location":"Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"65594160","username":"giasison","profile_image_url":"https://pbs.twimg.com/profile_images/1446076589419085827/o0uVWCsG_normal.jpg","verified":true,"name":"Dr. Gia Sison","description":"Doctor. Host. MH Advocate. Breast CA Survivor. PH Leader Livestrong Foundation. Co-Founder #HealthXPh. G Talks Host, https://t.co/HaIEFdp7q3 / giasison@gmail.com","protected":false,"created_at":"2009-08-14T08:29:54.000Z","public_metrics":{"followers_count":160645,"following_count":4722,"tweet_count":141073,"listed_count":865},"url":"https://t.co/yTqZLxNJvo","location":"Manila, Philippines","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yTqZLxNJvo","expanded_url":"http://padayonph.com","display_url":"padayonph.com"}]},"description":{"mentions":{},"hashtags":[{"start":91,"end":101,"tag":"HealthXPh"}],"urls":[{"start":117,"end":140,"url":"https://t.co/HaIEFdp7q3","expanded_url":"http://cnn.ph","display_url":"cnn.ph"}]}},"pinned_tweet_id":"1321760087988264961"},{"id":"65461631","username":"wild_diva","profile_image_url":"https://pbs.twimg.com/profile_images/1438232611567067136/1mJ2kYo4_normal.jpg","verified":false,"name":"Eddy Verónica Mora","description":"I'm a Pathologist. I left my Hospital IOMPC. No Surgery, no radiotherapy. #SOSVenezuela","protected":false,"created_at":"2009-08-13T20:39:39.000Z","public_metrics":{"followers_count":1740,"following_count":1248,"tweet_count":66949,"listed_count":0},"url":"","location":"Venezuela","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":74,"end":87,"tag":"SOSVenezuela"}],"urls":{}}},"pinned_tweet_id":"1437381256875069442"},{"id":"31432586","username":"_M_Masa","profile_image_url":"https://pbs.twimg.com/profile_images/1214425640/avatar_marc_normal.jpg","verified":false,"name":"Marc Masa","description":"Health & Biomedicine Department Head at Leitat. -Opinions are my own-","protected":false,"created_at":"2009-04-15T15:25:14.000Z","public_metrics":{"followers_count":647,"following_count":991,"tweet_count":4438,"listed_count":51},"url":"https://t.co/qnNAy4qZtx","location":"Barcelona, Catalunya","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/qnNAy4qZtx","expanded_url":"https://es.linkedin.com/in/marcmasa","display_url":"es.linkedin.com/in/marcmasa"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"30891529","username":"ONAcom","profile_image_url":"https://pbs.twimg.com/profile_images/1471220620205690883/tzHaSFE-_normal.jpg","verified":false,"name":"OncologyNurseAdvisor","description":"Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.","protected":false,"created_at":"2009-04-13T16:01:25.000Z","public_metrics":{"followers_count":4253,"following_count":307,"tweet_count":16422,"listed_count":125},"url":"https://t.co/0efvi93XcR","location":"New York, NY","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0efvi93XcR","expanded_url":"http://www.oncologynurseadvisor.com/","display_url":"oncologynurseadvisor.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"847536019","username":"CASMIorg","profile_image_url":"https://pbs.twimg.com/profile_images/1177604466629140480/miEQapls_normal.jpg","verified":false,"name":"CASMI","description":"The Collaboration for the Advancement of Sustainable Medical Innovation aims to develop better and more sustainable means of effecting medical innovation","protected":false,"created_at":"2012-09-26T14:43:47.000Z","public_metrics":{"followers_count":569,"following_count":484,"tweet_count":839,"listed_count":19},"url":"https://t.co/LfjDx7eZUk","location":"UCL","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LfjDx7eZUk","expanded_url":"http://www.ucl.ac.uk/slms/research/casmi","display_url":"ucl.ac.uk/slms/research/…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2198604157","username":"AdriausWorld","profile_image_url":"https://pbs.twimg.com/profile_images/433025931167289344/GpNxluTK_normal.jpeg","verified":false,"name":"AdrianaStefancic","description":"","protected":false,"created_at":"2013-11-17T00:00:43.000Z","public_metrics":{"followers_count":12,"following_count":19,"tweet_count":38,"listed_count":0},"url":"http://t.co/OA0pIJbBge","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OA0pIJbBge","expanded_url":"http://adriaus.com","display_url":"adriaus.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"49340629","username":"thechris73","profile_image_url":"https://pbs.twimg.com/profile_images/1300473110882390016/baRq3B-V_normal.jpg","verified":false,"name":"Chris Thubron","description":"Dad of 3 passionate about tech,running and recovery since 05/01/2016 #wedorecover #recovery #odatt","protected":false,"created_at":"2009-06-21T15:28:38.000Z","public_metrics":{"followers_count":489,"following_count":1862,"tweet_count":1337,"listed_count":0},"url":"https://t.co/GslMKP7znE","location":"Washington Tyne and Wear UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GslMKP7znE","expanded_url":"https://www.strava.com/athletes/55220748","display_url":"strava.com/athletes/55220…"}]},"description":{"mentions":{},"hashtags":[{"start":69,"end":81,"tag":"wedorecover"},{"start":82,"end":91,"tag":"recovery"},{"start":92,"end":98,"tag":"odatt"}],"urls":{}}}},{"id":"1242516320","username":"PharmaExpertise","profile_image_url":"https://pbs.twimg.com/profile_images/3339928235/a3cf62ebbafbef02c100d17b062ff30a_normal.png","verified":false,"name":"PharmaExpertise","description":"PharmaExpertise is the proactive online community for pharma-biotech industry news and careers for life science professionals.","protected":false,"created_at":"2013-03-05T00:30:18.000Z","public_metrics":{"followers_count":198,"following_count":105,"tweet_count":2773,"listed_count":36},"url":"http://t.co/i7w44IlCLS","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/i7w44IlCLS","expanded_url":"http://www.pharmaexpertise.com","display_url":"pharmaexpertise.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"514255564","username":"QPQuandary","profile_image_url":"https://pbs.twimg.com/profile_images/2840697714/9645fba30104ca233c120f21e6f04745_normal.png","verified":false,"name":"Alex Hall💙","description":"QPQuandary Training Solutions offers a bespoke service to the pharma industry, for Qualified Person training. All opinions are my own.","protected":false,"created_at":"2012-03-04T11:50:45.000Z","public_metrics":{"followers_count":441,"following_count":171,"tweet_count":9878,"listed_count":37},"url":"https://t.co/7vTDMynHgL","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7vTDMynHgL","expanded_url":"http://www.QPQuandary.com","display_url":"QPQuandary.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"377336516","username":"PierrikFaure","profile_image_url":"https://pbs.twimg.com/profile_images/547916393908535297/3UDno1JQ_normal.jpeg","verified":false,"name":"Faure pierrik","description":"#teamchaman #teamhomeo #teamosteo #teametjerro #teammagie  #teamteam","protected":false,"created_at":"2011-09-21T12:21:59.000Z","public_metrics":{"followers_count":426,"following_count":544,"tweet_count":3227,"listed_count":10},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":0,"end":11,"tag":"teamchaman"},{"start":12,"end":22,"tag":"teamhomeo"},{"start":23,"end":33,"tag":"teamosteo"},{"start":34,"end":46,"tag":"teametjerro"},{"start":47,"end":57,"tag":"teammagie"},{"start":59,"end":68,"tag":"teamteam"}],"urls":{}}}},{"id":"51445321","username":"ANDREAFERRAIOLO","profile_image_url":"https://pbs.twimg.com/profile_images/1328088973537906691/tE5glGun_normal.jpg","verified":false,"name":"ANDREA FERRAIOLO","description":"I 'm Pharmacist and i work in Gsk Medical Affair.These views are my own and do not necessarily reflect the views of GSK","protected":false,"created_at":"2009-06-27T14:02:36.000Z","public_metrics":{"followers_count":262,"following_count":713,"tweet_count":3899,"listed_count":13},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"830901563543711744"},{"id":"286245228","username":"juanhidal","profile_image_url":"https://pbs.twimg.com/profile_images/597055554306048000/fmOr0FD9_normal.jpg","verified":false,"name":"Juan Hidalgo Cabrera","description":"“Se puede llegar al mismo sitio de formas distintas” #Farmacéutico #FarmaciaHospital","protected":false,"created_at":"2011-04-22T16:33:43.000Z","public_metrics":{"followers_count":611,"following_count":681,"tweet_count":3545,"listed_count":24},"url":"","location":"Lucena, Córdoba. Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":53,"end":66,"tag":"Farmacéutico"},{"start":67,"end":84,"tag":"FarmaciaHospital"}],"urls":{}}}},{"id":"2208098471","username":"EspinCano","profile_image_url":"https://pbs.twimg.com/profile_images/378800000834032936/4cf91c749a89707625f647e9d3ba78d3_normal.jpeg","verified":false,"name":"Cristina Cano ","description":"Tecnico de Farmacia del Hospital de Jerez","protected":false,"created_at":"2013-12-05T00:17:02.000Z","public_metrics":{"followers_count":53,"following_count":113,"tweet_count":30,"listed_count":0},"url":"","location":"Hospital de Jerez","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"914462377","username":"sefh_","profile_image_url":"https://pbs.twimg.com/profile_images/875695863267557378/wAJmcQOY_normal.jpg","verified":false,"name":"S.E.F.H","description":"Sociedad Española de Farmacia Hospitalaria, SEFH.\n\nPolítica de privacidad ➡️ https://t.co/69mnkTxXo5","protected":false,"created_at":"2012-10-30T11:43:26.000Z","public_metrics":{"followers_count":22451,"following_count":533,"tweet_count":25265,"listed_count":344},"url":"http://t.co/AJLNPY7rRm","location":"C/ Serrano, 40 – 2º Dcha. 28001 Madrid","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/AJLNPY7rRm","expanded_url":"http://www.sefh.es","display_url":"sefh.es"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":77,"end":100,"url":"https://t.co/69mnkTxXo5","expanded_url":"http://ow.ly/Bqxk50C2qZP","display_url":"ow.ly/Bqxk50C2qZP"}]}},"pinned_tweet_id":"1498200841815212035"},{"id":"328653957","username":"SynergyVision","profile_image_url":"https://pbs.twimg.com/profile_images/1153333162178678785/8B6j1OB4_normal.jpg","verified":false,"name":"Synergy Vision","description":"Synergy Vision | award winning agency | delivering the difference in medical communications | Fresh. Smart. Open. Real. |","protected":false,"created_at":"2011-07-03T19:44:27.000Z","public_metrics":{"followers_count":973,"following_count":1759,"tweet_count":2538,"listed_count":34},"url":"http://t.co/OlAJSp7BpU","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OlAJSp7BpU","expanded_url":"http://www.synergy-vision.com","display_url":"synergy-vision.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1367076329267601410"},{"id":"16947313","username":"trished","profile_image_url":"https://pbs.twimg.com/profile_images/1006242945236918272/jPLFvR93_normal.jpg","verified":false,"name":"Trish Groves","description":"Traveller, optimist, sceptic, retired medical journal editor ORCID 0000-0001-7915-6419","protected":false,"created_at":"2008-10-24T10:52:31.000Z","public_metrics":{"followers_count":9846,"following_count":1767,"tweet_count":32009,"listed_count":339},"url":"https://t.co/GxawoU0hYo","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GxawoU0hYo","expanded_url":"https://uk.linkedin.com/in/trishgroves","display_url":"uk.linkedin.com/in/trishgroves"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"22255878","username":"sTuDiO54x","profile_image_url":"https://pbs.twimg.com/profile_images/3358179519/c9fe58b5447853c9b562441bc1e91954_normal.jpeg","verified":false,"name":"Fab","description":"♫♫ ❝I ♥ ELEKTRO❞ ♫♫ ♂","protected":false,"created_at":"2009-02-28T13:45:06.000Z","public_metrics":{"followers_count":13,"following_count":60,"tweet_count":501,"listed_count":2},"url":"https://t.co/3u5CnPCaEB","location":"Köln [GER/ EU]","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3u5CnPCaEB","expanded_url":"http://facebook.com/sTuDiO54x","display_url":"facebook.com/sTuDiO54x"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2178765794","username":"ZamboninMarco","profile_image_url":"https://pbs.twimg.com/profile_images/378800000864093355/OLrVIYsU_normal.jpeg","verified":false,"name":"Marco Zambonin","description":"Farmacista e Informatore","protected":false,"created_at":"2013-11-06T20:38:13.000Z","public_metrics":{"followers_count":66,"following_count":151,"tweet_count":893,"listed_count":9},"url":"","location":"Padova, Italy","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"220854424","username":"not4every1","profile_image_url":"https://pbs.twimg.com/profile_images/905817654618984449/Xgr4MuF3_normal.jpg","verified":false,"name":"AlbertK","description":"Tra Napoli e Milano; Project Manager Pharma, Appassionato di Politica,Surfer apprendista, Neofita della cucina,Tifoso,Twitter-based,Cosmopolita. #tuttocambia","protected":false,"created_at":"2010-11-29T01:15:41.000Z","public_metrics":{"followers_count":149,"following_count":374,"tweet_count":3021,"listed_count":0},"url":"","location":"Milano, Italia","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":145,"end":157,"tag":"tuttocambia"}],"urls":{}}},"pinned_tweet_id":"845546098433372160"},{"id":"1548804618","username":"louis_ide","profile_image_url":"https://pbs.twimg.com/profile_images/1465701438642819079/4q4uzG7e_normal.jpg","verified":true,"name":"Louis Ide","description":"MD microbiologie, antibioticabeleid & infectiecontrole & nationaal secretaris van N-VA. Auteur ‘Het Project’ & ‘Holy Land’. Niemands meester, niemands knecht.","protected":false,"created_at":"2013-06-26T18:35:21.000Z","public_metrics":{"followers_count":7254,"following_count":960,"tweet_count":17057,"listed_count":143},"url":"https://t.co/ogdSEw90Ok","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ogdSEw90Ok","expanded_url":"https://www.n-va.be/wie-is-wie/louis-ide","display_url":"n-va.be/wie-is-wie/lou…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1258428531656228865"},{"id":"318584391","username":"BCDPIC","profile_image_url":"https://pbs.twimg.com/profile_images/1293228021042692097/JvXh-id2_normal.png","verified":false,"name":"BC Drug and Poison Information Centre","description":"If you suspect you're poisoned, call 1-800-567-8911 or 604-682-5050 in BC and the Yukon to reach a poison expert for help 24/7. Multilingual, fast, free.","protected":false,"created_at":"2011-06-16T18:27:14.000Z","public_metrics":{"followers_count":509,"following_count":237,"tweet_count":3884,"listed_count":23},"url":"https://t.co/NSK76j7kHK","location":"Vancouver, British Columbia","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/NSK76j7kHK","expanded_url":"http://www.dpic.org/","display_url":"dpic.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1374020591511072768"},{"id":"20815041","username":"Roche","profile_image_url":"https://pbs.twimg.com/profile_images/1477333982949826560/_SMvcV5v_normal.png","verified":true,"name":"Roche","description":"Doing now what patients need next! Read our community guidelines: https://t.co/7k1HdbdrYL","protected":false,"created_at":"2009-02-13T22:52:00.000Z","public_metrics":{"followers_count":240334,"following_count":1462,"tweet_count":13532,"listed_count":2810},"url":"https://t.co/Xv8kEDkzYX","location":"Basel, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xv8kEDkzYX","expanded_url":"http://www.roche.com","display_url":"roche.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":66,"end":89,"url":"https://t.co/7k1HdbdrYL","expanded_url":"http://go.roche.com/CG","display_url":"go.roche.com/CG"}]}},"pinned_tweet_id":"1489192047630290946"},{"id":"307539793","username":"al_mercier","profile_image_url":"https://pbs.twimg.com/profile_images/378800000525982772/2181821d035a9dc21dec16d573a31417_normal.jpeg","verified":false,"name":"Mercier Anne-Laure","description":"Re-tweete très bien. \nJournaliste @ContexteESante, ex-@mindHealthfr, bilingue #Légifrance\n🍿 DM ouverts, Signal, Telegram, etc.\nAussi team @SOSMedFrance","protected":false,"created_at":"2011-05-29T20:35:59.000Z","public_metrics":{"followers_count":400,"following_count":1667,"tweet_count":1762,"listed_count":11},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":34,"end":49,"username":"ContexteESante"},{"start":54,"end":67,"username":"mindHealthfr"},{"start":138,"end":151,"username":"SOSMedFrance"}],"hashtags":[{"start":78,"end":89,"tag":"Légifrance"}],"urls":{}}}},{"id":"1339508364","username":"PharmaciendeF","profile_image_url":"https://pbs.twimg.com/profile_images/1183030227104161792/jcThos6m_normal.jpg","verified":false,"name":"Le Pharmacien de France","description":"","protected":false,"created_at":"2013-04-09T15:46:33.000Z","public_metrics":{"followers_count":5005,"following_count":9,"tweet_count":4653,"listed_count":81},"url":"http://t.co/NN0f29nwg6","location":"Paris","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/NN0f29nwg6","expanded_url":"http://www.lepharmaciendefrance.fr","display_url":"lepharmaciendefrance.fr"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1481580368293728257"},{"id":"96485229","username":"s_travis_king","profile_image_url":"https://pbs.twimg.com/profile_images/960005067901427712/I7qFlByr_normal.jpg","verified":false,"name":"Travis King","description":"#InfectiousDiseases PharmD; @OleMissRebels grad. Mississippi ➡️ NOLA. All things Antibiotics, Transplant ID and #SEC sports. @OchsnerID @UQMedicine","protected":false,"created_at":"2009-12-13T04:35:26.000Z","public_metrics":{"followers_count":1051,"following_count":1583,"tweet_count":5794,"listed_count":28},"url":"https://t.co/9D0r9aj1VI","location":"New Orleans, LA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/9D0r9aj1VI","expanded_url":"https://www.researchgate.net/profile/Travis_King","display_url":"researchgate.net/profile/Travis…"}]},"description":{"mentions":[{"start":28,"end":42,"username":"OleMissRebels"},{"start":125,"end":135,"username":"OchsnerID"},{"start":136,"end":147,"username":"UQMedicine"}],"hashtags":[{"start":0,"end":19,"tag":"InfectiousDiseases"},{"start":112,"end":116,"tag":"SEC"}],"urls":{}}},"pinned_tweet_id":"1236451774808100864"},{"id":"362772214","username":"FinansciCenk","profile_image_url":"https://pbs.twimg.com/profile_images/3764152669/aea93214e72bc72e210967dfea16758e_normal.jpeg","verified":false,"name":"FinansciCenk","description":"","protected":false,"created_at":"2011-08-26T23:39:46.000Z","public_metrics":{"followers_count":62,"following_count":363,"tweet_count":774,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"614450788","username":"thedanalyst","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"thedanalyst","description":"","protected":false,"created_at":"2012-06-21T17:30:21.000Z","public_metrics":{"followers_count":83,"following_count":278,"tweet_count":492,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"344763008","username":"Arrrrmatey","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Arrrr Matey","description":"","protected":false,"created_at":"2011-07-29T15:07:49.000Z","public_metrics":{"followers_count":0,"following_count":2,"tweet_count":3,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"423776545","username":"KaiGriebenow","profile_image_url":"https://pbs.twimg.com/profile_images/779460252068515840/1tnzFsHN_normal.jpg","verified":false,"name":"KHG","description":"Biochemistry Professor, Kite Maker, Photographer, Ultramarathon Runner","protected":false,"created_at":"2011-11-28T22:46:03.000Z","public_metrics":{"followers_count":234,"following_count":315,"tweet_count":5117,"listed_count":7},"url":"","location":"Puerto Rico","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"597154294","username":"Masdeutaff","profile_image_url":"https://pbs.twimg.com/profile_images/465808428796219392/rtlmNWAb_normal.jpeg","verified":false,"name":"MigTaff","description":"Looking for clues","protected":false,"created_at":"2012-06-02T06:31:06.000Z","public_metrics":{"followers_count":100,"following_count":229,"tweet_count":446,"listed_count":6},"url":"","location":"Barcelona & Banyoles","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"200109222","username":"JBTrethowan","profile_image_url":"https://pbs.twimg.com/profile_images/1193846046809624577/_yTU6I2Q_normal.jpg","verified":false,"name":"Jonathan Trethowan","description":"Pharma #Regulatory Affairs Professional. Tweets about #healthcare, #regulatory, #biotech, #business and #Cornwall.","protected":false,"created_at":"2010-10-08T13:32:25.000Z","public_metrics":{"followers_count":369,"following_count":226,"tweet_count":1142,"listed_count":11},"url":"https://t.co/gNcsUJFuLQ","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/gNcsUJFuLQ","expanded_url":"https://www.linkedin.com/in/jonathan-trethowan-9399009/","display_url":"linkedin.com/in/jonathan-tr…"}]},"description":{"mentions":{},"hashtags":[{"start":7,"end":18,"tag":"Regulatory"},{"start":54,"end":65,"tag":"healthcare"},{"start":67,"end":78,"tag":"regulatory"},{"start":80,"end":88,"tag":"biotech"},{"start":90,"end":99,"tag":"business"},{"start":104,"end":113,"tag":"Cornwall"}],"urls":{}}}},{"id":"1171771501","username":"Wolf_S_Punk","profile_image_url":"https://pbs.twimg.com/profile_images/3437816264/fb7da1dcb358c416808ba9ded828bbb9_normal.png","verified":false,"name":"Wolfspunk ☠","description":"#Suizid als #Nebenwirkung. #Lariam® (#Mefloquin) von @roche_de Kritische Betrachtung der Umsetzung von Richtlinien zur #Arzneimittelsicherheit @bfarm_de","protected":false,"created_at":"2013-02-12T12:02:42.000Z","public_metrics":{"followers_count":225,"following_count":2017,"tweet_count":3098,"listed_count":0},"url":"http://t.co/Nwgc0hZIpK","location":"Internet","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Nwgc0hZIpK","expanded_url":"http://www.nebenwirkung-suizid.de","display_url":"nebenwirkung-suizid.de"}]},"description":{"mentions":[{"start":53,"end":62,"username":"roche_de"},{"start":143,"end":152,"username":"bfarm_de"}],"hashtags":[{"start":0,"end":7,"tag":"Suizid"},{"start":12,"end":25,"tag":"Nebenwirkung"},{"start":27,"end":34,"tag":"Lariam"},{"start":37,"end":47,"tag":"Mefloquin"},{"start":119,"end":142,"tag":"Arzneimittelsicherheit"}],"urls":{}}},"pinned_tweet_id":"1340008570327330818"},{"id":"223456379","username":"agesnews","profile_image_url":"https://pbs.twimg.com/profile_images/1042678557061906432/CMUKc0oY_normal.jpg","verified":true,"name":"AGES","description":"Österreichische Agentur für Gesundheit und Ernährungssicherheit | Austrian Agency for Health and Food Safety","protected":false,"created_at":"2010-12-06T12:58:47.000Z","public_metrics":{"followers_count":10363,"following_count":693,"tweet_count":5701,"listed_count":116},"url":"http://t.co/2Nyvg7YkJw","location":"Wien","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/2Nyvg7YkJw","expanded_url":"http://www.ages.at","display_url":"ages.at"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"883240026863226886"},{"id":"261643662","username":"tomayates","profile_image_url":"https://pbs.twimg.com/profile_images/911204854072143872/qeUYSvI5_normal.jpg","verified":false,"name":"Tom Yates","description":"Health, politics, chess, outdoor stuff","protected":false,"created_at":"2011-03-06T11:17:17.000Z","public_metrics":{"followers_count":1334,"following_count":1385,"tweet_count":14381,"listed_count":36},"url":"https://t.co/B6krJp4cnz","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/B6krJp4cnz","expanded_url":"https://www.researchgate.net/profile/Tom_Yates","display_url":"researchgate.net/profile/Tom_Ya…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1490735184215486465"},{"id":"1003782248","username":"frosa_farma","profile_image_url":"https://pbs.twimg.com/profile_images/1252929730682269697/-2XPa8ic_normal.jpg","verified":false,"name":"Francisco Rosa","description":"Periodista con vocación social","protected":false,"created_at":"2012-12-11T10:47:41.000Z","public_metrics":{"followers_count":1029,"following_count":1313,"tweet_count":2313,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14648460","username":"Yenenga","profile_image_url":"https://pbs.twimg.com/profile_images/972052702514511872/B1QIe5jS_normal.jpg","verified":false,"name":"Dubididada","description":"","protected":false,"created_at":"2008-05-04T14:36:48.000Z","public_metrics":{"followers_count":56,"following_count":139,"tweet_count":105,"listed_count":0},"url":"","location":"wanna b ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"9751972","username":"GoodOne","profile_image_url":"https://pbs.twimg.com/profile_images/760865832905957377/1G6ThvVw_normal.jpg","verified":false,"name":"Glm.","description":"All false love and affection","protected":false,"created_at":"2007-10-28T11:43:41.000Z","public_metrics":{"followers_count":79,"following_count":262,"tweet_count":324,"listed_count":1},"url":"","location":"Paris","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"16842175","username":"RK_PassingCloud","profile_image_url":"https://pbs.twimg.com/profile_images/1944539967/art_caesar_ap_normal.jpg","verified":false,"name":"RichKEngland","description":"I.T. Cloud guru. Open Source.\r\nPicture is the oldest known bust of Julius Ceaser. He looks how I feel...","protected":false,"created_at":"2008-10-18T19:08:34.000Z","public_metrics":{"followers_count":52,"following_count":276,"tweet_count":1001,"listed_count":5},"url":"http://t.co/Hw8wcfBaxu","location":"Southampton England UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Hw8wcfBaxu","expanded_url":"http://passingclouditservices.com","display_url":"passingclouditservices.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"355424757","username":"Rayafadil","profile_image_url":"https://pbs.twimg.com/profile_images/378800000346991866/c5b4dad69ab50533763fc2666eb87335_normal.jpeg","verified":false,"name":"Raya Fadil","description":"MSc.pharmaceutical Sci-RSC. Love my Family. Proud of my son, love peace,hope and faith. Reading,healthy style & fashion are my passion. Respect +ve thinkers!","protected":false,"created_at":"2011-08-15T10:07:43.000Z","public_metrics":{"followers_count":184,"following_count":554,"tweet_count":1721,"listed_count":9},"url":"","location":"London, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1361869286","username":"UCB_Challenge","profile_image_url":"https://pbs.twimg.com/profile_images/413615629648687105/oyjzduee_normal.png","verified":false,"name":"UCB Challenge","description":"UCB is searching the planet for rare phenotypes (traits or natural abilities), but the planet is a big place so we will need some help!","protected":false,"created_at":"2013-04-18T13:00:07.000Z","public_metrics":{"followers_count":57,"following_count":489,"tweet_count":350,"listed_count":4},"url":"http://t.co/4WaZmyx0iW","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/4WaZmyx0iW","expanded_url":"http://ucbinnovationchallenge.com","display_url":"ucbinnovationchallenge.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"554667907","username":"alljoinjack","profile_image_url":"https://pbs.twimg.com/profile_images/1189843798832095232/IBdSgK7d_normal.jpg","verified":false,"name":"Joining Jack","description":"We are joining Jack in the fight to find a cure for duchenne muscular dystrophy. Will you?","protected":false,"created_at":"2012-04-15T21:55:47.000Z","public_metrics":{"followers_count":65334,"following_count":1762,"tweet_count":19425,"listed_count":74},"url":"https://t.co/iF6KodmXIH","location":"Wigan","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/iF6KodmXIH","expanded_url":"http://www.joiningjack.org","display_url":"joiningjack.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"633978297","username":"jagasquet","profile_image_url":"https://pbs.twimg.com/profile_images/2546173677/by2macf06eid3l83z0eb_normal.jpeg","verified":false,"name":"Jose Antonio Gasquet","description":"Pharmaceutical/Biotechnology Professional focused on Oncology. \r\nOpinions are my own","protected":false,"created_at":"2012-07-12T17:24:56.000Z","public_metrics":{"followers_count":658,"following_count":330,"tweet_count":3162,"listed_count":63},"url":"http://t.co/vp3JIdZzuF","location":"Barcelona, Spain","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/vp3JIdZzuF","expanded_url":"http://es.linkedin.com/in/jagasquet","display_url":"es.linkedin.com/in/jagasquet"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1588972196","username":"HTACanada","profile_image_url":"https://pbs.twimg.com/profile_images/378800000601349581/f997b6fd6156d0dadd7b228389470685_normal.jpeg","verified":false,"name":"HTACanada","description":"Research and insights on HTA in Canada. Join our group on LinkedIn for networking opportunities.","protected":false,"created_at":"2013-07-12T17:14:43.000Z","public_metrics":{"followers_count":1319,"following_count":222,"tweet_count":4276,"listed_count":89},"url":"","location":"Canada","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"261891519","username":"o_halvardo","profile_image_url":"https://pbs.twimg.com/profile_images/1014163538380718080/Q1uyVzSp_normal.jpg","verified":false,"name":"Halvard - Halvari.","description":"Til og med Trond Giske har sin Runkedame han noen ganger er i kontakt med.Fiskerne har fått Radio på Havet. Mat; Man tager en Hval. Lever & Hvalgryte,Synonymer.","protected":false,"created_at":"2011-03-06T22:45:25.000Z","public_metrics":{"followers_count":129,"following_count":2150,"tweet_count":24551,"listed_count":3},"url":"https://t.co/DkbAUt8djU","location":"Skaun, Norge","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/DkbAUt8djU","expanded_url":"https://www.linkedin.com/in/pazqualli-nk-vx-halvard-lea-partisan-98aa11128/","display_url":"linkedin.com/in/pazqualli-n…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"137970368","username":"JillesHeringa","profile_image_url":"https://pbs.twimg.com/profile_images/544393600696455169/Z5QBRDky_normal.jpeg","verified":false,"name":"Jilles Heringa","description":"Communicatie en recht | Gezondheidsrecht | Boeken | Films | Jilles® - Advies in de zorg","protected":false,"created_at":"2010-04-28T08:03:53.000Z","public_metrics":{"followers_count":453,"following_count":341,"tweet_count":3895,"listed_count":10},"url":"https://t.co/LaNnaBgl48","location":"The Hague","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LaNnaBgl48","expanded_url":"http://www.jilles.nu","display_url":"jilles.nu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"294028805","username":"EURLex","profile_image_url":"https://pbs.twimg.com/profile_images/876708307859378178/7YshLWim_normal.jpg","verified":true,"name":"EUR-Lex","description":"The official #EULaw database & home of the EU Official Journal. Tips & tricks with #eurlextip Public service from the Publications Office of the European Union.","protected":false,"created_at":"2011-05-06T12:08:13.000Z","public_metrics":{"followers_count":27651,"following_count":9177,"tweet_count":15632,"listed_count":890},"url":"https://t.co/Xgcz1zkfXx","location":"Luxembourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xgcz1zkfXx","expanded_url":"https://eur-lex.europa.eu","display_url":"eur-lex.europa.eu"}]},"description":{"mentions":{},"hashtags":[{"start":13,"end":19,"tag":"EULaw"},{"start":83,"end":93,"tag":"eurlextip"}],"urls":{}}}},{"id":"71542880","username":"ThePharmaLetter","profile_image_url":"https://pbs.twimg.com/profile_images/1286243845659856897/vbFCz4-e_normal.jpg","verified":false,"name":"The Pharma Letter","description":"Breaking news and analysis for the global pharmaceutical and biotechnology industries","protected":false,"created_at":"2009-09-04T14:07:54.000Z","public_metrics":{"followers_count":22188,"following_count":1959,"tweet_count":18074,"listed_count":533},"url":"http://t.co/jdUQkYartj","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/jdUQkYartj","expanded_url":"http://www.thepharmaletter.com","display_url":"thepharmaletter.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17411532","username":"epilepsyaction","profile_image_url":"https://pbs.twimg.com/profile_images/1474365483776454658/WAl_nUo9_normal.jpg","verified":true,"name":"Epilepsy Action","description":"The UK's leading member-led epilepsy charity, providing information for the 600,000 people with epilepsy in the UK and anyone with an interest in the condition","protected":false,"created_at":"2008-11-15T19:16:43.000Z","public_metrics":{"followers_count":30797,"following_count":2177,"tweet_count":33216,"listed_count":471},"url":"https://t.co/OxabsAjpf2","location":"Leeds, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/OxabsAjpf2","expanded_url":"http://www.epilepsy.org.uk","display_url":"epilepsy.org.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2201973482","username":"SmokinSlimSala","profile_image_url":"https://pbs.twimg.com/profile_images/489833028177248256/bAP4nZtw_normal.jpeg","verified":false,"name":"S Slim-ee Salabiminy","description":"Where the stalk of sensimilla meets the grape vine.","protected":false,"created_at":"2013-11-18T20:58:49.000Z","public_metrics":{"followers_count":28,"following_count":221,"tweet_count":477,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1299643704","username":"EFA_Patients","profile_image_url":"https://pbs.twimg.com/profile_images/1198937001929650176/pmFZo7pu_normal.png","verified":false,"name":"EFA Patients","description":"We are a federation of 42 associations representing allergy, asthma and COPD patients in 25 European countries. Our work pillars: #InformPreventCare","protected":false,"created_at":"2013-03-25T14:16:29.000Z","public_metrics":{"followers_count":2456,"following_count":1120,"tweet_count":5818,"listed_count":98},"url":"https://t.co/gQUBQm2bpr","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/gQUBQm2bpr","expanded_url":"https://efanet.org/inform/youth-parliament","display_url":"efanet.org/inform/youth-p…"}]},"description":{"mentions":{},"hashtags":[{"start":130,"end":148,"tag":"InformPreventCare"}],"urls":{}}},"pinned_tweet_id":"1455831231942340610"},{"id":"1536274003","username":"AlzheimerEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1117717426735652864/nRrKu78A_normal.png","verified":false,"name":"Alzheimer Europe","description":"Non-profit NGO making #dementia a European priority\nGet news https://t.co/K7PH2uUs6i\nConference #32AEC \nOur channels https://t.co/BJJNMlWsQL","protected":false,"created_at":"2013-06-21T10:48:43.000Z","public_metrics":{"followers_count":12810,"following_count":5431,"tweet_count":22630,"listed_count":293},"url":"https://t.co/RCmEWR0fxD","location":"Luxembourg, Luxembourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RCmEWR0fxD","expanded_url":"http://www.alzheimer-europe.org","display_url":"alzheimer-europe.org"}]},"description":{"mentions":{},"hashtags":[{"start":22,"end":31,"tag":"dementia"},{"start":96,"end":102,"tag":"32AEC"}],"urls":[{"start":61,"end":84,"url":"https://t.co/K7PH2uUs6i","expanded_url":"http://bit.ly/AE_news_signup","display_url":"bit.ly/AE_news_signup"},{"start":117,"end":140,"url":"https://t.co/BJJNMlWsQL","expanded_url":"http://linktr.ee/AlzheimerEurope","display_url":"linktr.ee/AlzheimerEurope"}]}},"pinned_tweet_id":"1493198297225441285"},{"id":"300289123","username":"JPNDeurope","profile_image_url":"https://pbs.twimg.com/profile_images/1148535065640611840/nS_jAk3a_normal.png","verified":false,"name":"JPND Research","description":"JPND is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.","protected":false,"created_at":"2011-05-17T14:27:51.000Z","public_metrics":{"followers_count":2520,"following_count":1360,"tweet_count":1373,"listed_count":62},"url":"http://t.co/VeUCLBT39L","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/VeUCLBT39L","expanded_url":"http://www.jpnd.eu","display_url":"jpnd.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"77047226","username":"LV_MPA","profile_image_url":"https://pbs.twimg.com/profile_images/434253778/Lakemedelsverket_normal.jpg","verified":false,"name":"Läkemedelsverket LV","description":"LV arbetar med läkemedel, kosmetika & medicinteknik. 8-18 må-fr svarar Läkemedelsupplysningen på läkemedelsfrågor 0771-46 70 10. Ärenden: registrator@mpa.se","protected":false,"created_at":"2009-09-24T21:30:22.000Z","public_metrics":{"followers_count":6197,"following_count":211,"tweet_count":2753,"listed_count":133},"url":"http://t.co/64KbbhfHCs","location":"Uppsala, Sweden","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/64KbbhfHCs","expanded_url":"http://www.lakemedelsverket.se/","display_url":"lakemedelsverket.se"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1458715946504306689"},{"id":"19394390","username":"FEDER_ONG","profile_image_url":"https://pbs.twimg.com/profile_images/1491699442554126337/j1SvLuN4_normal.png","verified":false,"name":"FEDER","description":"Somos la voz de 3 millones de personas con #enfermedadesraras en España. Representamos a 387 asociaciones de pacientes y a 1.313 patologías poco frecuentes","protected":false,"created_at":"2009-01-23T13:48:35.000Z","public_metrics":{"followers_count":35111,"following_count":8215,"tweet_count":76381,"listed_count":825},"url":"https://t.co/tQ0Tj1drwA","location":"España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/tQ0Tj1drwA","expanded_url":"http://www.enfermedades-raras.org","display_url":"enfermedades-raras.org"}]},"description":{"mentions":{},"hashtags":[{"start":43,"end":61,"tag":"enfermedadesraras"}],"urls":{}}},"pinned_tweet_id":"1498180014281576451"},{"id":"1392501529","username":"INFARMED_IP","profile_image_url":"https://pbs.twimg.com/profile_images/3672803012/f16d5bdb04d2f2dc11f3c41e53c7ea80_normal.jpeg","verified":true,"name":"INFARMED, I. P.","description":"Twiiter oficial do INFARMED, I.P. Pedidos de informação para cimi@infarmed.pt.","protected":false,"created_at":"2013-04-30T16:39:51.000Z","public_metrics":{"followers_count":10061,"following_count":24,"tweet_count":3571,"listed_count":68},"url":"https://t.co/LbGbUn6bK3","location":"Portugal","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LbGbUn6bK3","expanded_url":"http://www.infarmed.pt","display_url":"infarmed.pt"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"105275296","username":"loicrigal","profile_image_url":"https://pbs.twimg.com/profile_images/1102562281764868096/MkU3kM6n_normal.jpg","verified":false,"name":"Dr Loïc Rigal","description":"Doctor in public law @Univ_Paris | Member @instidroitsante @EURORDIS @Assedea | #orphandrugs 🧬 #patientaccess 🦾 #chronicpain 🥲 | #velotaf 🌿| Views my own |","protected":false,"created_at":"2010-01-15T22:27:27.000Z","public_metrics":{"followers_count":422,"following_count":437,"tweet_count":4093,"listed_count":14},"url":"https://t.co/0cmgNd8UAj","location":"French Alps","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0cmgNd8UAj","expanded_url":"http://www.assedea.fr","display_url":"assedea.fr"}]},"description":{"mentions":[{"start":21,"end":32,"username":"Univ_Paris"},{"start":42,"end":58,"username":"instidroitsante"},{"start":59,"end":68,"username":"EURORDIS"},{"start":69,"end":77,"username":"Assedea"}],"hashtags":[{"start":80,"end":92,"tag":"orphandrugs"},{"start":95,"end":109,"tag":"patientaccess"},{"start":112,"end":124,"tag":"chronicpain"},{"start":129,"end":137,"tag":"velotaf"}],"urls":{}}},"pinned_tweet_id":"1252230714239541249"},{"id":"253672396","username":"scalisabelle","profile_image_url":"https://pbs.twimg.com/profile_images/970678120415154179/tb6HP-ln_normal.jpg","verified":false,"name":"IssyScali","description":"Moments & movement creator. Global health comms professional & passionate dance teacher.","protected":false,"created_at":"2011-02-17T18:45:14.000Z","public_metrics":{"followers_count":77,"following_count":172,"tweet_count":860,"listed_count":1},"url":"https://t.co/ExkNuFpsYO","location":"London, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ExkNuFpsYO","expanded_url":"https://www.linkedin.com/in/isabelle-scali-2a34654","display_url":"linkedin.com/in/isabelle-sc…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"40722651","username":"xOneStepBehind","profile_image_url":"https://pbs.twimg.com/profile_images/890225425099743236/jRz0tJ3s_normal.jpg","verified":false,"name":"xOneStepBehind","description":"Biomedical scientist working on finding a cure for cancer, samt vikarierende omsorgsminister. Kritisk_Personell_TM","protected":false,"created_at":"2009-05-17T19:46:26.000Z","public_metrics":{"followers_count":1522,"following_count":2524,"tweet_count":29012,"listed_count":26},"url":"https://t.co/swYgHLaetk","location":"Oslo","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/swYgHLaetk","expanded_url":"http://intoyoureyes.com/blog/","display_url":"intoyoureyes.com/blog/"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"256435789","username":"FarmaMadridAP","profile_image_url":"https://pbs.twimg.com/profile_images/1480454486380449793/k-7ujPhE_normal.jpg","verified":false,"name":"Farmacia Madrid AP","description":"Primary Care Pharmacist, Madrid (Spain) #Farmacéuticos de Atención Primaria del Servicio Madrileño de Salud #Información para profesionales sanitarios.","protected":false,"created_at":"2011-02-23T09:43:24.000Z","public_metrics":{"followers_count":5242,"following_count":426,"tweet_count":19172,"listed_count":0},"url":"","location":"Comunidad de Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":40,"end":54,"tag":"Farmacéuticos"},{"start":108,"end":120,"tag":"Información"}],"urls":{}}},"pinned_tweet_id":"1494626994553819137"},{"id":"1857882480","username":"LeSecretdesR","profile_image_url":"https://pbs.twimg.com/profile_images/378800000448042583/df6f48aaa5ca8b695816b85d4dcda401_normal.jpeg","verified":false,"name":"SecretdesRôtisseurs","description":"A French \u0003restaurant in London’s Canary Wharf serving perfectly cooked \u0003rôtisserie-roasted chicken.","protected":false,"created_at":"2013-09-12T16:47:11.000Z","public_metrics":{"followers_count":234,"following_count":351,"tweet_count":488,"listed_count":12},"url":"http://t.co/Xk7zSG6PN5","location":"37 Westferry circus - E14 8RR","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Xk7zSG6PN5","expanded_url":"http://eatlesecret.co.uk","display_url":"eatlesecret.co.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1566153090","username":"_TomasKB","profile_image_url":"https://pbs.twimg.com/profile_images/1295288542806118400/SLj0iM4Q_normal.jpg","verified":false,"name":"Tomás 😷","description":"SustainableDevelopment Innovation Media Budo Travel Mediterranean","protected":false,"created_at":"2013-07-03T16:35:51.000Z","public_metrics":{"followers_count":360,"following_count":427,"tweet_count":6097,"listed_count":18},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"50802199","username":"Geckoella","profile_image_url":"https://pbs.twimg.com/profile_images/702484199123632128/PplDifxQ_normal.jpg","verified":false,"name":"Jenna // Follow me for TB news & research","description":"I'm an IR Graduate and Digital Marketing Specialist with a passion to help #EndTB. Follow me for everything #Tuberculosis, #AMR, #PublicHealth & #Zoonoses.","protected":false,"created_at":"2009-06-25T22:57:16.000Z","public_metrics":{"followers_count":856,"following_count":1885,"tweet_count":1827,"listed_count":33},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":75,"end":81,"tag":"EndTB"},{"start":108,"end":121,"tag":"Tuberculosis"},{"start":123,"end":127,"tag":"AMR"},{"start":129,"end":142,"tag":"PublicHealth"},{"start":145,"end":154,"tag":"Zoonoses"}],"urls":{}}}},{"id":"73774967","username":"AlecGaffney","profile_image_url":"https://pbs.twimg.com/profile_images/1225168849705848834/54rMiVoS_normal.jpg","verified":false,"name":"Alexander Gaffney","description":"Executive Director, Life Sci @Politico's AgencyIQ. Alum: @PwCUS, @RAPSorg, @umsop. Tweets about #FDA regulation of #Pharma, #MedicalDevice, #Biotech, #Health.","protected":false,"created_at":"2009-09-13T00:52:31.000Z","public_metrics":{"followers_count":7234,"following_count":916,"tweet_count":22421,"listed_count":0},"url":"https://t.co/9nob9FC1nz","location":"Washington, DC","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/9nob9FC1nz","expanded_url":"https://www.agencyiq.com/subscribe-fda-today/","display_url":"agencyiq.com/subscribe-fda-…"}]},"description":{"mentions":[{"start":29,"end":38,"username":"Politico"},{"start":57,"end":63,"username":"PwCUS"},{"start":65,"end":73,"username":"RAPSorg"},{"start":75,"end":81,"username":"umsop"}],"hashtags":[{"start":96,"end":100,"tag":"FDA"},{"start":115,"end":122,"tag":"Pharma"},{"start":124,"end":138,"tag":"MedicalDevice"},{"start":140,"end":148,"tag":"Biotech"},{"start":150,"end":157,"tag":"Health"}],"urls":{}}},"pinned_tweet_id":"963783894595235840"},{"id":"210934369","username":"HenkJanOut","profile_image_url":"https://pbs.twimg.com/profile_images/1416569310877822976/mXgbBwX5_normal.jpg","verified":false,"name":"Henk Jan Out","description":"MD PhD | Chief Scientific Officer Asia-Pacific, Ferring Pharmaceuticals | Author 'Leve het Geneesmiddel!' | Piano | Church Organ | Tweets are my own","protected":false,"created_at":"2010-11-01T20:50:13.000Z","public_metrics":{"followers_count":2881,"following_count":591,"tweet_count":13690,"listed_count":95},"url":"https://t.co/8PjiAGZrQk","location":"Shanghai, China","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8PjiAGZrQk","expanded_url":"http://www.henkjanout.nl","display_url":"henkjanout.nl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"440170995","username":"DGPreece","profile_image_url":"https://pbs.twimg.com/profile_images/716318318831996930/XKvT0_1H_normal.jpg","verified":false,"name":"David Preece","description":"Pharmacist with a passion for all things European. Loves travelling and exploring the world. A midlander working in the North and enjoying the pies!","protected":false,"created_at":"2011-12-18T17:18:04.000Z","public_metrics":{"followers_count":1291,"following_count":2445,"tweet_count":5003,"listed_count":19},"url":"","location":"York, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1455665373240565763"},{"id":"104839524","username":"EPSA_Online","profile_image_url":"https://pbs.twimg.com/profile_images/834078575125024768/TjE_-5l7_normal.jpg","verified":false,"name":"EPSA","description":"European Pharmaceutical Students' Association represents over 100 000 pharmaceutical students from 36 European countries through 42 member associations.","protected":false,"created_at":"2010-01-14T15:21:10.000Z","public_metrics":{"followers_count":5151,"following_count":1013,"tweet_count":5799,"listed_count":75},"url":"https://t.co/lCeTVMvwNs","location":"Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/lCeTVMvwNs","expanded_url":"http://www.epsa-online.org","display_url":"epsa-online.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1489210020671758338"},{"id":"443963165","username":"emsa_europe","profile_image_url":"https://pbs.twimg.com/profile_images/1281294846175608833/xZxJ7FbS_normal.jpg","verified":false,"name":"EMSA","description":"European Medical Students' Association (EMSA) is an organization that represents medical students across Europe.","protected":false,"created_at":"2011-12-22T18:51:18.000Z","public_metrics":{"followers_count":1985,"following_count":240,"tweet_count":3491,"listed_count":40},"url":"https://t.co/DfX3qXoyML","location":"Brussels, Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/DfX3qXoyML","expanded_url":"http://www.emsa-europe.eu","display_url":"emsa-europe.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1600732507","username":"RoshersT","profile_image_url":"https://pbs.twimg.com/profile_images/943465478172872705/Rp1I7DQr_normal.jpg","verified":false,"name":"Roshni Morjaria","description":"Favourite pass time; eating 🧀","protected":false,"created_at":"2013-07-17T11:09:11.000Z","public_metrics":{"followers_count":235,"following_count":436,"tweet_count":3276,"listed_count":4},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"56493220","username":"EUnetHTA","profile_image_url":"https://pbs.twimg.com/profile_images/1384085535694589962/2G5cU-bV_normal.jpg","verified":false,"name":"EUnetHTA","description":"Official account for the European Network for Health Technology Assessment. Retweets are not endorsements.","protected":false,"created_at":"2009-07-13T21:07:32.000Z","public_metrics":{"followers_count":2795,"following_count":194,"tweet_count":1073,"listed_count":37},"url":"","location":"Europe","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"180728609","username":"IAPOvoice","profile_image_url":"https://pbs.twimg.com/profile_images/537914224299626496/jKE63aZ8_normal.png","verified":false,"name":"IAPO","description":"A global alliance representing patients of all nations across all disease areas and promoting patient-centred healthcare across the world.","protected":false,"created_at":"2010-08-20T09:46:24.000Z","public_metrics":{"followers_count":3569,"following_count":1660,"tweet_count":7776,"listed_count":106},"url":"https://t.co/1Y2RCgHRz9","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/1Y2RCgHRz9","expanded_url":"http://www.iapo.org.uk","display_url":"iapo.org.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"432633912","username":"pharmacjw","profile_image_url":"https://pbs.twimg.com/profile_images/718192955752910848/u9mgsLQC_normal.jpg","verified":false,"name":"Christopher Wooden","description":"#Pharma sales & marketing insights. Advising Big Pharma on what works. Work for @IQVIA_global @IQVIA_GMI | views my own. RTs don't = endorsements.","protected":false,"created_at":"2011-12-09T16:20:42.000Z","public_metrics":{"followers_count":1004,"following_count":902,"tweet_count":3783,"listed_count":52},"url":"https://t.co/hqdbWkEaQS","location":"Paris","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hqdbWkEaQS","expanded_url":"https://www.iqvia.com/","display_url":"iqvia.com"}]},"description":{"mentions":[{"start":80,"end":93,"username":"IQVIA_global"},{"start":94,"end":104,"username":"IQVIA_GMI"}],"hashtags":[{"start":0,"end":7,"tag":"Pharma"}],"urls":{}}}},{"id":"59842124","username":"colinpurrington","profile_image_url":"https://pbs.twimg.com/profile_images/1185154205595701248/fPkbqWGn_normal.jpg","verified":false,"name":"colinpurrington","description":"Nature and photography fan.","protected":false,"created_at":"2009-07-24T17:42:53.000Z","public_metrics":{"followers_count":2877,"following_count":714,"tweet_count":17820,"listed_count":73},"url":"https://t.co/APFMz2IkmR","location":"Swarthmore, PA USA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/APFMz2IkmR","expanded_url":"http://colinpurrington.com/","display_url":"colinpurrington.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"829162375","username":"ami89_pharma","profile_image_url":"https://pbs.twimg.com/profile_images/1064259667096993792/HWxA6dE2_normal.jpg","verified":false,"name":"ami89","description":"Pharmacien adjoint. Je dispense donc tu suis - René DesCartes Vitales.","protected":false,"created_at":"2012-09-17T14:23:21.000Z","public_metrics":{"followers_count":1511,"following_count":891,"tweet_count":32451,"listed_count":53},"url":"https://t.co/82ZJZrSqdR","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/82ZJZrSqdR","expanded_url":"http://ami89-pharma.blogspot.fr/","display_url":"ami89-pharma.blogspot.fr"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1482076938424438792"},{"id":"115990590","username":"Pirouette4","profile_image_url":"https://pbs.twimg.com/profile_images/3519647575/3915775476020f925695112e0248328c_normal.jpeg","verified":false,"name":"Pirouette","description":"MG à la campagne.\nG1P3. Maman de Tanguy, Speedy et la Pépine. \nJardinage en été, couture en hiver, et pâtisserie quand il me reste du temps.","protected":false,"created_at":"2010-02-20T18:31:10.000Z","public_metrics":{"followers_count":1481,"following_count":525,"tweet_count":23593,"listed_count":39},"url":"","location":"La tête dans les nuages","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1285591051","username":"FloodBreda","profile_image_url":"https://pbs.twimg.com/profile_images/926884217673474048/WtW-NMdH_normal.jpg","verified":false,"name":"Breda Flood","description":"Teacher still learning.\nAssoc. memb @IPCRG\nFormer President @EFA_Patients\nVolunteer @AsthmaIreland\nH/C Officer @OulartBallagh \nAll views my own","protected":false,"created_at":"2013-03-21T09:58:05.000Z","public_metrics":{"followers_count":976,"following_count":1557,"tweet_count":13316,"listed_count":42},"url":"","location":"Wexford, Ireland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":36,"end":42,"username":"IPCRG"},{"start":60,"end":73,"username":"EFA_Patients"},{"start":84,"end":98,"username":"AsthmaIreland"},{"start":111,"end":125,"username":"OulartBallagh"}],"hashtags":{},"urls":{}}}},{"id":"17485749","username":"karlosponders","profile_image_url":"https://pbs.twimg.com/profile_images/705886024640110593/rJT4ZFs5_normal.jpg","verified":false,"name":"Karl Hamilton","description":"Irish travel lover living in Amsterdam, posting my musings on life, news, politics and technology. All tweets are posted in a personal capacity.","protected":false,"created_at":"2008-11-19T13:35:29.000Z","public_metrics":{"followers_count":163,"following_count":245,"tweet_count":2630,"listed_count":21},"url":"https://t.co/RzDt2cDySu","location":"Amsterdam, Nederland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RzDt2cDySu","expanded_url":"http://karlhamilton.com","display_url":"karlhamilton.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"560986046","username":"RomainCasanova","profile_image_url":"https://pbs.twimg.com/profile_images/378800000484039959/237c3c7c845ed31f5e9d050f56bf0eaa_normal.jpeg","verified":false,"name":"romain casanova","description":"","protected":false,"created_at":"2012-04-23T09:48:18.000Z","public_metrics":{"followers_count":2,"following_count":20,"tweet_count":7,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"53039176","username":"FDA_Drug_Info","profile_image_url":"https://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_normal.jpg","verified":true,"name":"FDA Drug Information","description":"Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - http://t.co/DUce95M3Ty.","protected":false,"created_at":"2009-07-02T11:39:43.000Z","public_metrics":{"followers_count":334535,"following_count":68,"tweet_count":7565,"listed_count":4338},"url":"http://t.co/KF8gl4wGzV","location":"Silver Spring","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/KF8gl4wGzV","expanded_url":"http://www.fda.gov/AboutDDI","display_url":"fda.gov/AboutDDI"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":124,"end":146,"url":"http://t.co/DUce95M3Ty","expanded_url":"http://www.fda.gov/privacy","display_url":"fda.gov/privacy"}]}},"pinned_tweet_id":"1482032594053214209"},{"id":"36329597","username":"Europarl_EN","profile_image_url":"https://pbs.twimg.com/profile_images/1438085505128837121/VIGsR6R-_normal.png","verified":true,"name":"European Parliament","description":"Follow for the latest information from the European Parliament. Account managed by the Parliament's web team. Privacy statement: https://t.co/pgMRBckG2S","protected":false,"created_at":"2009-04-29T10:32:40.000Z","public_metrics":{"followers_count":827075,"following_count":9047,"tweet_count":21544,"listed_count":6590},"url":"https://t.co/kD49qgstGP","location":"Brussels/Strasbourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/kD49qgstGP","expanded_url":"https://www.europarl.europa.eu/news/en","display_url":"europarl.europa.eu/news/en"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":129,"end":152,"url":"https://t.co/pgMRBckG2S","expanded_url":"http://eptwitter.eu/privacy","display_url":"eptwitter.eu/privacy"}]}},"pinned_tweet_id":"1493145567425449988"},{"id":"951333319","username":"EP_Environment","profile_image_url":"https://pbs.twimg.com/profile_images/878207909099966468/NQWrGXMW_normal.jpg","verified":true,"name":"ENVI Committee Press","description":"European Parliament Committee on Environment, Public Health and Food Safety. Managed by Thomas Haahr & Dana Popp. RTs ≠ endorsement.","protected":false,"created_at":"2012-11-16T09:19:50.000Z","public_metrics":{"followers_count":26430,"following_count":444,"tweet_count":3783,"listed_count":824},"url":"https://t.co/EOor1hh5VV","location":"Brussels/Strasbourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/EOor1hh5VV","expanded_url":"http://bit.ly/1nuMkcu","display_url":"bit.ly/1nuMkcu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1495699145985769474"},{"id":"784869524","username":"AIM_Healthcare","profile_image_url":"https://pbs.twimg.com/profile_images/880731060987940865/c98Og85X_normal.jpg","verified":false,"name":"AIM","description":"AIM, The International Association of non-for-profit healthcare payers represents health mutuals and health insurance funds in Europe and in the world.","protected":false,"created_at":"2012-08-27T15:15:12.000Z","public_metrics":{"followers_count":1836,"following_count":1294,"tweet_count":6933,"listed_count":105},"url":"https://t.co/vKDDEF6TTg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/vKDDEF6TTg","expanded_url":"http://www.aim-mutual.org","display_url":"aim-mutual.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1403359865762942977"},{"id":"15536425","username":"edarutechoes","profile_image_url":"https://pbs.twimg.com/profile_images/1298539875688488961/8iiY_hrT_normal.jpg","verified":false,"name":"Emmanuelle Darut - French translation services","description":"Business, Legal & Life Sciences #translation • #French human #translator at Echoes translation •\n🇬🇧 🇪🇦 into 🇨🇵","protected":false,"created_at":"2008-07-22T20:07:44.000Z","public_metrics":{"followers_count":2802,"following_count":911,"tweet_count":6801,"listed_count":126},"url":"https://t.co/i9VjuRvoQC","location":"Woking, Surrey, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/i9VjuRvoQC","expanded_url":"http://www.echoestranslation.com","display_url":"echoestranslation.com"}]},"description":{"mentions":{},"hashtags":[{"start":32,"end":44,"tag":"translation"},{"start":47,"end":54,"tag":"French"},{"start":61,"end":72,"tag":"translator"}],"urls":{}}},"pinned_tweet_id":"1301816279905566721"},{"id":"34651221","username":"healthglobal","profile_image_url":"https://pbs.twimg.com/profile_images/178913770/362929633_152bf73b59_s.jpg_normal.jpeg","verified":false,"name":"eHealthGlobalHealth","description":"Global & Public Health, Health Equity, Disparities, #eHealth, Health Promotion, #ParticipatoryMedicine, #CBPR #SDOH #COVID19","protected":false,"created_at":"2009-04-23T16:06:35.000Z","public_metrics":{"followers_count":16357,"following_count":7474,"tweet_count":12677,"listed_count":794},"url":"","location":"Boston, MA","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":52,"end":60,"tag":"eHealth"},{"start":80,"end":102,"tag":"ParticipatoryMedicine"},{"start":104,"end":109,"tag":"CBPR"},{"start":110,"end":115,"tag":"SDOH"},{"start":116,"end":124,"tag":"COVID19"}],"urls":{}}}},{"id":"3314634701","username":"HAIEurope","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"HAI Europe","description":"We've moved our Twitter account to @HAImedicines. Please follow us there!","protected":false,"created_at":"2015-06-09T07:55:13.000Z","public_metrics":{"followers_count":2,"following_count":0,"tweet_count":1,"listed_count":3},"url":"","location":"Amsterdam, Nederland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":35,"end":48,"username":"HAImedicines"}],"hashtags":{},"urls":{}}}},{"id":"1734766740","username":"MeadowcroftRob","profile_image_url":"https://pbs.twimg.com/profile_images/569923890164817920/-wZdwQ9w_normal.jpeg","verified":false,"name":"Robert Meadowcroft","description":"Interests: Integrity in public life and good governance; role of nonprofits supporting individuals and communities.\nBy the river #FFC\nViews strictly my own.","protected":false,"created_at":"2013-09-06T11:13:45.000Z","public_metrics":{"followers_count":2098,"following_count":1347,"tweet_count":25489,"listed_count":80},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":129,"end":133,"tag":"FFC"}],"urls":{}}},"pinned_tweet_id":"1171315301071433728"},{"id":"250753435","username":"bilgeceydilek","profile_image_url":"https://pbs.twimg.com/profile_images/1477675368786059264/0pTIMB-1_normal.jpg","verified":false,"name":"bilge ceydilek","description":"İstanbul’da bir Ankarasever - Hekim - Endokrinoloji - 🦅🦅🦅- #VamosRafa - #bakıpgördüklerim - #hiçşiirsizolurmu","protected":false,"created_at":"2011-02-11T18:49:18.000Z","public_metrics":{"followers_count":751,"following_count":654,"tweet_count":9792,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":59,"end":69,"tag":"VamosRafa"},{"start":72,"end":89,"tag":"bakıpgördüklerim"},{"start":92,"end":109,"tag":"hiçşiirsizolurmu"}],"urls":{}}},"pinned_tweet_id":"770010347386314752"},{"id":"129802718","username":"turquoisejulia","profile_image_url":"https://pbs.twimg.com/profile_images/726048288529592320/gM6BTsQb_normal.jpg","verified":false,"name":"Julia McKenzie 💙","description":"Dundee Uni Grad, living life by the sea, Christian #MentalHealth #Diabeties #insulin #BPD #Fibro #Endo #osteoarthritis #AcuteMacularNeuroretinopathy","protected":false,"created_at":"2010-04-05T12:57:57.000Z","public_metrics":{"followers_count":860,"following_count":2292,"tweet_count":10778,"listed_count":13},"url":"https://t.co/VDPeRZp6A2","location":"Weston-super-Mare, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VDPeRZp6A2","expanded_url":"http://www.facebook.com/TropQwsm","display_url":"facebook.com/TropQwsm"}]},"description":{"mentions":{},"hashtags":[{"start":51,"end":64,"tag":"MentalHealth"},{"start":65,"end":75,"tag":"Diabeties"},{"start":76,"end":84,"tag":"insulin"},{"start":85,"end":89,"tag":"BPD"},{"start":90,"end":96,"tag":"Fibro"},{"start":97,"end":102,"tag":"Endo"},{"start":103,"end":118,"tag":"osteoarthritis"},{"start":119,"end":148,"tag":"AcuteMacularNeuroretinopathy"}],"urls":{}}}},{"id":"138820530","username":"WilliamPShelley","profile_image_url":"https://pbs.twimg.com/profile_images/378800000077893945/b00d5da27e35470693ab294859a41112_normal.jpeg","verified":false,"name":"William P. Shelley","description":"I love GOD then i'm a biotrader","protected":false,"created_at":"2010-04-30T18:01:33.000Z","public_metrics":{"followers_count":240,"following_count":472,"tweet_count":4047,"listed_count":12},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"21079030","username":"PharmaScrip","profile_image_url":"https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg","verified":false,"name":"Scrip","description":"Scrip goes beyond the headlines and focuses on delivering insight & analysis on the whole of the drug discovery, development and product life cycle value chain.","protected":false,"created_at":"2009-02-17T10:33:29.000Z","public_metrics":{"followers_count":21916,"following_count":1624,"tweet_count":36001,"listed_count":658},"url":"","location":"Global","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"221009551","username":"LucGroot","profile_image_url":"https://pbs.twimg.com/profile_images/1081450480251723777/At9hC8kn_normal.jpg","verified":false,"name":"Luc Groot","description":"#Europeaan #Heracles #landbouw #landschap #cooperatief🤝- werkt @De_FPG - voorzitter MR Julianaschool - voetbaltrainer @dvov_nl - #3 #GR2022 @CDAArnhem","protected":false,"created_at":"2010-11-29T13:53:06.000Z","public_metrics":{"followers_count":2626,"following_count":788,"tweet_count":12336,"listed_count":57},"url":"","location":"Arnhem, Nederland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":63,"end":70,"username":"De_FPG"},{"start":118,"end":126,"username":"dvov_nl"},{"start":140,"end":150,"username":"CDAArnhem"}],"hashtags":[{"start":0,"end":10,"tag":"Europeaan"},{"start":11,"end":20,"tag":"Heracles"},{"start":21,"end":30,"tag":"landbouw"},{"start":31,"end":41,"tag":"landschap"},{"start":42,"end":54,"tag":"cooperatief"},{"start":132,"end":139,"tag":"GR2022"}],"urls":{}}}},{"id":"25950355","username":"NEJM","profile_image_url":"https://pbs.twimg.com/profile_images/893483773362393088/US3DliFV_normal.jpg","verified":true,"name":"NEJM","description":"The New England Journal of Medicine (http://t.co/YKINVyRNEl) is the world’s leading medical journal and website.","protected":false,"created_at":"2009-03-23T04:10:07.000Z","public_metrics":{"followers_count":875263,"following_count":397,"tweet_count":25056,"listed_count":10066},"url":"http://t.co/MskhpINH4c","location":"Boston, MA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/MskhpINH4c","expanded_url":"http://NEJM.org","display_url":"NEJM.org"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":37,"end":59,"url":"http://t.co/YKINVyRNEl","expanded_url":"http://NEJM.org","display_url":"NEJM.org"}]}},"pinned_tweet_id":"1496847553685426177"},{"id":"1108967047","username":"M_Pajewska","profile_image_url":"https://pbs.twimg.com/profile_images/1106557716884017152/BJeYU3jG_normal.png","verified":false,"name":"Magdalena Pajewska Lewandowska","description":"","protected":false,"created_at":"2013-01-21T12:54:45.000Z","public_metrics":{"followers_count":254,"following_count":657,"tweet_count":1377,"listed_count":11},"url":"","location":"Canada, Ottawa","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"326845755","username":"AEMPSGOB","profile_image_url":"https://pbs.twimg.com/profile_images/1369221235838775299/6RotinPV_normal.jpg","verified":true,"name":"AEMPS","description":"Agencia Española de Medicamentos y Productos Sanitarios","protected":false,"created_at":"2011-06-30T15:49:14.000Z","public_metrics":{"followers_count":49966,"following_count":139,"tweet_count":2070,"listed_count":812},"url":"https://t.co/yW8X0gBz8i","location":"España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yW8X0gBz8i","expanded_url":"https://www.aemps.gob.es/","display_url":"aemps.gob.es"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496833431937953798"},{"id":"596292370","username":"albertoporrasc","profile_image_url":"https://pbs.twimg.com/profile_images/2682706229/cac06e483cc2ad59a427c66ef5e0db16_normal.jpeg","verified":false,"name":"Alberto Porras","description":"Doctor en Medicina  #investigación, #gestión, #docencia","protected":false,"created_at":"2012-06-01T09:14:28.000Z","public_metrics":{"followers_count":314,"following_count":176,"tweet_count":1636,"listed_count":21},"url":"","location":"Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":20,"end":34,"tag":"investigación"},{"start":36,"end":44,"tag":"gestión"},{"start":46,"end":55,"tag":"docencia"}],"urls":{}}}},{"id":"1482049878","username":"TomA_Riq","profile_image_url":"https://pbs.twimg.com/profile_images/1042868633045803008/T3tVJNMe_normal.jpg","verified":false,"name":"Thomas Riquier","description":"consultant santé  Pharmacien hospitalier ex-chargé de mission à la DGOS et ancien co-président 2014-2015 de la FNSIP-BM mes tweets n'engagent que moi","protected":false,"created_at":"2013-06-04T11:43:37.000Z","public_metrics":{"followers_count":615,"following_count":1096,"tweet_count":1903,"listed_count":9},"url":"","location":"Paris","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1255880755454115841"},{"id":"515837126","username":"ciarakirke","profile_image_url":"https://pbs.twimg.com/profile_images/1256253163658764291/X-6jqgpz_normal.jpg","verified":false,"name":"Ciara Kirke","description":"Trying to improve patient safety and quality in healthcare. Clinical lead, medication safety with HSE. Likes sweet treats and gumption","protected":false,"created_at":"2012-03-05T20:31:08.000Z","public_metrics":{"followers_count":2182,"following_count":1116,"tweet_count":13101,"listed_count":0},"url":"https://t.co/en15fGFFdD","location":"Dublin, Ireland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/en15fGFFdD","expanded_url":"http://www.safermeds.ie","display_url":"safermeds.ie"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"23810643","username":"rabarg","profile_image_url":"https://pbs.twimg.com/profile_images/1485233266856759301/JKTDrb2s_normal.jpg","verified":false,"name":"Edda Grabar","description":"#Journalistin & #Autorin  versteht etwas von Biochemie #Medicine #Pharma überzeugt für die #EU und den @fckoeln","protected":false,"created_at":"2009-03-11T19:13:44.000Z","public_metrics":{"followers_count":800,"following_count":219,"tweet_count":7710,"listed_count":75},"url":"","location":"Kölner Großraum","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":103,"end":111,"username":"fckoeln"}],"hashtags":[{"start":0,"end":13,"tag":"Journalistin"},{"start":16,"end":24,"tag":"Autorin"},{"start":55,"end":64,"tag":"Medicine"},{"start":65,"end":72,"tag":"Pharma"},{"start":91,"end":94,"tag":"EU"}],"urls":{}}},"pinned_tweet_id":"1485232872353058824"},{"id":"17994531","username":"dennisandre","profile_image_url":"https://pbs.twimg.com/profile_images/284144225/twitterpic_normal.jpg","verified":false,"name":"Dennis Ballwieser","description":"Chefredakteur @AU_de // Arzt & Redakteur // früher @spiegelonline @djsde @lmu_uniklinikum // #KlartextCorona #NeDosisWissen // d.ballwieser@apotheken-umschau.de","protected":false,"created_at":"2008-12-09T16:21:47.000Z","public_metrics":{"followers_count":1169,"following_count":3858,"tweet_count":2091,"listed_count":47},"url":"https://t.co/HVLgKlqwXt","location":"Munich, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/HVLgKlqwXt","expanded_url":"https://www.apotheken-umschau.de/","display_url":"apotheken-umschau.de"}]},"description":{"mentions":[{"start":14,"end":20,"username":"AU_de"},{"start":51,"end":65,"username":"spiegelonline"},{"start":66,"end":72,"username":"djsde"},{"start":73,"end":89,"username":"lmu_uniklinikum"}],"hashtags":[{"start":93,"end":108,"tag":"KlartextCorona"},{"start":109,"end":123,"tag":"NeDosisWissen"}],"urls":{}}}},{"id":"597167039","username":"drdjpanchal","profile_image_url":"https://pbs.twimg.com/profile_images/774549158615257088/9RfYwLU1_normal.jpg","verified":false,"name":"Yeh Desh Pardesh","description":"Nationalist","protected":false,"created_at":"2012-06-02T07:00:21.000Z","public_metrics":{"followers_count":10,"following_count":43,"tweet_count":563,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17966242","username":"trinevillemann","profile_image_url":"https://pbs.twimg.com/profile_images/992811045550002176/y12TiDu5_normal.jpg","verified":false,"name":"trinevillemann","description":"#Danish  director of #documentary #MalcolmisaLittleUnwell.See link below. Author.Journalist.TV-producer.All views mine.","protected":false,"created_at":"2008-12-08T16:50:16.000Z","public_metrics":{"followers_count":486,"following_count":405,"tweet_count":2609,"listed_count":16},"url":"https://t.co/ZMWGY1KReU","location":"London, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ZMWGY1KReU","expanded_url":"https://vimeo.com/288990058","display_url":"vimeo.com/288990058"}]},"description":{"mentions":{},"hashtags":[{"start":0,"end":7,"tag":"Danish"},{"start":21,"end":33,"tag":"documentary"},{"start":34,"end":57,"tag":"MalcolmisaLittleUnwell"}],"urls":{}}},"pinned_tweet_id":"1216339619228332033"},{"id":"1430840870","username":"RareDiseasesEU","profile_image_url":"https://pbs.twimg.com/profile_images/1214536863366569984/tzJ1peJx_normal.png","verified":false,"name":"Rare Disease Policy","description":"@RareDiseasesEU is currently managed by Victoria Hedley, RD Policy Manager @ Newcastle University (formerly account  4 RD-ACTION & EUCERD JA). Views now my own","protected":false,"created_at":"2013-05-15T15:58:58.000Z","public_metrics":{"followers_count":3377,"following_count":957,"tweet_count":2891,"listed_count":100},"url":"","location":"Newcastle, UK","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":0,"end":15,"username":"RareDiseasesEU"}],"hashtags":{},"urls":{}}}},{"id":"362672893","username":"GBRChris_A","profile_image_url":"https://pbs.twimg.com/profile_images/797991661800452096/O97j26qc_normal.jpg","verified":false,"name":"Christopher Anton","description":"Pharmacovigilante, Cox at Birmingham RC, World Rowing umpire, British Rowing Regional Chair. All thoughts mine.","protected":false,"created_at":"2011-08-26T19:58:48.000Z","public_metrics":{"followers_count":1134,"following_count":827,"tweet_count":44625,"listed_count":30},"url":"","location":"Birmingham, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14433267","username":"wouterhavinga","profile_image_url":"https://pbs.twimg.com/profile_images/476319940770009089/9PBDjxOY_normal.jpeg","verified":false,"name":"Wouter Havinga","description":"retired family doctor","protected":false,"created_at":"2008-04-18T14:03:24.000Z","public_metrics":{"followers_count":1375,"following_count":4940,"tweet_count":16801,"listed_count":66},"url":"","location":"United Kingdom","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"52084584","username":"EFPIA","profile_image_url":"https://pbs.twimg.com/profile_images/600282411314712576/oSBUt3G9_normal.jpg","verified":false,"name":"EFPIA","description":"EFPIA is the voice of the research-based pharmaceutical industry in Europe \n#WeWontRest #TeamVaccines\nhttps://t.co/y1FLniUcoT","protected":false,"created_at":"2009-06-29T15:16:42.000Z","public_metrics":{"followers_count":25740,"following_count":3888,"tweet_count":27435,"listed_count":608},"url":"http://t.co/kGrDP4le","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":20,"url":"http://t.co/kGrDP4le","expanded_url":"http://www.efpia.eu","display_url":"efpia.eu"}]},"description":{"mentions":{},"hashtags":[{"start":76,"end":87,"tag":"WeWontRest"},{"start":88,"end":101,"tag":"TeamVaccines"}],"urls":[{"start":102,"end":125,"url":"https://t.co/y1FLniUcoT","expanded_url":"http://efpia.eu","display_url":"efpia.eu"}]}},"pinned_tweet_id":"1406907697275060226"},{"id":"243301370","username":"Elena_Tomas","profile_image_url":"https://pbs.twimg.com/profile_images/938674421547507713/EfGMkSq6_normal.jpg","verified":false,"name":"Elena Tomas","description":"","protected":false,"created_at":"2011-01-26T19:08:53.000Z","public_metrics":{"followers_count":94,"following_count":566,"tweet_count":2104,"listed_count":0},"url":"","location":"Vilassar de Mar ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1425017433052508166"},{"id":"790421354","username":"cureLauncher","profile_image_url":"https://pbs.twimg.com/profile_images/3540121861/8ab5b11edd6de7319baa7c440e451bd3_normal.png","verified":false,"name":"CureLauncher","description":"Personalized Clinical Trial Matching Team \nPatientCentered.SurvivorInspired #clinicaltrials Official LIVESTRONG Partner\nhttp://t.co/0hxQWygyjO","protected":false,"created_at":"2012-08-30T00:10:03.000Z","public_metrics":{"followers_count":1038,"following_count":1836,"tweet_count":3548,"listed_count":36},"url":"http://t.co/34XeZgo0IC","location":"USA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/34XeZgo0IC","expanded_url":"http://curelauncher.com","display_url":"curelauncher.com"}]},"description":{"mentions":{},"hashtags":[{"start":76,"end":91,"tag":"clinicaltrials"}],"urls":[{"start":120,"end":142,"url":"http://t.co/0hxQWygyjO","expanded_url":"http://www.facebook.com/cureLauncher","display_url":"facebook.com/cureLauncher"}]}}},{"id":"182561601","username":"velascozamora","profile_image_url":"https://pbs.twimg.com/profile_images/543061037004500992/rgbN2h3R_normal.png","verified":false,"name":"Jorge Velasco Zamora","description":"Jorge Velasco Zamora. Médico reumatólogo. Investigador Principal, MBA.\r\nSite Manager @CERInstitute. Pte Fundación Articular\r\nhttp://t.co/okrdF0zaOq","protected":false,"created_at":"2010-08-24T22:03:58.000Z","public_metrics":{"followers_count":7452,"following_count":3729,"tweet_count":21161,"listed_count":123},"url":"http://t.co/BOO2C7eUUn","location":"Buenos Aires - Argentina","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/BOO2C7eUUn","expanded_url":"http://www.jorgevelascozamora.com/","display_url":"jorgevelascozamora.com"}]},"description":{"mentions":[{"start":85,"end":98,"username":"CERInstitute"}],"hashtags":{},"urls":[{"start":125,"end":147,"url":"http://t.co/okrdF0zaOq","expanded_url":"http://cerclinicaltrials.com/","display_url":"cerclinicaltrials.com"}]}}},{"id":"184756856","username":"EPHA_EU","profile_image_url":"https://pbs.twimg.com/profile_images/1470767114294382599/a_d37jhG_normal.jpg","verified":false,"name":"EPHA","description":"The European Public Health Alliance is a change agent – Europe’s leading NGO alliance advocating for better health. Retweets are not endorsements.","protected":false,"created_at":"2010-08-30T12:11:13.000Z","public_metrics":{"followers_count":15302,"following_count":1893,"tweet_count":13499,"listed_count":437},"url":"https://t.co/B7bodgX2W1","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/B7bodgX2W1","expanded_url":"http://www.epha.org","display_url":"epha.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"207897978","username":"lakemedel","profile_image_url":"https://pbs.twimg.com/profile_images/1188766274295402496/pHQMCyTn_normal.jpg","verified":false,"name":"Mikael Hoffmann","description":"\"Droppen urholkar stenen\"\nLäkare & patient. Privata tweets.\nChef NEPI, ordf Läkaresällskapets läkemedelsgrupp, medlem Läkemedelsverkets vetenskapliga råd.","protected":false,"created_at":"2010-10-26T07:44:29.000Z","public_metrics":{"followers_count":2143,"following_count":432,"tweet_count":20982,"listed_count":42},"url":"https://t.co/hFy80Jm4NV","location":"Linköping, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hFy80Jm4NV","expanded_url":"http://www.nepi.net","display_url":"nepi.net"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1449616378525360133"},{"id":"183177433","username":"MedtechAmanda","profile_image_url":"https://pbs.twimg.com/profile_images/572720346856308736/pBxeAVob_normal.jpeg","verified":false,"name":"Amanda Maxwell","description":"#medtech regulations expert at @Medtech_Insight. #medicaldevices, #IVDs & #drug/device combinations. Own opinions. @Pharma_Intelligence","protected":false,"created_at":"2010-08-26T10:06:53.000Z","public_metrics":{"followers_count":1781,"following_count":158,"tweet_count":6594,"listed_count":144},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":31,"end":47,"username":"Medtech_Insight"},{"start":115,"end":135,"username":"Pharma_Intelligence"}],"hashtags":[{"start":0,"end":8,"tag":"medtech"},{"start":49,"end":64,"tag":"medicaldevices"},{"start":66,"end":71,"tag":"IVDs"},{"start":74,"end":79,"tag":"drug"}],"urls":{}}}},{"id":"1262320285","username":"VaccinesEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1253680106352119809/XMRZTvHq_normal.jpg","verified":false,"name":"VaccinesEurope","description":"VE represents major innovative research-based vaccine companies operating in Europe, including SMEs.\nVE is a specialised group within EFPIA. #WeWontRest","protected":false,"created_at":"2013-03-12T16:08:10.000Z","public_metrics":{"followers_count":6123,"following_count":1008,"tweet_count":4927,"listed_count":102},"url":"https://t.co/TPJJSanMkb","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TPJJSanMkb","expanded_url":"http://www.vaccineseurope.eu","display_url":"vaccineseurope.eu"}]},"description":{"mentions":{},"hashtags":[{"start":141,"end":152,"tag":"WeWontRest"}],"urls":{}}},"pinned_tweet_id":"1448641886009192450"},{"id":"595127053","username":"MarvinOLicious","profile_image_url":"https://pbs.twimg.com/profile_images/3560527314/f4bc361222d5485f9f30d7081edca248_normal.jpeg","verified":false,"name":"Marvin O'Licious","description":"","protected":true,"created_at":"2012-05-31T03:10:55.000Z","public_metrics":{"followers_count":0,"following_count":123,"tweet_count":138,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"5383942","username":"GSK","profile_image_url":"https://pbs.twimg.com/profile_images/1324755585837993988/Suh2dHvH_normal.png","verified":true,"name":"GSK","description":"Latest news and views from science-led global healthcare company GSK. Run by the global digital comms team. Community guidelines: https://t.co/oOQS7yzSyY","protected":false,"created_at":"2007-04-21T18:19:31.000Z","public_metrics":{"followers_count":234058,"following_count":725,"tweet_count":13025,"listed_count":2279},"url":"https://t.co/W5S4VfZfEG","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/W5S4VfZfEG","expanded_url":"http://www.gsk.com","display_url":"gsk.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":130,"end":153,"url":"https://t.co/oOQS7yzSyY","expanded_url":"http://gsk.to/1OCpCfJ","display_url":"gsk.to/1OCpCfJ"}]}}},{"id":"51995902","username":"Jesduarte","profile_image_url":"https://pbs.twimg.com/profile_images/1432093139645382658/7dxnVloz_normal.jpg","verified":false,"name":"João Duarte","description":"Living the living life. | RT or like ≠ Endorsement | Tweets and views are personal.","protected":false,"created_at":"2009-06-29T07:54:14.000Z","public_metrics":{"followers_count":359,"following_count":696,"tweet_count":2513,"listed_count":2},"url":"","location":"Paris, France","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1324830324585566208"},{"id":"392623482","username":"GacetaMedicaCom","profile_image_url":"https://pbs.twimg.com/profile_images/1347508599749283840/9o3JJzLH_normal.jpg","verified":false,"name":"Gaceta Médica","description":"Diario de información de Sanidad, Profesionales, Política y Opinión.","protected":false,"created_at":"2011-10-17T10:07:17.000Z","public_metrics":{"followers_count":53840,"following_count":2475,"tweet_count":37558,"listed_count":1087},"url":"https://t.co/zYckKrdW1o","location":"Madrid","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/zYckKrdW1o","expanded_url":"http://www.gacetamedica.com","display_url":"gacetamedica.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496485066838618115"},{"id":"717962540","username":"Asphalion","profile_image_url":"https://pbs.twimg.com/profile_images/1454163191521480712/UwvBT6Lr_normal.jpg","verified":false,"name":"Asphalion","description":"Latest news on the regulatory affairs and pharmaceutical sector! \nInternacional Scientific and Regulatory Affairs Consultancy","protected":false,"created_at":"2012-07-26T11:51:00.000Z","public_metrics":{"followers_count":603,"following_count":854,"tweet_count":2476,"listed_count":12},"url":"https://t.co/YMyNVKdJw5","location":"Barcelona, España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/YMyNVKdJw5","expanded_url":"http://www.asphalion.com","display_url":"asphalion.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484176236163178501"},{"id":"206819876","username":"K_N_Atuah","profile_image_url":"https://pbs.twimg.com/profile_images/1674926096/image_normal.jpg","verified":false,"name":"Kwame N. Atuah","description":"","protected":false,"created_at":"2010-10-23T20:14:25.000Z","public_metrics":{"followers_count":12,"following_count":121,"tweet_count":19,"listed_count":0},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1725069487","username":"pharmatweat","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Pharmatweat","description":"","protected":false,"created_at":"2013-09-03T10:10:14.000Z","public_metrics":{"followers_count":1,"following_count":0,"tweet_count":2,"listed_count":0},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"266609916","username":"Mailas1809","profile_image_url":"https://pbs.twimg.com/profile_images/378800000591051403/6e068bdfb3ba4378f98e700273b9eaf0_normal.jpeg","verified":false,"name":"Marina I. Assetta, MRQA","description":"Pharmaceutical Consultant at MIA Clinical Research Services - Global Clinical Trial Management, GCP Auditing, Quality Evaluator Manager","protected":false,"created_at":"2011-03-15T14:21:42.000Z","public_metrics":{"followers_count":144,"following_count":161,"tweet_count":3654,"listed_count":8},"url":"","location":"Clinical Trial Mgt. ex-US","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"247239882","username":"PrescrireMieux","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"PrescrireMieux","description":"","protected":false,"created_at":"2011-02-04T11:36:24.000Z","public_metrics":{"followers_count":165,"following_count":0,"tweet_count":4,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"873777758","username":"EUombudsman","profile_image_url":"https://pbs.twimg.com/profile_images/1194630187788300288/bE3Y5tdH_normal.jpg","verified":true,"name":"European Ombudsman","description":"🇪🇺 Ombudsman O'Reilly promotes good EU administration by investigating complaints and systemic issues. Account managed by the comms team. https://t.co/YbpgtPtsjM","protected":false,"created_at":"2012-10-11T15:02:05.000Z","public_metrics":{"followers_count":32440,"following_count":5806,"tweet_count":7852,"listed_count":793},"url":"https://t.co/uaDmsPxpmt","location":"Strasbourg/Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/uaDmsPxpmt","expanded_url":"https://www.ombudsman.europa.eu/en/home","display_url":"ombudsman.europa.eu/en/home"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":138,"end":161,"url":"https://t.co/YbpgtPtsjM","expanded_url":"http://europa.eu/!bc33kQ","display_url":"europa.eu/!bc33kQ"}]}}},{"id":"1675439491","username":"daferlo647","profile_image_url":"https://pbs.twimg.com/profile_images/378800000307059685/a68ab459450a2222801f587761fa9c9d_normal.jpeg","verified":false,"name":"REPARACIONES LOBERA","description":"Reparaciones Lobera ¡Que no vuelvan a tomarte el pelo!","protected":false,"created_at":"2013-08-16T10:40:04.000Z","public_metrics":{"followers_count":37,"following_count":57,"tweet_count":208,"listed_count":0},"url":"http://t.co/rONvWqKRAv","location":"Madrid y España","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/rONvWqKRAv","expanded_url":"http://danielfernandezlober.wix.com/reparaciones","display_url":"danielfernandezlober.wix.com/reparaciones"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1300585957","username":"StopEssure","profile_image_url":"https://pbs.twimg.com/profile_images/3429587261/2532ad842d7e6239957abd68d0bb816c_normal.jpeg","verified":false,"name":"Essure Uncensored","description":"Essure sterilization is destroying women forcing them into hysterectomies at young ages. #Essure #EssureProblems https://t.co/OYobkjNQkD","protected":false,"created_at":"2013-03-25T18:25:41.000Z","public_metrics":{"followers_count":2513,"following_count":2230,"tweet_count":12082,"listed_count":37},"url":"https://t.co/GPArqWcdV1","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GPArqWcdV1","expanded_url":"https://www.facebook.com/groups/Essureproblems/","display_url":"facebook.com/groups/Essurep…"}]},"description":{"mentions":{},"hashtags":[{"start":89,"end":96,"tag":"Essure"},{"start":97,"end":112,"tag":"EssureProblems"}],"urls":[{"start":113,"end":136,"url":"https://t.co/OYobkjNQkD","expanded_url":"http://essureproblems.webs.com/home","display_url":"essureproblems.webs.com/home"}]}}},{"id":"223692135","username":"cooldoc123","profile_image_url":"https://pbs.twimg.com/profile_images/1430256320/Doctor_Photo_normal.jpg","verified":false,"name":"docnuman","description":"Medical affairs Director ,clinical development ,commercial strategy. Posts/tweets DO NOT reflect the views of the company that i work for","protected":false,"created_at":"2010-12-07T02:23:02.000Z","public_metrics":{"followers_count":302,"following_count":2499,"tweet_count":7234,"listed_count":18},"url":"https://t.co/6ZJWJXGeIg","location":"usa","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6ZJWJXGeIg","expanded_url":"http://www.linkedin.com/profile/view?id=36238831&trk=tab_pro","display_url":"linkedin.com/profile/view?i…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"166509226","username":"LindaMcAvanMEP","profile_image_url":"https://pbs.twimg.com/profile_images/755321530394050560/P53-Z2Mi_normal.jpg","verified":true,"name":"Linda McAvan","description":"","protected":false,"created_at":"2010-07-14T09:43:09.000Z","public_metrics":{"followers_count":10873,"following_count":4384,"tweet_count":3732,"listed_count":377},"url":"","location":"sheffield ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"65877691","username":"iu_st","profile_image_url":"https://pbs.twimg.com/profile_images/1461961014354890756/K9ralWZv_normal.jpg","verified":false,"name":"M.Justyna M.","description":"tu niemedycznie, med info na @iust_med /foto własne/","protected":false,"created_at":"2009-08-15T11:08:18.000Z","public_metrics":{"followers_count":3162,"following_count":3865,"tweet_count":53694,"listed_count":31},"url":"","location":"Warszawa","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":29,"end":38,"username":"iust_med"}],"hashtags":{},"urls":{}}}},{"id":"1496947920","username":"StripSafely","profile_image_url":"https://pbs.twimg.com/profile_images/378800000469372933/0534062edbd39f2766a2842e959b466b_normal.png","verified":false,"name":"StripSafely","description":"People with Diabetes Need Safe & Accurate Test Strips. Join the Campaign http://t.co/nNiHOJdnGs","protected":false,"created_at":"2013-06-10T00:34:07.000Z","public_metrics":{"followers_count":745,"following_count":439,"tweet_count":1275,"listed_count":16},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/nNiHOJdnGs","expanded_url":"http://www.StripSafely.com","display_url":"StripSafely.com"}]}}},{"id":"758619698","username":"webDM1","profile_image_url":"https://pbs.twimg.com/profile_images/1457784920848273409/4zFgja92_normal.png","verified":false,"name":"Dani Royo","description":"Trabajo para las personas en el Serv. Atención y Comunicación con el Paciente de @GVAsanitat .Pitufo gruñón. Me interesa la #diabetESP Still to come","protected":false,"created_at":"2012-08-15T05:09:55.000Z","public_metrics":{"followers_count":6718,"following_count":1710,"tweet_count":45837,"listed_count":221},"url":"https://t.co/cpMNFN2DkS","location":"Valencia. España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cpMNFN2DkS","expanded_url":"http://www.diabetestipo1.es/","display_url":"diabetestipo1.es"}]},"description":{"mentions":[{"start":81,"end":92,"username":"GVAsanitat"}],"hashtags":[{"start":124,"end":134,"tag":"diabetESP"}],"urls":{}}},"pinned_tweet_id":"1472267380764123141"},{"id":"17509073","username":"wombarrapete","profile_image_url":"https://pbs.twimg.com/profile_images/378800000229073961/d9357ca96b2f6472c5eedf5e64a282e2_normal.jpeg","verified":false,"name":"wombarrapete","description":"","protected":false,"created_at":"2008-11-20T10:39:57.000Z","public_metrics":{"followers_count":6,"following_count":24,"tweet_count":41,"listed_count":0},"url":"","location":"Planet Earth","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1367162942","username":"Fiouw","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Jolanda de Fiouw","description":"","protected":false,"created_at":"2013-04-20T14:24:00.000Z","public_metrics":{"followers_count":15,"following_count":14,"tweet_count":29,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1397042496","username":"EconCancerRes","profile_image_url":"https://pbs.twimg.com/profile_images/3602809183/474f88507873d062e0cec490604744b3_normal.png","verified":false,"name":"Economics of Cancer","description":"Economics of Cancer Research Group Research - Dissemination - Collaboration","protected":false,"created_at":"2013-05-02T12:20:34.000Z","public_metrics":{"followers_count":807,"following_count":943,"tweet_count":1642,"listed_count":23},"url":"http://t.co/wrFawJEmhA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wrFawJEmhA","expanded_url":"http://economicsofcancer.com","display_url":"economicsofcancer.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"661819458353274881"},{"id":"296358959","username":"engenerico","profile_image_url":"https://pbs.twimg.com/profile_images/809859064972853248/lBew9Dy2_normal.jpg","verified":false,"name":"en genérico","description":"Queremos aprender contigo sobre los medicamentos genéricos, cómo usar de forma responsable nuestro sistema sanitario y cuidar nuestra salud. ¡Bienvenid@s!","protected":false,"created_at":"2011-05-10T16:37:49.000Z","public_metrics":{"followers_count":12667,"following_count":11691,"tweet_count":17321,"listed_count":213},"url":"https://t.co/6e7dKHPfoi","location":"Madrid, Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6e7dKHPfoi","expanded_url":"http://www.engenerico.com","display_url":"engenerico.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"79702114","username":"EASDnews","profile_image_url":"https://pbs.twimg.com/profile_images/1489176521667399684/ph8Y_kOl_normal.jpg","verified":false,"name":"EASD","description":"EASD is a non-profit association for HCP's with an interest in #diabetes and related subjects. Privacy Policy: https://t.co/j4xYeJHX5W…","protected":false,"created_at":"2009-10-04T10:24:49.000Z","public_metrics":{"followers_count":10356,"following_count":91,"tweet_count":6064,"listed_count":184},"url":"https://t.co/S8s8VGA8Nd","location":"Düsseldorf, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/S8s8VGA8Nd","expanded_url":"http://www.easd.org","display_url":"easd.org"}]},"description":{"mentions":{},"hashtags":[{"start":63,"end":72,"tag":"diabetes"}],"urls":[{"start":111,"end":134,"url":"https://t.co/j4xYeJHX5W","expanded_url":"http://easd.org/easd/privacy-p","display_url":"easd.org/easd/privacy-p"}]}}},{"id":"917639060","username":"FarmaOnco","profile_image_url":"https://pbs.twimg.com/profile_images/2930931336/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","verified":false,"name":"FarmaOnco","description":"Farmacéutica hospitalaria que intenta mantenerse al día en onco, hemato y otras cosas","protected":false,"created_at":"2012-10-31T20:48:41.000Z","public_metrics":{"followers_count":2592,"following_count":1180,"tweet_count":22164,"listed_count":102},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17437735","username":"Boehringer","profile_image_url":"https://pbs.twimg.com/profile_images/1118140978366492672/aAynk1K9_normal.png","verified":true,"name":"Boehringer Ingelheim","description":"Let’s connect for better health.","protected":false,"created_at":"2008-11-17T08:55:11.000Z","public_metrics":{"followers_count":103051,"following_count":3611,"tweet_count":15004,"listed_count":1512},"url":"https://t.co/75h3xQFmCt","location":"Ingelheim, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/75h3xQFmCt","expanded_url":"https://b-i.news/socialtermstw","display_url":"b-i.news/socialtermstw"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1535265686","username":"BarryPharmacist","profile_image_url":"https://pbs.twimg.com/profile_images/1024031630392872960/M2qQUPbZ_normal.jpg","verified":false,"name":"Barry Power 🇨🇦","description":"Pharmacist in primary care and information management; Dad of awesome @kiwaterloo grad; my wife says I'm a music snob","protected":false,"created_at":"2013-06-20T23:20:55.000Z","public_metrics":{"followers_count":769,"following_count":178,"tweet_count":1589,"listed_count":15},"url":"","location":"Ottawa, ON","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":70,"end":81,"username":"kiwaterloo"}],"hashtags":{},"urls":{}}}},{"id":"525779070","username":"LillyPadEU","profile_image_url":"https://pbs.twimg.com/profile_images/1158305851381288961/f1p4NOFE_normal.jpg","verified":true,"name":"LillyPad EU","description":"The Eli Lilly and Company BXL team official Twitter\nprofile - Tweets on EU Health Policy, Innovation, Life at Lilly and\nCorporate Responsibility","protected":false,"created_at":"2012-03-15T21:46:21.000Z","public_metrics":{"followers_count":10276,"following_count":1510,"tweet_count":5341,"listed_count":177},"url":"https://t.co/vLAT3UlTM7","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/vLAT3UlTM7","expanded_url":"https://lillypad.eu/","display_url":"lillypad.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"216527950","username":"sanoysalvoblog","profile_image_url":"https://pbs.twimg.com/profile_images/967801202942595073/q51FncDd_normal.jpg","verified":false,"name":"Sano y salvo","description":"Seguridad del Paciente en Atención Primaria de Salud. Grupo de Trabajo en #SegPac de semFYC. Patient Safety #PtSafety, Primary Health Care.","protected":false,"created_at":"2010-11-16T23:47:03.000Z","public_metrics":{"followers_count":10960,"following_count":299,"tweet_count":22888,"listed_count":307},"url":"https://t.co/E7DzsUb00a","location":"España - Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/E7DzsUb00a","expanded_url":"http://sanoysalvo.es","display_url":"sanoysalvo.es"}]},"description":{"mentions":{},"hashtags":[{"start":74,"end":81,"tag":"SegPac"},{"start":108,"end":117,"tag":"PtSafety"}],"urls":{}}},"pinned_tweet_id":"1474813000536182785"},{"id":"31437646","username":"Margaritus","profile_image_url":"https://pbs.twimg.com/profile_images/762107553304248320/52sDPouc_normal.jpg","verified":false,"name":"I am Margaritus","description":"","protected":false,"created_at":"2009-04-15T15:47:02.000Z","public_metrics":{"followers_count":802,"following_count":916,"tweet_count":69325,"listed_count":22},"url":"","location":"Santiago, Chile","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"897191683028385793"},{"id":"158105629","username":"Sergiplata","profile_image_url":"https://pbs.twimg.com/profile_images/1344012499528658946/GXAo4pGC_normal.jpg","verified":false,"name":"Sergio Plata","description":"Especialista en #FarmaciaHospitalaria en @SanidadAlbacete. CoAutor de @StopErroresMed","protected":false,"created_at":"2010-06-21T20:06:53.000Z","public_metrics":{"followers_count":2059,"following_count":1052,"tweet_count":5942,"listed_count":72},"url":"https://t.co/S7hqUApYLE","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/S7hqUApYLE","expanded_url":"http://www.stoperroresdemedicacion.org","display_url":"stoperroresdemedicacion.org"}]},"description":{"mentions":[{"start":41,"end":57,"username":"SanidadAlbacete"},{"start":70,"end":85,"username":"StopErroresMed"}],"hashtags":[{"start":16,"end":37,"tag":"FarmaciaHospitalaria"}],"urls":{}}}},{"id":"378478769","username":"SIOPEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1035522356213469187/0eTtdio__normal.jpg","verified":false,"name":"SIOPE 🎗️","description":"SIOP Europe, the European Society of Paediatric Oncology (SIOPE), promotes optimal standards of care for children and adolescents with cancer.","protected":false,"created_at":"2011-09-23T08:27:32.000Z","public_metrics":{"followers_count":5306,"following_count":1696,"tweet_count":8980,"listed_count":102},"url":"https://t.co/75A1bKVAgG","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/75A1bKVAgG","expanded_url":"http://www.siope.eu","display_url":"siope.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14499829","username":"WHO","profile_image_url":"https://pbs.twimg.com/profile_images/875476478988886016/_l61qZdR_normal.jpg","verified":true,"name":"World Health Organization (WHO)","description":"We are the #UnitedNations’ health agency - #HealthForAll.\n▶️ Always check our latest tweets on #COVID19 for updated advice/information.","protected":false,"created_at":"2008-04-23T19:56:27.000Z","public_metrics":{"followers_count":10726535,"following_count":1746,"tweet_count":68017,"listed_count":34883},"url":"https://t.co/wVulKuROWG","location":"Geneva, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/wVulKuROWG","expanded_url":"http://www.who.int","display_url":"who.int"}]},"description":{"mentions":{},"hashtags":[{"start":11,"end":25,"tag":"UnitedNations"},{"start":43,"end":56,"tag":"HealthForAll"},{"start":95,"end":103,"tag":"COVID19"}],"urls":{}}},"pinned_tweet_id":"1497281701847961612"},{"id":"13636102","username":"rqgb","profile_image_url":"https://pbs.twimg.com/profile_images/3780735805/829660781d3103c3bc37d64aa6d30b4e_normal.jpeg","verified":false,"name":"rqgb","description":"General Practitioner. Interested in communication, human beings, #ehealth, IT, social media and all the interactions...","protected":false,"created_at":"2008-02-18T18:45:12.000Z","public_metrics":{"followers_count":2027,"following_count":2037,"tweet_count":15515,"listed_count":178},"url":"http://t.co/bvbVz6trxD","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/bvbVz6trxD","expanded_url":"http://rqgb.eu","display_url":"rqgb.eu"}]},"description":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"ehealth"}],"urls":{}}},"pinned_tweet_id":"1463853472982446080"},{"id":"349775607","username":"vdgmeu","profile_image_url":"https://pbs.twimg.com/profile_images/672280152399847425/VFYgnF9c_normal.jpg","verified":false,"name":"Vasco da Gama Movement","description":"Welcome to the Vasco da Gama Movement, the WONCA Europe Network for New and Future General Practitioners.","protected":false,"created_at":"2011-08-06T17:36:42.000Z","public_metrics":{"followers_count":2827,"following_count":209,"tweet_count":3642,"listed_count":45},"url":"http://t.co/khtWi2oSGF","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/khtWi2oSGF","expanded_url":"http://www.vdgm.eu","display_url":"vdgm.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497849191980146690"},{"id":"1238217276","username":"rengerwitkamp","profile_image_url":"https://pbs.twimg.com/profile_images/650212857473142785/Kc1sIqub_normal.jpg","verified":false,"name":"Food&Pharma","description":"Professor in Nutritional Biology | Nutrition and Medicines during Ageing; Lifestyle as Medicine; (endo-)Cannabinoids; Food Supplements","protected":false,"created_at":"2013-03-03T07:36:54.000Z","public_metrics":{"followers_count":2198,"following_count":1152,"tweet_count":13296,"listed_count":70},"url":"http://t.co/SKOrZJQclp","location":"Wageningen, Netherlands","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/SKOrZJQclp","expanded_url":"http://nl.linkedin.com/pub/renger-witkamp/6/70/693","display_url":"nl.linkedin.com/pub/renger-wit…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"305434870","username":"ICH_news","profile_image_url":"https://pbs.twimg.com/profile_images/1562052762/logo_only_transparent_normal.png","verified":false,"name":"ICH","description":"International Council for Harmonisation of Technical Requirements for \nPharmaceuticals for Human Use","protected":false,"created_at":"2011-05-26T06:29:14.000Z","public_metrics":{"followers_count":2590,"following_count":31,"tweet_count":153,"listed_count":57},"url":"http://t.co/tLbkcqnfEA","location":"Geneva","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/tLbkcqnfEA","expanded_url":"http://www.ich.org","display_url":"ich.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"43617900","username":"elazzouzim","profile_image_url":"https://pbs.twimg.com/profile_images/378800000399321490/22c77bf73ee1c991102aeecb81f65aef_normal.jpeg","verified":false,"name":"Monir El Azzouzi","description":"Med Dev & Pharma, QA/RA. Favorite question : Would I give this product to a member of my family? #meddevice #medtech #leadership #management #medicaldevices","protected":false,"created_at":"2009-05-30T23:47:55.000Z","public_metrics":{"followers_count":2145,"following_count":838,"tweet_count":73652,"listed_count":214},"url":"https://t.co/bbMmsphOoe","location":"Solothurn - Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/bbMmsphOoe","expanded_url":"https://easymedicaldevice.com","display_url":"easymedicaldevice.com"}]},"description":{"mentions":{},"hashtags":[{"start":97,"end":107,"tag":"meddevice"},{"start":108,"end":116,"tag":"medtech"},{"start":117,"end":128,"tag":"leadership"},{"start":129,"end":140,"tag":"management"},{"start":141,"end":156,"tag":"medicaldevices"}],"urls":{}}},"pinned_tweet_id":"1440225651580039178"},{"id":"498073573","username":"t_swam","profile_image_url":"https://pbs.twimg.com/profile_images/1338873336625950721/yL2GrSvW_normal.jpg","verified":false,"name":"Tara Swami","description":"Rheumatology Fellow a UOttawa, Former Internal Medicine Resident at USask and Lifelong Learner","protected":false,"created_at":"2012-02-20T17:22:31.000Z","public_metrics":{"followers_count":148,"following_count":286,"tweet_count":552,"listed_count":0},"url":"","location":"Saskatoon, Saskatchewan","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"115898830","username":"DIJs_pistol","profile_image_url":"https://pbs.twimg.com/profile_images/1379772113234501635/OHU8tHkf_normal.jpg","verified":false,"name":"ぴす","description":"メロンソーダとチリドックがあれば生きていけると思っている最新型のあれです。たまに株とかFXとか弄ってます。円定期よりよく回ってくれればそれでいいです。何もわかりません。。6年持ち続けたそーせいをあの大相場直前に手放し1年半気を失っていました。2017辛勝2018快勝2019善戦2020惨敗。今年は稼ぐよ！！","protected":false,"created_at":"2010-02-20T10:44:20.000Z","public_metrics":{"followers_count":117,"following_count":35,"tweet_count":5088,"listed_count":0},"url":"","location":"ひたちし","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"26791880","username":"apotekare","profile_image_url":"https://pbs.twimg.com/profile_images/1490228956217417728/A5VS12R4_normal.jpg","verified":false,"name":"Jon Haraldsson","description":"Apotekare och Rotarian som jobbar för Allas bästa. I hela Lerum. Styrelseledamot Lerums kommun. Även hematologiansvarig på GSK Sverige","protected":false,"created_at":"2009-03-26T16:55:22.000Z","public_metrics":{"followers_count":326,"following_count":499,"tweet_count":3879,"listed_count":16},"url":"https://t.co/r5QwW9S22o","location":"Lerum, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/r5QwW9S22o","expanded_url":"http://www.socialdemokraternailerum.se","display_url":"socialdemokraternailerum.se"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1545818551","username":"stevekshwang","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"베를린천사","description":"","protected":false,"created_at":"2013-06-25T13:55:02.000Z","public_metrics":{"followers_count":0,"following_count":1,"tweet_count":3,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"325032216","username":"paulinemacco","profile_image_url":"https://pbs.twimg.com/profile_images/1445875890026475524/EdNFbXZP_normal.jpg","verified":false,"name":"dr pauline mccormack","description":"@NCLSociology health and illness, bioethics, patient experiences of health technologies, the patient voice","protected":false,"created_at":"2011-06-27T16:39:46.000Z","public_metrics":{"followers_count":534,"following_count":205,"tweet_count":2192,"listed_count":21},"url":"https://t.co/yevrSKMG7O","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yevrSKMG7O","expanded_url":"https://www.ncl.ac.uk/gps/staff/profile/paulinemccormack.html","display_url":"ncl.ac.uk/gps/staff/prof…"}]},"description":{"mentions":[{"start":0,"end":13,"username":"NCLSociology"}],"hashtags":{},"urls":{}}}},{"id":"1216228962","username":"BushbyKate","profile_image_url":"https://pbs.twimg.com/profile_images/664909171930869760/db0plyta_normal.jpg","verified":false,"name":"Katie Bushby","description":"Professor Emerita in Neuromuscular Genetics Newcastle University JWMDRC. Fan of Northumberland seaside & good food.","protected":false,"created_at":"2013-02-24T18:37:13.000Z","public_metrics":{"followers_count":3091,"following_count":1168,"tweet_count":5768,"listed_count":67},"url":"https://t.co/4W08QAXO8t","location":"Newcastle upon Tyne","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4W08QAXO8t","expanded_url":"http://www.ncl.ac.uk/igm/services/muscle","display_url":"ncl.ac.uk/igm/services/m…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1460651427827785743"},{"id":"1299022237","username":"asociacionamife","profile_image_url":"https://pbs.twimg.com/profile_images/1433473878584614913/3gI6cb9V_normal.jpg","verified":false,"name":"AMIFE","description":"Asociación de Medicina de la Industria Farmacéutica en España","protected":false,"created_at":"2013-03-25T11:26:07.000Z","public_metrics":{"followers_count":1321,"following_count":594,"tweet_count":4385,"listed_count":48},"url":"https://t.co/KPAsOsA2gu","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/KPAsOsA2gu","expanded_url":"http://www.amife.net","display_url":"amife.net"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"16579894","username":"pauldixey","profile_image_url":"https://pbs.twimg.com/profile_images/1040258710516510723/KK1R8WHb_normal.jpg","verified":false,"name":"Paul Dixey","description":"Healthcare Customer Engagement Consultant","protected":false,"created_at":"2008-10-03T16:26:09.000Z","public_metrics":{"followers_count":1167,"following_count":1052,"tweet_count":2308,"listed_count":77},"url":"https://t.co/Xw1UF3MTrH","location":"Kinoulton, Nottinghamshire","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xw1UF3MTrH","expanded_url":"http://uk.linkedin.com/in/pauldixey","display_url":"uk.linkedin.com/in/pauldixey"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"23783432","username":"PMLIVE","profile_image_url":"https://pbs.twimg.com/profile_images/633898284/PMTWITTERLOGO_normal.jpg","verified":false,"name":"PM LIVE Team","description":"A Think Forward Music Magazine . Exposing  Quality Music Through An Original Lens.","protected":false,"created_at":"2009-03-11T16:08:20.000Z","public_metrics":{"followers_count":1082,"following_count":1484,"tweet_count":1216,"listed_count":15},"url":"http://t.co/clSU1r42fo","location":"Everywhere","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/clSU1r42fo","expanded_url":"http://www.pm-live.com","display_url":"pm-live.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1497946333","username":"Pharmaforkids","profile_image_url":"https://pbs.twimg.com/profile_images/3781533827/4edf2b66cd95a7f7233a359e1e2a0843_normal.png","verified":false,"name":"Paeds Pharmacologist (Dan)","description":"Dan Hawcutt, senior lecturer/consultant in paediatric pharmacology at University of Liverpool & Alder Hey Children's hospital. My opinions.","protected":false,"created_at":"2013-06-10T10:21:48.000Z","public_metrics":{"followers_count":1424,"following_count":722,"tweet_count":2102,"listed_count":18},"url":"","location":"Liverpool, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"137349917","username":"FondazioneE35","profile_image_url":"https://pbs.twimg.com/profile_images/964066062474989568/TWtSaKPn_normal.jpg","verified":false,"name":"Fondazione E35","description":"Fondazione per la Progettazione europea e la Cooperazione Internazionale del territorio di Reggio Emilia e Provincia","protected":false,"created_at":"2010-04-26T14:11:23.000Z","public_metrics":{"followers_count":1759,"following_count":1211,"tweet_count":5957,"listed_count":76},"url":"https://t.co/NOxCx9FkqE","location":"Reggio Emilia","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/NOxCx9FkqE","expanded_url":"http://www.e-35.it","display_url":"e-35.it"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"482482613","username":"Wyattheinforma","profile_image_url":"https://pbs.twimg.com/profile_images/643308466807963648/76WhEN79_normal.jpg","verified":false,"name":"James Wyatt","description":"In transition...","protected":false,"created_at":"2012-02-03T23:40:49.000Z","public_metrics":{"followers_count":59,"following_count":121,"tweet_count":484,"listed_count":3},"url":"","location":"London, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"63136204","username":"Informa_LS","profile_image_url":"https://pbs.twimg.com/profile_images/504927436530647040/GM045l_d_normal.png","verified":false,"name":"Informa LifeSciences","description":"Providing quality, expert-led conferences; delivering the knowledge our clients need to excel, guaranteeing a competitive advantage for their organisations.","protected":false,"created_at":"2009-08-05T13:46:27.000Z","public_metrics":{"followers_count":1826,"following_count":1818,"tweet_count":4852,"listed_count":35},"url":"http://t.co/712HIOKYGY","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/712HIOKYGY","expanded_url":"http://www.informa-ls.com","display_url":"informa-ls.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1114124408","username":"JnlAnaesthesia","profile_image_url":"https://pbs.twimg.com/profile_images/558270610069934081/QvsSWr99_normal.jpeg","verified":false,"name":"JournalAnaesthesia","description":"Journal of #Anaesthesia Practice, ideal for the #anesthetists & #anesthesiologist. Sign up to receive our newletter - https://t.co/e4Zw7M0AC1","protected":false,"created_at":"2013-01-23T11:11:20.000Z","public_metrics":{"followers_count":2225,"following_count":933,"tweet_count":993,"listed_count":27},"url":"http://t.co/iI3lat9m9M","location":"Harrogate, UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/iI3lat9m9M","expanded_url":"http://www.japractice.com","display_url":"japractice.com"}]},"description":{"mentions":{},"hashtags":[{"start":11,"end":23,"tag":"Anaesthesia"},{"start":48,"end":61,"tag":"anesthetists"},{"start":64,"end":81,"tag":"anesthesiologist"}],"urls":[{"start":118,"end":141,"url":"https://t.co/e4Zw7M0AC1","expanded_url":"http://eepurl.com/bqNDuf","display_url":"eepurl.com/bqNDuf"}]}}},{"id":"956329627","username":"Docjedy","profile_image_url":"https://pbs.twimg.com/profile_images/443733090784256000/zeYlggvp_normal.jpeg","verified":false,"name":"Jedi","description":"MG - Running - Papa de 4","protected":false,"created_at":"2012-11-18T22:15:06.000Z","public_metrics":{"followers_count":2176,"following_count":703,"tweet_count":19747,"listed_count":29},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"292158149","username":"docdu16","profile_image_url":"https://pbs.twimg.com/profile_images/963442295952506880/xCZ0_ue3_normal.jpg","verified":false,"name":"Grange JC","description":"Ex Médecin Généraliste. Selon le décret 2012-745 du 9/5/12 : pas de liens d’intérêts avec les industriels de la santé.","protected":false,"created_at":"2011-05-03T06:03:07.000Z","public_metrics":{"followers_count":5135,"following_count":168,"tweet_count":86372,"listed_count":151},"url":"https://t.co/Qb2NaTx96M","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Qb2NaTx96M","expanded_url":"http://docteurdu16.blogspot.com/","display_url":"docteurdu16.blogspot.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1040349271277621248"},{"id":"292400876","username":"doctorhelgi","profile_image_url":"https://pbs.twimg.com/profile_images/1447854028226957312/nNXwMioa_normal.jpg","verified":false,"name":"Dr Helgi 🇺🇦","description":"Dr Helgi Johannsson - doctor specialising in anaesthesia at Imperial. Runner, singer. RCOA council member. Many opinions, all mine. 🇮🇸🇬🇧🇪🇺🏳️‍🌈","protected":false,"created_at":"2011-05-03T15:55:52.000Z","public_metrics":{"followers_count":30064,"following_count":2942,"tweet_count":45393,"listed_count":258},"url":"https://t.co/nXAcMIyvs6","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/nXAcMIyvs6","expanded_url":"https://www.drhelgi.com","display_url":"drhelgi.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1487334471594651649"},{"id":"232124120","username":"sanidadgob","profile_image_url":"https://pbs.twimg.com/profile_images/1495890330020896769/eA3ridxS_normal.jpg","verified":true,"name":"Ministerio de Sanidad","description":"Ministerio de Sanidad #YoMeVacunoSeguro","protected":false,"created_at":"2010-12-30T09:00:21.000Z","public_metrics":{"followers_count":687348,"following_count":699,"tweet_count":21725,"listed_count":4139},"url":"https://t.co/Uz115LXvLp","location":"Madrid, España","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Uz115LXvLp","expanded_url":"https://www.sanidad.gob.es/","display_url":"sanidad.gob.es"}]},"description":{"mentions":{},"hashtags":[{"start":22,"end":39,"tag":"YoMeVacunoSeguro"}],"urls":{}}}},{"id":"317401291","username":"BIOcomuniCAT","profile_image_url":"https://pbs.twimg.com/profile_images/1513015956/Biocomunicat_LOGO_normal.jpg","verified":false,"name":"BIOcomuniCA'T","description":"Som un equip de joves investigadors internacionals i organitzem activitats científiques, jornades de divulgació i tallers! Si hi estàs interessat contacta'ns!","protected":false,"created_at":"2011-06-14T21:48:51.000Z","public_metrics":{"followers_count":1018,"following_count":169,"tweet_count":1607,"listed_count":47},"url":"http://t.co/DgW5eQOb3y","location":"barcelona","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/DgW5eQOb3y","expanded_url":"http://www.biocomunicat.cat","display_url":"biocomunicat.cat"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"123864717","username":"the_prbb","profile_image_url":"https://pbs.twimg.com/profile_images/1328459121637683208/op7uOSfo_normal.png","verified":false,"name":"Biomedicina BCN","description":"Biomedical research with a view | La millor recerca biomèdica amb vistes\ncc @IMIM_research @CRGenomica @UPFbiomed @EMBLBarcelona @IBE_Barcelona @ISGlobalorg","protected":false,"created_at":"2010-03-17T13:05:36.000Z","public_metrics":{"followers_count":19238,"following_count":1616,"tweet_count":26160,"listed_count":406},"url":"https://t.co/HGFHt5QV7y","location":"Barcelona","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/HGFHt5QV7y","expanded_url":"http://www.prbb.org","display_url":"prbb.org"}]},"description":{"mentions":[{"start":76,"end":90,"username":"IMIM_research"},{"start":91,"end":102,"username":"CRGenomica"},{"start":103,"end":113,"username":"UPFbiomed"},{"start":114,"end":128,"username":"EMBLBarcelona"},{"start":129,"end":143,"username":"IBE_Barcelona"},{"start":144,"end":156,"username":"ISGlobalorg"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496788271183056896"},{"id":"756505452515512324","username":"HSJDBCN","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Adrian Cook","description":"","protected":false,"created_at":"2016-07-22T15:05:29.000Z","public_metrics":{"followers_count":8,"following_count":0,"tweet_count":0,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"122015101","username":"SIETES7","profile_image_url":"https://pbs.twimg.com/profile_images/586093630030512128/mUToIj5w_normal.jpg","verified":false,"name":"Sietes.org","description":"SIETES, Sistema de Información Esencial en Terapéutica y Salud | Electronic information system on medicines & therapeutics | @FundacioICF | RT≠Endorsements","protected":false,"created_at":"2010-03-11T09:29:42.000Z","public_metrics":{"followers_count":3549,"following_count":363,"tweet_count":9009,"listed_count":202},"url":"http://t.co/dmfCfQexne","location":"Vall d'Hebron, Barcelona","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/dmfCfQexne","expanded_url":"http://www.sietes.org","display_url":"sietes.org"}]},"description":{"mentions":[{"start":125,"end":137,"username":"FundacioICF"}],"hashtags":{},"urls":{}}}},{"id":"228845995","username":"3NT","profile_image_url":"https://pbs.twimg.com/profile_images/1496939277896278017/v7HqoU5L_normal.jpg","verified":false,"name":"Pieter Droppert","description":"","protected":false,"created_at":"2010-12-20T20:58:41.000Z","public_metrics":{"followers_count":799,"following_count":228,"tweet_count":16594,"listed_count":140},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"44614314","username":"Annals_Oncology","profile_image_url":"https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_normal.png","verified":false,"name":"Annals of Oncology","description":"Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.","protected":false,"created_at":"2009-06-04T13:26:20.000Z","public_metrics":{"followers_count":38109,"following_count":507,"tweet_count":3437,"listed_count":664},"url":"https://t.co/VTawI7ghHV","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VTawI7ghHV","expanded_url":"https://www.annalsofoncology.org/","display_url":"annalsofoncology.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1255835557516763138"},{"id":"912929083","username":"BairdAM","profile_image_url":"https://pbs.twimg.com/profile_images/1345095746480197635/linNbKeb_normal.jpg","verified":false,"name":"Dr Anne-Marie Baird","description":"Cancer Researcher @tcddublin; Advocate; President @LungCancerEU; @EuropeanCancer PAC; @Donegal_SAL @LungCommunity Views are my own #NoStigma #LCSM","protected":false,"created_at":"2012-10-29T17:53:43.000Z","public_metrics":{"followers_count":3494,"following_count":1608,"tweet_count":16557,"listed_count":114},"url":"https://t.co/sH2hQXyxSD","location":"Dublin, Ireland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sH2hQXyxSD","expanded_url":"https://ie.linkedin.com/in/bairdam","display_url":"ie.linkedin.com/in/bairdam"}]},"description":{"mentions":[{"start":18,"end":28,"username":"tcddublin"},{"start":50,"end":63,"username":"LungCancerEU"},{"start":65,"end":80,"username":"EuropeanCancer"},{"start":86,"end":98,"username":"Donegal_SAL"},{"start":99,"end":113,"username":"LungCommunity"}],"hashtags":[{"start":131,"end":140,"tag":"NoStigma"},{"start":141,"end":146,"tag":"LCSM"}],"urls":{}}}},{"id":"125456212","username":"oncology23","profile_image_url":"https://pbs.twimg.com/profile_images/1905719124/Poza_Cluj_2_normal.jpg","verified":false,"name":"Banu Eugeniu","description":"Senior board-certified medical oncologist (France and Romania), Saint-Constantin Hospital. Focus on personalised treatment, clinical research, networking.","protected":false,"created_at":"2010-03-22T21:57:21.000Z","public_metrics":{"followers_count":1197,"following_count":1828,"tweet_count":5633,"listed_count":37},"url":"http://t.co/wRQq8ZxQy4","location":"Brasov, Romania","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wRQq8ZxQy4","expanded_url":"http://wefollow.com/oncology23","display_url":"wefollow.com/oncology23"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"330036521","username":"jrgralow","profile_image_url":"https://pbs.twimg.com/profile_images/1320709251711463424/ZbKnmp5J_normal.jpg","verified":false,"name":"Julie Gralow","description":"Chief Medical Officer, American Society of Clinical Oncology (ASCO). Tweets are my own.","protected":false,"created_at":"2011-07-06T00:37:16.000Z","public_metrics":{"followers_count":8775,"following_count":700,"tweet_count":12718,"listed_count":260},"url":"https://t.co/PxgRGvpoOr","location":"Seattle WA & Alexandria VA USA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/PxgRGvpoOr","expanded_url":"https://www.asco.org/about-asco/asco-overview/leadership/senior-leadership","display_url":"asco.org/about-asco/asc…"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"170039453","username":"drseisenberg","profile_image_url":"https://pbs.twimg.com/profile_images/829486029438492672/NAbK6KKh_normal.jpg","verified":true,"name":"Dr. Steven Eisenberg","description":"Text me +1 (310) 564-8857 #Oncologist | #Host, The @drstevenshow | #Songwriter 4 people living w/ #cancer | New Book: Love Is the Strongest Medicine @hayhouse","protected":false,"created_at":"2010-07-23T20:04:31.000Z","public_metrics":{"followers_count":36866,"following_count":11953,"tweet_count":62886,"listed_count":1373},"url":"https://t.co/UQ5ZYkk7MB","location":"San Diego, CA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/UQ5ZYkk7MB","expanded_url":"http://bit.ly/loveisthestrongestmedicine","display_url":"bit.ly/loveisthestron…"}]},"description":{"mentions":[{"start":51,"end":64,"username":"drstevenshow"},{"start":149,"end":158,"username":"hayhouse"}],"hashtags":[{"start":26,"end":37,"tag":"Oncologist"},{"start":40,"end":45,"tag":"Host"},{"start":67,"end":78,"tag":"Songwriter"},{"start":98,"end":105,"tag":"cancer"}],"urls":{}}},"pinned_tweet_id":"1369080785106440193"},{"id":"177176270","username":"aftimosp","profile_image_url":"https://pbs.twimg.com/profile_images/1476472143038795777/M9ygX33Q_normal.jpg","verified":false,"name":"Philippe Aftimos, MD","description":"Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/PeEXATwb02","protected":false,"created_at":"2010-08-11T13:04:08.000Z","public_metrics":{"followers_count":5258,"following_count":3929,"tweet_count":16521,"listed_count":185},"url":"https://t.co/sMMkyHZPzt","location":"Brussels, BELGIUM","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sMMkyHZPzt","expanded_url":"http://be.linkedin.com/pub/philippe-aftimos-md/25/a76/664","display_url":"be.linkedin.com/pub/philippe-a…"}]},"description":{"mentions":[{"start":44,"end":56,"username":"JulesBordet"}],"hashtags":[{"start":57,"end":70,"tag":"BreastCancer"},{"start":71,"end":89,"tag":"PrecisionMedicine"}],"urls":[{"start":106,"end":129,"url":"https://t.co/PeEXATwb02","expanded_url":"https://coi.asco.org/share/SJ5-FFQQ/Philippe%20Aftimos","display_url":"coi.asco.org/share/SJ5-FFQQ…"}]}},"pinned_tweet_id":"1357354116343816195"},{"id":"196132848","username":"mlazqui","profile_image_url":"https://pbs.twimg.com/profile_images/1262490438130376704/BGRHGts2_normal.jpg","verified":false,"name":"Martín Lázaro","description":"Medical oncologist. Lung and genitourinary cancer.\n#lcsm #pcsm #kcsm","protected":false,"created_at":"2010-09-28T12:19:20.000Z","public_metrics":{"followers_count":3885,"following_count":3312,"tweet_count":20947,"listed_count":0},"url":"https://t.co/3yh0L7qfN9","location":"Vigo","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3yh0L7qfN9","expanded_url":"http://www.novedadesenoncologia.blogspot.com","display_url":"novedadesenoncologia.blogspot.com"}]},"description":{"mentions":{},"hashtags":[{"start":51,"end":56,"tag":"lcsm"},{"start":57,"end":62,"tag":"pcsm"},{"start":63,"end":68,"tag":"kcsm"}],"urls":{}}}},{"id":"1180456747","username":"FlBontemps","profile_image_url":"https://pbs.twimg.com/profile_images/1081116738572431360/wCSLdNcJ_normal.jpg","verified":false,"name":"Florence Bontemps","description":"#TeamPharma. J’ai créé l’application mobile de formation sur les médicaments @defimedoc. ExDirectrice scientifique du Moniteur des Pharmacies.","protected":false,"created_at":"2013-02-14T22:12:00.000Z","public_metrics":{"followers_count":1716,"following_count":1181,"tweet_count":4219,"listed_count":53},"url":"https://t.co/JdO3D5SJy6","location":"Paris, France","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JdO3D5SJy6","expanded_url":"http://www.defimedoc.fr","display_url":"defimedoc.fr"}]},"description":{"mentions":[{"start":77,"end":87,"username":"defimedoc"}],"hashtags":[{"start":0,"end":11,"tag":"TeamPharma"}],"urls":{}}},"pinned_tweet_id":"1173901655705817088"},{"id":"142310101","username":"cesareserono","profile_image_url":"https://pbs.twimg.com/profile_images/888956353/logo_serono2_normal.jpg","verified":false,"name":"Fondazione Serono","description":"La Fondazione Serono si occupa di sclerosi multipla, oncologia, endocrinologia, fertilità e malattie rare, guidata dal principio della centralità della persona","protected":false,"created_at":"2010-05-10T14:50:15.000Z","public_metrics":{"followers_count":1270,"following_count":140,"tweet_count":6950,"listed_count":29},"url":"http://t.co/O2IbGgMgTj","location":"Italy","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/O2IbGgMgTj","expanded_url":"http://www.fondazioneserono.org","display_url":"fondazioneserono.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"120702168","username":"goursaho","profile_image_url":"https://pbs.twimg.com/profile_images/561964853003583488/m34_KtY8_normal.jpeg","verified":false,"name":"Goursaho","description":"Beaucoup de santé, un peu de droit et des embruns bretons. Les propos tenus dans mes tweets n'engagent que moi.","protected":false,"created_at":"2010-03-07T08:10:25.000Z","public_metrics":{"followers_count":494,"following_count":1307,"tweet_count":15272,"listed_count":119},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"117459814","username":"jdflaysakier","profile_image_url":"https://pbs.twimg.com/profile_images/446015525718470657/GED4_rOw_normal.jpeg","verified":false,"name":"j.daniel Flaysakier","description":"J’utilise  mes neurones restants à essayer d’améliorer la qualité de vie des femmes ( et des hommes) traitées pour un cancer du sein.","protected":false,"created_at":"2010-02-25T16:45:58.000Z","public_metrics":{"followers_count":39392,"following_count":359,"tweet_count":120266,"listed_count":0},"url":"https://t.co/lfqJTCWCLT","location":"France","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/lfqJTCWCLT","expanded_url":"http://www.docteurjd.com","display_url":"docteurjd.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"264291314","username":"lucaspueyo","profile_image_url":"https://pbs.twimg.com/profile_images/441719701023252480/tj6zccTF_normal.jpeg","verified":false,"name":"Lucas Pueyo","description":"Industria farmaceútica. Interesado en todo lo referente a la salud. Es mi opinión. Ojalá se curen las enfermedades más graves. Siempre se puede aprender.","protected":false,"created_at":"2011-03-11T17:17:32.000Z","public_metrics":{"followers_count":3520,"following_count":3319,"tweet_count":42340,"listed_count":163},"url":"","location":"Pamplona, Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1431508154613895168"},{"id":"109792171","username":"iWomanish","profile_image_url":"https://pbs.twimg.com/profile_images/645973652199092224/GHftVkAC_normal.jpg","verified":false,"name":"María Zabala","description":"Periodista. Cuento cosas sobre tecnología y personas. #NoEsLaTecla — Autora de  📕 #SerPadresEnLaEraDigital","protected":false,"created_at":"2010-01-30T08:07:12.000Z","public_metrics":{"followers_count":4423,"following_count":1727,"tweet_count":18761,"listed_count":333},"url":"https://t.co/k2E7XvwliP","location":"Madrid, Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/k2E7XvwliP","expanded_url":"http://www.iwomanish.com","display_url":"iwomanish.com"}]},"description":{"mentions":{},"hashtags":[{"start":54,"end":66,"tag":"NoEsLaTecla"},{"start":82,"end":106,"tag":"SerPadresEnLaEraDigital"}],"urls":{}}},"pinned_tweet_id":"1433066046634827785"},{"id":"769373400","username":"FrancoisMaignen","profile_image_url":"https://pbs.twimg.com/profile_images/1425134116727574535/KUVXns8c_normal.jpg","verified":false,"name":"Francois Maignen","description":"I am the oomny chelloveck who will get you skorry horrorshow well with some bezoomny drencrom if you feel real bolnoy. 🇪🇺🇫🇷🇬🇧 #NoFakeMed #BlackLivesMatter","protected":false,"created_at":"2012-08-20T11:47:47.000Z","public_metrics":{"followers_count":214,"following_count":154,"tweet_count":9655,"listed_count":72},"url":"https://t.co/pIwuVYbJUL","location":"Londinium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/pIwuVYbJUL","expanded_url":"http://www.francoismaignen.eu","display_url":"francoismaignen.eu"}]},"description":{"mentions":{},"hashtags":[{"start":126,"end":136,"tag":"NoFakeMed"},{"start":137,"end":154,"tag":"BlackLivesMatter"}],"urls":{}}},"pinned_tweet_id":"1022232786042855424"}],"tweets":[{"source":"TweetDeck","text":"We've published a draft concept paper on a user safety guideline for topically administered #veterinary products: http://t.co/DMb3rzKtAp","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/DMb3rzKtAp","expanded_url":"http://bit.ly/1jmvhK2","display_url":"bit.ly/1jmvhK2"}],"hashtags":[{"start":92,"end":103,"tag":"veterinary"}],"mentions":{},"annotations":{}},"created_at":"2014-03-25T10:07:49.000Z","conversation_id":"448400855700873216","possibly_sensitive":false,"lang":"en","id":"448400855700873216","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"CMDh endorsed recommendations to restrict the use of #diacerein-containing medicines: http://t.co/lqlvQF8pmj","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/lqlvQF8pmj","expanded_url":"http://bit.ly/1r4R2iz","display_url":"bit.ly/1r4R2iz"}],"hashtags":[{"start":53,"end":63,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2014-03-21T12:45:01.000Z","conversation_id":"446990865974968321","possibly_sensitive":false,"lang":"en","id":"446990865974968321","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've issued recommendations for the composition of #flu vaccines for the coming season: http://t.co/YybwSTfTky","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/YybwSTfTky","expanded_url":"http://bit.ly/1g7Z5qu","display_url":"bit.ly/1g7Z5qu"}],"hashtags":[{"start":52,"end":56,"tag":"flu"}],"mentions":{},"annotations":{}},"created_at":"2014-03-21T12:31:42.000Z","conversation_id":"446987512662466560","possibly_sensitive":false,"lang":"en","id":"446987512662466560","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: 2014 Pharmacovigilance Day http://t.co/I6I3OUFfKg","entities":{"urls":[{"start":39,"end":61,"url":"http://t.co/I6I3OUFfKg","expanded_url":"http://bit.ly/OzQHWj","display_url":"bit.ly/OzQHWj"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-03-20T10:31:40.000Z","conversation_id":"446594917490769920","possibly_sensitive":false,"lang":"en","id":"446594917490769920","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're inviting companies to take part in a pilot project on #adaptivelicensing: http://t.co/1Xwzb9QxYp","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/1Xwzb9QxYp","expanded_url":"http://bit.ly/1fHHbWC","display_url":"bit.ly/1fHHbWC"}],"hashtags":[{"start":60,"end":78,"tag":"adaptivelicensing"}],"mentions":{},"annotations":{}},"created_at":"2014-03-19T16:51:02.000Z","conversation_id":"446328001979248641","possibly_sensitive":false,"lang":"en","id":"446328001979248641","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":6,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Aifa_ufficiale: Avastin - Lucentis: Position of the Italian Society of Pharmacology | Italian Medicines Agency http://t.co/8Px7Jd4RGB","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/8Px7Jd4RGB","expanded_url":"http://bit.ly/1nAp6nj","display_url":"bit.ly/1nAp6nj"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":90,"end":113,"probability":0.5453,"type":"Organization","normalized_text":"Italian Medicines Agency"}]},"created_at":"2014-03-18T10:38:21.000Z","conversation_id":"445871824807940096","possibly_sensitive":false,"lang":"en","id":"445871824807940096","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Prior assessment of medicinal products for human use for use in a hospital environment. http://t.co/GwLqGk67ap","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/GwLqGk67ap","expanded_url":"http://bit.ly/1fVPins","display_url":"bit.ly/1fVPins"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-03-18T12:49:53.000Z","conversation_id":"445904925856636929","possibly_sensitive":false,"lang":"en","id":"445904925856636929","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two weeks to comment on a paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"hashtags":[{"start":101,"end":114,"tag":"hypertension"}],"mentions":{},"annotations":{}},"created_at":"2014-03-17T10:38:52.000Z","conversation_id":"445509567720747008","possibly_sensitive":false,"lang":"en","id":"445509567720747008","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two weeks left to comment on our draft guideline on clinical development of medicines for treating #HIV infection: http://t.co/9jX4i4VlnA","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":99,"end":103,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2014-03-17T10:35:50.000Z","conversation_id":"445508802352525312","possibly_sensitive":false,"lang":"en","id":"445508802352525312","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@kerfors We're finalising a policy on access to trial data: http://t.co/5zznJo3X2a. Our board will discuss this week: http://t.co/dvLFzsUwhW","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/5zznJo3X2a","expanded_url":"http://bit.ly/Ywugka","display_url":"bit.ly/Ywugka"},{"start":118,"end":140,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"kerfors","id":"144624330"}],"annotations":{}},"created_at":"2014-03-17T10:05:10.000Z","conversation_id":"444583515603365888","possibly_sensitive":false,"lang":"en","id":"445501083923021824","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"444583515603365888"}],"in_reply_to_user_id":"144624330","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our Committee for Medicinal Products for Veterinary Use (#CVMP) has recommended authorisation of 2 #dog #vaccines: http://t.co/4plvQm9POY","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/4plvQm9POY","expanded_url":"http://bit.ly/1ilCSFM","display_url":"bit.ly/1ilCSFM"}],"hashtags":[{"start":57,"end":62,"tag":"CVMP"},{"start":99,"end":103,"tag":"dog"},{"start":104,"end":113,"tag":"vaccines"}],"mentions":{},"annotations":{}},"created_at":"2014-03-14T16:12:55.000Z","conversation_id":"444506469728522240","possibly_sensitive":false,"lang":"en","id":"444506469728522240","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Information on the new headquarters of the Polish medicines agency http://t.co/K8al9iibcL","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/K8al9iibcL","expanded_url":"http://bit.ly/1eAeLhC","display_url":"bit.ly/1eAeLhC"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2014-03-14T15:27:11.000Z","conversation_id":"444494960516403200","possibly_sensitive":false,"lang":"en","id":"444494960516403200","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Communication on the content of Supplement 8.1 to the eighth edition of the European Pharmacopoeia http://t.co/td3IcMflqI","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/td3IcMflqI","expanded_url":"http://bit.ly/1eAcqDv","display_url":"bit.ly/1eAcqDv"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-03-14T15:19:50.000Z","conversation_id":"444493110996115456","possibly_sensitive":false,"lang":"en","id":"444493110996115456","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EAHPtweet @GCessak We'll be publishing the agenda on this page shortly: http://t.co/dvLFzsUwhW","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"},{"start":11,"end":19,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-03-14T15:15:20.000Z","conversation_id":"444445442563383296","possibly_sensitive":false,"lang":"en","id":"444491978269810688","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"444468155050901504"}],"in_reply_to_user_id":"203357203","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: The use of ADHD medicines in 2013 identified http://t.co/bk3ICLnbV2","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/bk3ICLnbV2","expanded_url":"http://bit.ly/1njrlLQ","display_url":"bit.ly/1njrlLQ"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-03-12T11:53:28.000Z","conversation_id":"443716401317314561","possibly_sensitive":false,"lang":"en","id":"443716401317314561","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we started publishing summaries of risk-management plans for authorised human medicines: http://t.co/h8Hybr2YTs #transparency","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/h8Hybr2YTs","expanded_url":"http://bit.ly/1cR952c","display_url":"bit.ly/1cR952c"}],"hashtags":[{"start":122,"end":135,"tag":"transparency"}],"mentions":{},"annotations":{}},"created_at":"2014-03-12T09:53:01.000Z","conversation_id":"443686090189570048","possibly_sensitive":false,"lang":"en","id":"443686090189570048","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@GeoMurariu However please note that we don't approve medicines. The @EU_Commission approves after we've given an opinion.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2014-03-10T14:41:23.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","id":"443033884650135552","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"443033688855834624"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@GeoMurariu You can search human medicines at http://t.co/HKFvTyBOp8. We also have searches for veterinary and herbal medicines.","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/HKFvTyBOp8","expanded_url":"http://bit.ly/1oFjhQT","display_url":"bit.ly/1oFjhQT"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"}],"annotations":{}},"created_at":"2014-03-10T14:40:37.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","id":"443033688855834624","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"443022598331719680"}],"in_reply_to_user_id":"329999446","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Please help us improve our Twitter feed by completing this five-minute survey: http://t.co/q987RFusP6","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":27,"end":33,"probability":0.7008,"type":"Product","normalized_text":"Twitter"}]},"created_at":"2014-03-10T10:57:15.000Z","conversation_id":"442977479574429696","possibly_sensitive":false,"lang":"en","id":"442977479574429696","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC has re-examined #diacerein and recommended that it remain available with restrictions: http://t.co/BdfMVR4bOa","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/BdfMVR4bOa","expanded_url":"http://bit.ly/P843cU","display_url":"bit.ly/P843cU"}],"hashtags":[{"start":21,"end":31,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2014-03-07T12:23:50.000Z","conversation_id":"441912105214943232","possibly_sensitive":false,"lang":"en","id":"441912105214943232","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The EPAR for #Brintellix (#vortioxetine), a recently authorised medicine to treat major #depression, is available: http://t.co/Q2MrQmopwo","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Q2MrQmopwo","expanded_url":"http://bit.ly/1aZeKCi","display_url":"bit.ly/1aZeKCi"}],"hashtags":[{"start":13,"end":24,"tag":"Brintellix"},{"start":26,"end":39,"tag":"vortioxetine"},{"start":88,"end":99,"tag":"depression"}],"mentions":{},"annotations":{}},"created_at":"2014-01-16T15:20:22.000Z","conversation_id":"423837136668741632","possibly_sensitive":false,"lang":"en","id":"423837136668741632","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're extending by 2 years our programme for parallel assessment of #qualitybydesign applications with @US_FDA: http://t.co/CJXrp8mBj6","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/CJXrp8mBj6","expanded_url":"http://bit.ly/1g2QmFt","display_url":"bit.ly/1g2QmFt"}],"hashtags":[{"start":68,"end":84,"tag":"qualitybydesign"}],"mentions":[{"start":103,"end":110,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2014-03-07T10:47:19.000Z","conversation_id":"441887814486339584","possibly_sensitive":false,"lang":"en","id":"441887814486339584","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: If you notice side effects, contact your doctor, pharmacist, or national medicines agency directly http://t.co/G0lwJMcz0t","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/G0lwJMcz0t","expanded_url":"http://bit.ly/1gc0Y19","display_url":"bit.ly/1gc0Y19"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2014-03-06T09:53:04.000Z","conversation_id":"441511772135387136","possibly_sensitive":false,"lang":"en","id":"441511772135387136","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @igznl: Save the date: 19 June Dutch Healthcare Inspectorate patient safety conference. #IGZ #patientsafety http://t.co/DXIyedne0o","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/DXIyedne0o","expanded_url":"http://bit.ly/1c53daJ","display_url":"bit.ly/1c53daJ"}],"hashtags":[{"start":91,"end":95,"tag":"IGZ"},{"start":96,"end":110,"tag":"patientsafety"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"annotations":{}},"created_at":"2014-03-04T15:46:45.000Z","conversation_id":"440876007118348288","possibly_sensitive":false,"lang":"en","id":"440876007118348288","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Find out about our work in medicines for the treatment of rare diseases: http://t.co/jT9MpwkY7D #RareDiseaseDay","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"hashtags":[{"start":96,"end":111,"tag":"RareDiseaseDay"}],"mentions":{},"annotations":{}},"created_at":"2014-02-26T10:46:13.000Z","conversation_id":"438626046074953728","possibly_sensitive":false,"lang":"en","id":"438626046074953728","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":3,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #pharmacovigilance committee's (#PRAC) next meeting is next week. We're publishing the highlights on Friday: http://t.co/Uep4ZHWccW","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/Uep4ZHWccW","expanded_url":"http://bit.ly/1fvANas","display_url":"bit.ly/1fvANas"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":36,"end":41,"tag":"PRAC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-28T12:02:10.000Z","conversation_id":"439369935668936704","possibly_sensitive":false,"lang":"en","id":"439369935668936704","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended 12 medicines for the treatment of rare diseases over the past year: http://t.co/jT9MpwkY7D #RareDiseaseDay","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"hashtags":[{"start":109,"end":124,"tag":"RareDiseaseDay"}],"mentions":{},"annotations":{}},"created_at":"2014-02-25T14:58:38.000Z","conversation_id":"438327181207691264","possibly_sensitive":false,"lang":"en","id":"438327181207691264","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Treatment with paracetamol during pregnancy http://t.co/ag1o9Tz7Qi","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/ag1o9Tz7Qi","expanded_url":"http://bit.ly/1ljehnN","display_url":"bit.ly/1ljehnN"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-02-25T17:26:28.000Z","conversation_id":"438364385091010560","possibly_sensitive":false,"lang":"en","id":"438364385091010560","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@CDeRede No we don't because it falls outside of our remit. We suggest you contact @EU_enterprise or @EU_Health  for more information.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":8,"username":"CDeRede","id":"2254792730"},{"start":83,"end":97,"username":"EU_enterprise","id":"2562735307"},{"start":101,"end":111,"username":"EU_Health","id":"606325697"}],"annotations":{}},"created_at":"2014-02-25T16:05:34.000Z","conversation_id":"438341840572776448","possibly_sensitive":false,"lang":"en","id":"438344026258149377","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"438341840572776448"}],"in_reply_to_user_id":"2254792730","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on draft product-specific bioequivalence guidance for sunitinib: http://t.co/wxBKopxh3g","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/wxBKopxh3g","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-02-24T18:04:14.000Z","conversation_id":"438011501840855040","possibly_sensitive":false,"lang":"en","id":"438011501840855040","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We recommend that #Protelos / Osseor remain available but with further restrictions: http://t.co/lhgjSU3Dc7","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/lhgjSU3Dc7","expanded_url":"http://bit.ly/1edkwkm","display_url":"bit.ly/1edkwkm"}],"hashtags":[{"start":18,"end":27,"tag":"Protelos"}],"mentions":{},"annotations":{}},"created_at":"2014-02-21T13:08:49.000Z","conversation_id":"436849994252181504","possibly_sensitive":false,"lang":"en","id":"436849994252181504","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","text":"RT @INFARMED_IP: Protelos and Osseor - New recommendation to restrict use http://t.co/nnSeCwiYgP","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/nnSeCwiYgP","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9681873","display_url":"infarmed.pt/portal/page/po…"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-02-21T18:30:41.000Z","conversation_id":"436920210600112128","possibly_sensitive":false,"lang":"en","id":"436930995577962496","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"436920210600112128"}],"in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Information on the 75th meeting of the heads of EU medicines agencies (HMA): http://t.co/gJXw5vA2v5","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/gJXw5vA2v5","expanded_url":"http://bit.ly/1hv65jw","display_url":"bit.ly/1hv65jw"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":61,"end":62,"probability":0.5651,"type":"Organization","normalized_text":"EU"}]},"created_at":"2014-02-19T14:19:48.000Z","conversation_id":"436143081889730560","possibly_sensitive":false,"lang":"en","id":"436143081889730560","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Last chance to comment on draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/vlikiAtv9y","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/vlikiAtv9y","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-02-14T09:55:48.000Z","conversation_id":"434264704291450880","possibly_sensitive":false,"lang":"en","id":"434264704291450880","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: What does the #blacktriangle mean? http://t.co/qybC42RFtb http://t.co/K2ImcFfQoz","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/qybC42RFtb","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/09/WC500150608.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":71,"end":93,"url":"http://t.co/K2ImcFfQoz","expanded_url":"https://twitter.com/GCessak/status/385031341013618689/photo/1","display_url":"pic.twitter.com/K2ImcFfQoz"}],"hashtags":[{"start":27,"end":41,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2013-10-01T13:21:46.000Z","conversation_id":"385031787141148672","possibly_sensitive":false,"lang":"en","id":"385031787141148672","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":["3_385031341022007296"]}},{"source":"bitly bitlink","text":"Public consultation now open on review and update of our guidelines to implement best practice with regard to #3Rs: http://t.co/jM1xEGu7fI","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/jM1xEGu7fI","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"hashtags":[{"start":110,"end":114,"tag":"3Rs"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T16:21:45.000Z","conversation_id":"431825118810365952","possibly_sensitive":false,"lang":"en","id":"431825118810365952","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the #PRAC meeting highlights:  http://t.co/FmUJubL2Ns","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/FmUJubL2Ns","expanded_url":"http://bit.ly/Mxa6FR","display_url":"bit.ly/Mxa6FR"}],"hashtags":[{"start":25,"end":30,"tag":"PRAC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T12:09:33.000Z","conversation_id":"431761648748347392","possibly_sensitive":false,"lang":"en","id":"431761648748347392","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"There's just one week left to comment on our 16 product-specific guidelines on the demonstration of #bioequivalence: http://t.co/BZ9TH8Tn8U","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/BZ9TH8Tn8U","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"hashtags":[{"start":100,"end":115,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T12:27:03.000Z","conversation_id":"431766052519677952","possibly_sensitive":false,"lang":"en","id":"431766052519677952","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Vitamin C divides the oncologists: http://t.co/Yiynun3W75","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/Yiynun3W75","expanded_url":"http://bit.ly/1kjO5ZB","display_url":"bit.ly/1kjO5ZB"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-02-07T10:02:37.000Z","conversation_id":"431729705080086529","possibly_sensitive":false,"lang":"en","id":"431729705080086529","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"11 out of the 81 human #medicines we recommended for marketing authorisation in 2013 were for #rarediseases: http://t.co/0dNkvkxcPc #orphan","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0dNkvkxcPc","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"hashtags":[{"start":23,"end":33,"tag":"medicines"},{"start":94,"end":107,"tag":"rarediseases"},{"start":132,"end":139,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2014-02-03T15:08:57.000Z","conversation_id":"430357244220567552","possibly_sensitive":false,"lang":"en","id":"430357244220567552","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":5,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published the EPAR for #Sovaldi (#sofosbuvir), a new medicine to treat #hepatitisC in adults: http://t.co/PRCemaYFgo","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/PRCemaYFgo","expanded_url":"http://bit.ly/1lAybf1","display_url":"bit.ly/1lAybf1"}],"hashtags":[{"start":29,"end":37,"tag":"Sovaldi"},{"start":39,"end":50,"tag":"sofosbuvir"},{"start":77,"end":88,"tag":"hepatitisC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-06T10:38:05.000Z","conversation_id":"431376241577324544","possibly_sensitive":false,"lang":"en","id":"431376241577324544","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published a roundup of the activities of our committee on medicines for rare diseases: http://t.co/NlxscaNCnR  #orphan","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/NlxscaNCnR","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"hashtags":[{"start":117,"end":124,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2014-02-04T11:36:05.000Z","conversation_id":"430666062338600960","possibly_sensitive":false,"lang":"en","id":"430666062338600960","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@VanessaVanHalen The longest CHMP reviews: Natalizumab Elan Pharma (1,123 days, negative opinion); Zeftera (1,073 days, negative opinion)...","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":[{"start":43,"end":65,"probability":0.2582,"type":"Organization","normalized_text":"Natalizumab Elan Pharma"}]},"created_at":"2014-02-05T15:47:35.000Z","conversation_id":"430926683273986048","possibly_sensitive":false,"lang":"en","id":"431091742293884929","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"430926683273986048"}],"in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","text":"“@INFARMED_IP: Hydergine (dihydroergotoxin) - suspension of marketing authorisation http://t.co/lazd4seh2M”","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/lazd4seh2M","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9661314","display_url":"infarmed.pt/portal/page/po…"}],"hashtags":{},"mentions":[{"start":1,"end":13,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-02-03T19:55:57.000Z","conversation_id":"430395236133511168","possibly_sensitive":false,"lang":"en","id":"430429471888658433","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"430395236133511168"}],"in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@VanessaVanHalen Our committee, CHMP, is evaluating the application for Scenesse. We will release full details at the end of the evaluation.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":[{"start":72,"end":79,"probability":0.5067,"type":"Organization","normalized_text":"Scenesse"}]},"created_at":"2014-02-03T09:35:35.000Z","conversation_id":"429388398470889472","possibly_sensitive":false,"lang":"en","id":"430273350838263808","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"429388398470889472"}],"in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Read about the originators of innovative medicines in the EU in a new article by EMA staff: http://t.co/7jSb2sfTWY  #innovation","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/7jSb2sfTWY","expanded_url":"http://bit.ly/1gwFKBf","display_url":"bit.ly/1gwFKBf"}],"hashtags":[{"start":116,"end":127,"tag":"innovation"}],"mentions":{},"annotations":[{"start":81,"end":89,"probability":0.3522,"type":"Organization","normalized_text":"EMA staff"}]},"created_at":"2014-02-03T09:11:55.000Z","conversation_id":"430267392581570560","possibly_sensitive":false,"lang":"en","id":"430267392581570560","author_id":"116716199","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've released guidance on the use of #pharmacogenomics to improve the safety monitoring of medicines: http://t.co/kCeMEramUW","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/kCeMEramUW","expanded_url":"http://bit.ly/1gtHM59","display_url":"bit.ly/1gtHM59"}],"hashtags":[{"start":38,"end":55,"tag":"pharmacogenomics"}],"mentions":{},"annotations":{}},"created_at":"2014-01-30T14:40:49.000Z","conversation_id":"428900615251845120","possibly_sensitive":false,"lang":"en","id":"428900615251845120","author_id":"116716199","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":7,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@sTuDiO54x We're assessing a marketing-authorisation application and have issued an opinion on compassionate use: http://t.co/3tn1iLL9sg","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/3tn1iLL9sg","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"sTuDiO54x","id":"22255878"}],"annotations":{}},"created_at":"2014-01-31T09:52:59.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","id":"429190564509388800","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"429022076343554048"}],"in_reply_to_user_id":"22255878","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Notification and validation of the treatment of chronic hepatitis C http://t.co/lw98tM2oyf","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/lw98tM2oyf","expanded_url":"http://bit.ly/LsNWV2","display_url":"bit.ly/LsNWV2"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-01-30T16:18:07.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","id":"428925100986212354","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published the meeting minutes from all our scientific committees, including #CHMP, for the first time: http://t.co/2Dsjgi2xhH","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/2Dsjgi2xhH","expanded_url":"http://bit.ly/L5U0SH","display_url":"bit.ly/L5U0SH"}],"hashtags":[{"start":82,"end":87,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2014-01-29T10:54:38.000Z","conversation_id":"428481304682700800","possibly_sensitive":false,"lang":"en","id":"428481304682700800","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"@louis_ide We're awaiting responses to our outstanding issues now; recommendation to the CMDh expected in March: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":[{"start":89,"end":92,"probability":0.2901,"type":"Person","normalized_text":"CMDh"}]},"created_at":"2014-01-28T09:22:57.000Z","conversation_id":"428095843179065344","possibly_sensitive":false,"lang":"en","id":"428095843179065344","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Last Friday we published the CHMP meeting highlights: http://t.co/BzN9YLSAAu","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/BzN9YLSAAu","expanded_url":"http://bit.ly/KPtsVt","display_url":"bit.ly/KPtsVt"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-01-28T08:55:30.000Z","conversation_id":"428088936766771200","possibly_sensitive":false,"lang":"en","id":"428088936766771200","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've started a review of emergency #contraceptives: http://t.co/6FJ0akVFp1","entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/6FJ0akVFp1","expanded_url":"http://bit.ly/LPQqN8","display_url":"bit.ly/LPQqN8"}],"hashtags":[{"start":36,"end":51,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2014-01-24T12:22:11.000Z","conversation_id":"426691399715946497","possibly_sensitive":false,"lang":"en","id":"426691399715946497","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @igznl: The Netherlands refuses Ranbaxy raw materials for medicinal products #IGZ\nhttp://t.co/2JCCWkzxRy","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/2JCCWkzxRy","expanded_url":"http://bit.ly/1itiRP8","display_url":"bit.ly/1itiRP8"}],"hashtags":[{"start":80,"end":84,"tag":"IGZ"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"annotations":[{"start":15,"end":25,"probability":0.8397,"type":"Place","normalized_text":"Netherlands"}]},"created_at":"2014-01-24T11:43:51.000Z","conversation_id":"426681749369024512","possibly_sensitive":false,"lang":"en","id":"426681749369024512","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst We were referring to the December minutes. Minutes are adopted during the following month's meeting and published afterwards.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T17:46:55.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"426048345074049024","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"426046517380513794"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst We will be publishing the minutes after this week's meeting where they are being adopted, on this page: http://t.co/tgGL9p4r9N","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/tgGL9p4r9N","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T17:37:01.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"426045852231426048","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"426044437924298752"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst It will be included in the minutes from the meeting.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T09:43:49.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"425926768411697152","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425691010442596352"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Presentation from press conference - Safe Drugs \"Dissemination of information from the Safety Committee\" http://t.co/jfJGXOltgy","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/jfJGXOltgy","expanded_url":"http://bit.ly/1f5FYMs","display_url":"bit.ly/1f5FYMs"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":100,"end":115,"probability":0.5131,"type":"Organization","normalized_text":"Safety Committee"}]},"created_at":"2014-01-22T10:05:32.000Z","conversation_id":"425932234604814337","possibly_sensitive":false,"lang":"en","id":"425932234604814337","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst Not necessarily, it depends on whether CHMP has more questions that the company needs to answer.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-21T17:43:59.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"425685220067921920","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425673392335773697"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@KaiGriebenow @dsobek @Masdeutaff 17-20 Feb 2014. See our calendar for all forthcoming dates: http://t.co/11nNPPeBxP","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/11nNPPeBxP","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"KaiGriebenow","id":"423776545"},{"start":14,"end":21,"username":"dsobek","id":"243801041"},{"start":22,"end":33,"username":"Masdeutaff","id":"597154294"}],"annotations":{}},"created_at":"2014-01-21T16:41:09.000Z","conversation_id":"425666668686090240","possibly_sensitive":false,"lang":"en","id":"425669403863433216","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425668560501751808"}],"in_reply_to_user_id":"423776545","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Masdeutaff It will be discussed, with an oral explanation by the applicant, but it is not expected to go for opinion this week.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"Masdeutaff","id":"597154294"}],"annotations":{}},"created_at":"2014-01-21T15:58:07.000Z","conversation_id":"425655211177574400","possibly_sensitive":false,"lang":"en","id":"425658574606729216","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425655211177574400"}],"in_reply_to_user_id":"597154294","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"This year's @EMA_News / @IFAHEurope info day is on 13-14 March 2014 in London. Register now: http://t.co/PCGafNo5sr","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/PCGafNo5sr","expanded_url":"http://bit.ly/1mkyhm1","display_url":"bit.ly/1mkyhm1"}],"hashtags":{},"mentions":[{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":71,"end":76,"probability":0.9945,"type":"Place","normalized_text":"London"}]},"created_at":"2014-01-21T09:53:11.000Z","conversation_id":"425566738093076480","possibly_sensitive":false,"lang":"en","id":"425566738093076480","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk We have not published an EPAR on Lariam because it is authorised at national level, and not centrally at European Union level.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":[{"start":46,"end":51,"probability":0.3707,"type":"Organization","normalized_text":"Lariam"}]},"created_at":"2014-01-20T15:40:00.000Z","conversation_id":"425287357923721216","possibly_sensitive":false,"lang":"en","id":"425291626890539008","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425287357923721216"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk All documents mentioning mefloquine are listed in the search results here: http://t.co/tSRpVODW4a","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/tSRpVODW4a","expanded_url":"http://bit.ly/1e5UEKk","display_url":"bit.ly/1e5UEKk"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T16:26:45.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425303392982798336","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":4,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425302255202340865"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk Please forward your precise request to us at http://t.co/rMxJXKOpHn so that we can investigate and reply to you in full.","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T16:09:05.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425298945850347520","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425298339249135616"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk To get a more detailed answer, please send your questions and requests for documents to us at http://t.co/rMxJXKOpHn.","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T15:49:31.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425294022588895232","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425293604198686720"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk Mefloquine has not been referred to us, but our #pharmacovigilance committee is looking into a signal: http://t.co/vwyRLJn4cW","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/vwyRLJn4cW","expanded_url":"http://bit.ly/1aE7m2w","display_url":"bit.ly/1aE7m2w"}],"hashtags":[{"start":61,"end":79,"tag":"pharmacovigilance"}],"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":[{"start":13,"end":22,"probability":0.5122,"type":"Person","normalized_text":"Mefloquine"}]},"created_at":"2014-01-20T15:38:41.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425291295620206592","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425288995694592001"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Levetiracetam Hospira, a #generic of #Keppra to treat #epilepsy: http://t.co/SI2Os2FXlp","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/SI2Os2FXlp","expanded_url":"http://bit.ly/1e4EosY","display_url":"bit.ly/1e4EosY"}],"hashtags":[{"start":42,"end":56,"tag":"Levetiracetam"},{"start":68,"end":76,"tag":"generic"},{"start":80,"end":87,"tag":"Keppra"},{"start":97,"end":106,"tag":"epilepsy"}],"mentions":{},"annotations":{}},"created_at":"2014-01-20T14:37:29.000Z","conversation_id":"425275897512755200","possibly_sensitive":false,"lang":"en","id":"425275897512755200","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Last year we recommended 81 human #medicines for marketing authorisation, including 38 with new active substances: http://t.co/lxsIdWInwa","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/lxsIdWInwa","expanded_url":"http://bit.ly/1jhnSKI","display_url":"bit.ly/1jhnSKI"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"}],"mentions":{},"annotations":{}},"created_at":"2014-01-20T11:33:31.000Z","conversation_id":"425229600256696320","possibly_sensitive":false,"lang":"en","id":"425229600256696320","author_id":"116716199","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our human medicines committee, #CHMP, is meeting next week. Highlights out next Friday: http://t.co/WKYQ9BIxPn","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WKYQ9BIxPn","expanded_url":"http://bit.ly/1dAXr0q","display_url":"bit.ly/1dAXr0q"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2014-01-17T09:31:13.000Z","conversation_id":"424111658752278528","possibly_sensitive":false,"lang":"en","id":"424111658752278528","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@tomayates We will publish full details about the authorisation and its conditions after the @EU_Commission grants marketing authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"tomayates","id":"261643662"},{"start":93,"end":107,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2014-01-16T17:12:31.000Z","conversation_id":"420439570862206976","possibly_sensitive":false,"lang":"en","id":"423865361906143232","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"420439570862206976"}],"in_reply_to_user_id":"261643662","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Apply for our 2014 traineeship programme. Details and application form on our website: http://t.co/hEODiqQZxd","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/hEODiqQZxd","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-01-10T14:25:03.000Z","conversation_id":"421648886475005953","possibly_sensitive":false,"lang":"en","id":"421648886475005953","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@RK_PassingCloud Please discuss in detail with the treating doctor who may refer you to a suitable trial: http://t.co/Bg628FXr4V","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Bg628FXr4V","expanded_url":"http://bit.ly/1bKgEpO","display_url":"bit.ly/1bKgEpO"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"created_at":"2014-01-06T10:42:05.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","id":"420143226566098944","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"420135742090657793"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@RK_PassingCloud Please contact the sponsor for information. Check our site re. our role: http://t.co/c21zUA82wL http://t.co/Z7GrvbXFM6","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/c21zUA82wL","expanded_url":"http://bit.ly/1g6iA01","display_url":"bit.ly/1g6iA01"},{"start":113,"end":135,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"created_at":"2014-01-06T09:32:01.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","id":"420125593150042112","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"419170307492954112"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Kadcyla (#trastuzumab emtansine) for #breastcancer: http://t.co/eQKvCsvRtV","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/eQKvCsvRtV","expanded_url":"http://bit.ly/1jpyZCo","display_url":"bit.ly/1jpyZCo"}],"hashtags":[{"start":42,"end":50,"tag":"Kadcyla"},{"start":52,"end":64,"tag":"trastuzumab"},{"start":80,"end":93,"tag":"breastcancer"}],"mentions":{},"annotations":{}},"created_at":"2013-12-20T15:32:57.000Z","conversation_id":"414055830460583936","possibly_sensitive":false,"lang":"en","id":"414055830460583936","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"A few days left to comment on our draft concept paper on revising guidance on manufacture of finished dosage form: http://t.co/5lXkR8yTgH","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5lXkR8yTgH","expanded_url":"http://bit.ly/18Wdi2W","display_url":"bit.ly/18Wdi2W"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-12-20T12:07:01.000Z","conversation_id":"414004005950353408","possibly_sensitive":false,"lang":"en","id":"414004005950353408","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We launched a generic medicines application inspections initiative with the @US_FDA: http://t.co/dbZaxm220P","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/dbZaxm220P","expanded_url":"http://bit.ly/19cEIqS","display_url":"bit.ly/19cEIqS"}],"hashtags":{},"mentions":[{"start":76,"end":83,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2013-12-19T11:04:33.000Z","conversation_id":"413625897808179200","possibly_sensitive":false,"lang":"en","id":"413625897808179200","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Statements of non-compliance with good manufacturing practice (#GMP) are now publicly available on #EudraGMDP: http://t.co/DMg2SNPdNc","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/DMg2SNPdNc","expanded_url":"http://bit.ly/1fmIjB1","display_url":"bit.ly/1fmIjB1"}],"hashtags":[{"start":63,"end":67,"tag":"GMP"},{"start":99,"end":109,"tag":"EudraGMDP"}],"mentions":{},"annotations":{}},"created_at":"2013-12-18T14:52:38.000Z","conversation_id":"413320907516805121","possibly_sensitive":false,"lang":"en","id":"413320907516805121","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're looking to recruit a Head of #Communication Department. Apply by 29 January 2014: http://t.co/zxqfSWRmuj #vacancy #recruitment","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/zxqfSWRmuj","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":35,"end":49,"tag":"Communication"},{"start":111,"end":119,"tag":"vacancy"},{"start":120,"end":132,"tag":"recruitment"}],"mentions":{},"annotations":{}},"created_at":"2013-12-18T11:15:49.000Z","conversation_id":"413266343551827968","possibly_sensitive":false,"lang":"en","id":"413266343551827968","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Voluntary recall of batches of the drug sodium chloride 0.9% Viaflo 9 mg/ml, solution for infusion\nhttp://t.co/lWifgHUnAO","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/lWifgHUnAO","expanded_url":"http://bit.ly/18yrMev","display_url":"bit.ly/18yrMev"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-12-18T11:37:43.000Z","conversation_id":"413271855496060928","possibly_sensitive":false,"lang":"en","id":"413271855496060928","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FinansciCenk However, we do not include the outcomes in our 'highlights' press release on the Friday after the CHMP meeting.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"created_at":"2013-12-18T11:23:39.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","id":"413268315616718848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"413268133458087936"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FinansciCenk New routes of administration (= line extensions) to be discussed at the meeting are in the agenda, yes:http://t.co/vvjHnoel2U","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"created_at":"2013-12-18T11:22:55.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","id":"413268133458087936","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"413248888129081344"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide We are reviewing the benefits and the risks thoroughly. Any concerns in the meantime, please speak to your doctor or pharmacist.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-12-16T17:47:04.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412640030633385984","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"412621529583599616"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide Some issues remain outstanding; recommendation from #pharmacovigilance committee now expected in March: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"}],"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-12-16T16:28:14.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412620192955383808","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"412618955539238913"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Message to healthcare professionals on severe skin reactions after using the medicine Xeloda® \nhttp://t.co/zF2VjtG0Jt","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/zF2VjtG0Jt","expanded_url":"http://bit.ly/1bKIN31","display_url":"bit.ly/1bKIN31"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-12-16T16:09:21.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412615439596781568","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our human medicine committee, #CHMP is meeting next week. We're publishing the highlights on Friday: http://t.co/GE7mdAWXzz","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/GE7mdAWXzz","expanded_url":"http://bit.ly/19lLTel","display_url":"bit.ly/19lLTel"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-12-13T09:12:24.000Z","conversation_id":"411423347470524416","possibly_sensitive":false,"lang":"en","id":"411423347470524416","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Monthly report from the CHMP (November 2013) http://t.co/IoR8EMKrwB","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/IoR8EMKrwB","expanded_url":"http://bit.ly/1ffBKkg","display_url":"bit.ly/1ffBKkg"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2013-12-10T09:37:59.000Z","conversation_id":"410342623254024192","possibly_sensitive":false,"lang":"en","id":"410342623254024192","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: New requirements for notification of withdrawal of medicines http://t.co/Hv5TSJXgGS","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Hv5TSJXgGS","expanded_url":"http://bit.ly/Iwj1pr","display_url":"bit.ly/Iwj1pr"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-12-06T16:53:47.000Z","conversation_id":"409002743143997440","possibly_sensitive":false,"lang":"en","id":"409002743143997440","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're providing enhanced fee-reduction rates for companies developing #orphan medicines in 2014: http://t.co/noAje7cQxJ","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/noAje7cQxJ","expanded_url":"http://bit.ly/1hv98H5","display_url":"bit.ly/1hv98H5"}],"hashtags":[{"start":70,"end":77,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2013-12-03T10:44:14.000Z","conversation_id":"407822577571491840","possibly_sensitive":false,"lang":"en","id":"407822577571491840","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"It's World #AIDS Day on 1 December. Read about our activities in the area of medicines for #HIV: http://t.co/zUUzoLZvRr","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zUUzoLZvRr","expanded_url":"http://bit.ly/1iWdAhb","display_url":"bit.ly/1iWdAhb"}],"hashtags":[{"start":11,"end":16,"tag":"AIDS"},{"start":91,"end":95,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2013-11-28T17:01:21.000Z","conversation_id":"406105545859284992","possibly_sensitive":false,"lang":"en","id":"406105545859284992","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: How to report side effects #sideeffects http://t.co/L7qkUzN0RO","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/L7qkUzN0RO","expanded_url":"http://bit.ly/17TisiL","display_url":"bit.ly/17TisiL"}],"hashtags":[{"start":42,"end":54,"tag":"sideeffects"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-11-27T09:32:48.000Z","conversation_id":"405630274286780416","possibly_sensitive":false,"lang":"en","id":"405630274286780416","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended approval of #sofosbuvir for the treatment of chronic #hepatitis C: http://t.co/D8cMLabt1c","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/D8cMLabt1c","expanded_url":"http://bit.ly/1bIip72","display_url":"bit.ly/1bIip72"}],"hashtags":[{"start":27,"end":38,"tag":"sofosbuvir"},{"start":68,"end":78,"tag":"hepatitis"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:00:17.000Z","conversation_id":"404927514843152384","possibly_sensitive":false,"lang":"en","id":"404927514843152384","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We advised on compassionate use of #daclatasvir: http://t.co/1Lqp35yNgG","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/1Lqp35yNgG","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":[{"start":35,"end":47,"tag":"daclatasvir"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:00:52.000Z","conversation_id":"404927660783988736","possibly_sensitive":false,"lang":"en","id":"404927660783988736","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended two new treatment options for #tuberculosis: http://t.co/6GdMNc4PWF","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/6GdMNc4PWF","expanded_url":"http://bit.ly/1i1ALJf","display_url":"bit.ly/1i1ALJf"}],"hashtags":[{"start":45,"end":58,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:02:07.000Z","conversation_id":"404927978422800384","possibly_sensitive":false,"lang":"en","id":"404927978422800384","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended approval of new #HIV medicine: http://t.co/SdNvISL7B7","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/SdNvISL7B7","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"hashtags":[{"start":31,"end":35,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:03:21.000Z","conversation_id":"404928286175674368","possibly_sensitive":false,"lang":"en","id":"404928286175674368","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended extending use of #Abraxane to include treatment of #pancreatic #cancer: http://t.co/ouON7w6FJn","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/ouON7w6FJn","expanded_url":"http://bit.ly/1i1AYfp","display_url":"bit.ly/1i1AYfp"}],"hashtags":[{"start":32,"end":41,"tag":"Abraxane"},{"start":66,"end":77,"tag":"pancreatic"},{"start":78,"end":85,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:04:08.000Z","conversation_id":"404928483668668416","possibly_sensitive":false,"lang":"en","id":"404928483668668416","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/7tcQRaJck3","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/7tcQRaJck3","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T10:54:55.000Z","conversation_id":"404926163421630464","possibly_sensitive":false,"lang":"en","id":"404926163421630464","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: http://t.co/GjnqCdtG7k","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/GjnqCdtG7k","expanded_url":"http://bit.ly/1fqSKGT","display_url":"bit.ly/1fqSKGT"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-11-22T13:49:23.000Z","conversation_id":"403882908366417920","possibly_sensitive":false,"lang":"en","id":"403882908366417920","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/n3K4MBRpnC","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/n3K4MBRpnC","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2013-11-22T12:20:17.000Z","conversation_id":"403860484606418944","possibly_sensitive":false,"lang":"en","id":"403860484606418944","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/0TNrxR4BIK","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/0TNrxR4BIK","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"hashtags":[{"start":52,"end":63,"tag":"veterinary"},{"start":85,"end":99,"tag":"antimicrobial"}],"mentions":{},"annotations":{}},"created_at":"2013-11-22T09:13:44.000Z","conversation_id":"403813536201068544","possibly_sensitive":false,"lang":"en","id":"403813536201068544","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We finalised review of medicines concerned by Roche pharmacovigilance inspection: http://t.co/af5AuucTZq","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/af5AuucTZq","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"hashtags":{},"mentions":{},"annotations":[{"start":46,"end":50,"probability":0.4128,"type":"Person","normalized_text":"Roche"}]},"created_at":"2013-11-20T10:40:59.000Z","conversation_id":"403110718049771521","possibly_sensitive":false,"lang":"en","id":"403110718049771521","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've agreed a joint work plan with @EUnetHTA: http://t.co/pA9fAlJQTx","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/pA9fAlJQTx","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"hashtags":{},"mentions":[{"start":36,"end":45,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-11-19T10:04:55.000Z","conversation_id":"402739254440513536","possibly_sensitive":false,"lang":"en","id":"402739254440513536","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Article co-authored by senior EMA staff states that excessive risk aversion not in best interest of public health: http://t.co/BteCcdG2L4","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/BteCcdG2L4","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":{},"mentions":{},"annotations":[{"start":30,"end":32,"probability":0.6403,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-11-18T10:53:06.000Z","conversation_id":"402388994295472128","possibly_sensitive":false,"lang":"en","id":"402388994295472128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New article on the risks of risk aversion in drug #regulation, co-authored by senior EMA staff and committee members: http://t.co/9bqYDKK8r9","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/9bqYDKK8r9","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":[{"start":50,"end":61,"tag":"regulation"}],"mentions":{},"annotations":[{"start":85,"end":87,"probability":0.6983,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-11-15T11:44:15.000Z","conversation_id":"401314703114522624","possibly_sensitive":false,"lang":"en","id":"401314703114522624","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published 16 product-specific guidance documents on demonstrating #bioequivalence, open for consultation: http://t.co/LFE1dwRYqR","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/LFE1dwRYqR","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"hashtags":[{"start":72,"end":87,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-11-15T14:21:38.000Z","conversation_id":"401354309168013312","possibly_sensitive":false,"lang":"en","id":"401354309168013312","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Registration is open for the annual EMA review of the year and outlook for 2014, on 28-29 November in London: http://t.co/WjECFTKOn2","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/WjECFTKOn2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"mentions":{},"annotations":[{"start":102,"end":107,"probability":0.9926,"type":"Place","normalized_text":"London"}]},"created_at":"2013-11-14T16:40:35.000Z","conversation_id":"401026888480460800","possibly_sensitive":false,"lang":"en","id":"401026888480460800","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"The annual EMA review of the year and outlook for 2014 takes place on 28-29 November in London: http://t.co/FToe2jiGg2","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/FToe2jiGg2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"mentions":{},"annotations":[{"start":88,"end":93,"probability":0.9918,"type":"Place","normalized_text":"London"}]},"created_at":"2013-11-14T11:21:00.000Z","conversation_id":"400946463574069248","possibly_sensitive":false,"lang":"en","id":"400946463574069248","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've provided an update on our policy on the publication of clinical-trial data http://t.co/pVZWUx4ubB #ctdata","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/pVZWUx4ubB","expanded_url":"http://bit.ly/18ra6LY","display_url":"bit.ly/18ra6LY"}],"hashtags":[{"start":104,"end":111,"tag":"ctdata"}],"mentions":{},"annotations":{}},"created_at":"2013-11-13T10:22:46.000Z","conversation_id":"400569418544971776","possibly_sensitive":false,"lang":"en","id":"400569418544971776","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Aifa_ufficiale: All information on #medicines just a click away. We present the Medicines Databank #AIFA http://t.co/TaIIxlHZo1","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/TaIIxlHZo1","expanded_url":"http://bit.ly/1gJghTN","display_url":"bit.ly/1gJghTN"}],"hashtags":[{"start":39,"end":49,"tag":"medicines"},{"start":103,"end":108,"tag":"AIFA"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"created_at":"2013-11-13T12:21:59.000Z","conversation_id":"400599420137259008","possibly_sensitive":false,"lang":"en","id":"400599420137259008","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@ScripRegMaureen We will provide an update following our next Management Board meeting on 11-12 December at the latest.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":16,"username":"ScripRegMaureen","id":"552617924"}],"annotations":{}},"created_at":"2013-11-13T10:41:03.000Z","conversation_id":"400572507893161984","possibly_sensitive":false,"lang":"en","id":"400574018836656128","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"400572507893161984"}],"in_reply_to_user_id":"552617924","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends suspension of #diacerein-containing medicines: http://t.co/vLptpM8Fnu","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/vLptpM8Fnu","expanded_url":"http://bit.ly/HCA0Wn","display_url":"bit.ly/HCA0Wn"}],"hashtags":[{"start":30,"end":40,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2013-11-08T12:26:33.000Z","conversation_id":"398788629373661184","possibly_sensitive":false,"lang":"en","id":"398788629373661184","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Remember the EMA website will be unavailable from 09:00 to 18:00 tomorrow Sat 9 Nov due to maintenance: http://t.co/b0a7p9EaWx","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/b0a7p9EaWx","expanded_url":"http://bit.ly/17RiKXB","display_url":"bit.ly/17RiKXB"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-11-08T15:59:51.000Z","conversation_id":"398842309665517568","possibly_sensitive":false,"lang":"en","id":"398842309665517568","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @FDA_Drug_Info: #FDA asks the manufacturer #Iclusig (ponatinib) for leukaemia to suspend marketing and sale http://t.co/ffwgAvC14t","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ffwgAvC14t","expanded_url":"http://bit.ly/HqEgYP","display_url":"bit.ly/HqEgYP"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":46,"end":54,"tag":"Iclusig"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"created_at":"2013-11-04T13:18:06.000Z","conversation_id":"397352051811692545","possibly_sensitive":false,"lang":"en","id":"397352051811692545","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One day left to comment on need to revise condition–specific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"hashtags":[{"start":96,"end":103,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-10-30T12:06:20.000Z","conversation_id":"395522053295443968","possibly_sensitive":false,"lang":"en","id":"395522053295443968","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @HAIEurope: Policy Paper: 'Protecting Citizens' Health: Transparency of #ClinicalTrials Data in the EU' http://t.co/pNKBNLcjAi #ctdata","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/pNKBNLcjAi","expanded_url":"http://bit.ly/1a9Xrga","display_url":"bit.ly/1a9Xrga"}],"hashtags":[{"start":75,"end":90,"tag":"ClinicalTrials"},{"start":130,"end":137,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"created_at":"2013-10-30T10:04:03.000Z","conversation_id":"395491279347261440","possibly_sensitive":false,"lang":"en","id":"395491279347261440","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a report of our workshop on further involving patients in the benefit-risk assessment of #medicines: http://t.co/QuNgugyuVY","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/QuNgugyuVY","expanded_url":"http://bit.ly/18yrVaY","display_url":"bit.ly/18yrVaY"}],"hashtags":[{"start":105,"end":115,"tag":"medicines"}],"mentions":{},"annotations":{}},"created_at":"2013-10-29T14:39:40.000Z","conversation_id":"395198251882008577","possibly_sensitive":false,"lang":"en","id":"395198251882008577","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/yorxjZ6UK6","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/yorxjZ6UK6","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"mentions":{},"annotations":{}},"created_at":"2013-10-28T11:31:51.000Z","conversation_id":"394788597666029568","possibly_sensitive":false,"lang":"en","id":"394788597666029568","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: October 2013 http://t.co/PJfiwMbFCe","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/PJfiwMbFCe","expanded_url":"http://bit.ly/168zqJ5","display_url":"bit.ly/168zqJ5"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-25T12:24:44.000Z","conversation_id":"393714745758732289","possibly_sensitive":false,"lang":"en","id":"393714745758732289","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/bs9xeVastf","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/bs9xeVastf","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"mentions":{},"annotations":{}},"created_at":"2013-10-25T11:32:33.000Z","conversation_id":"393701613736833024","possibly_sensitive":false,"lang":"en","id":"393701613736833024","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"hashtags":[{"start":56,"end":67,"tag":"phthalates"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:25:17.000Z","conversation_id":"393337393517821953","possibly_sensitive":false,"lang":"en","id":"393337393517821953","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"hashtags":[{"start":63,"end":72,"tag":"parabens"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:25:44.000Z","conversation_id":"393337506659176449","possibly_sensitive":false,"lang":"en","id":"393337506659176449","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"hashtags":[{"start":84,"end":96,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:26:19.000Z","conversation_id":"393337653833134080","possibly_sensitive":false,"lang":"en","id":"393337653833134080","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"What does the #blacktriangle mean? Find out about additional monitoring of medicines by watching our video: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-22T08:21:32.000Z","conversation_id":"392566375182368768","possibly_sensitive":false,"lang":"en","id":"392566375182368768","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @HAIEurope: Paper supports #clinicaltrials data disclosure benefits for R&amp;D, efficiency &amp; #transparency  http://t.co/WwlcnrDgxQ #ctdata","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WwlcnrDgxQ","expanded_url":"http://bit.ly/18FtKak","display_url":"bit.ly/18FtKak"}],"hashtags":[{"start":30,"end":45,"tag":"clinicaltrials"},{"start":101,"end":114,"tag":"transparency"},{"start":139,"end":146,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"created_at":"2013-10-22T09:12:11.000Z","conversation_id":"392579123450638336","possibly_sensitive":false,"lang":"en","id":"392579123450638336","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Voluntary recall of batches of the medicine Captopril Zentiva http://t.co/sZZXn84JjE","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/sZZXn84JjE","expanded_url":"http://bit.ly/1i1qnvC","display_url":"bit.ly/1i1qnvC"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-10-18T10:47:18.000Z","conversation_id":"391153508210049024","possibly_sensitive":false,"lang":"en","id":"391153508210049024","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Intravenous hydroxyethyl starch: use restrictions http://t.co/QBzIFavx4w","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/QBzIFavx4w","expanded_url":"http://bit.ly/17tO1Mu","display_url":"bit.ly/17tO1Mu"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-10-16T15:37:01.000Z","conversation_id":"390501644112101376","possibly_sensitive":false,"lang":"en","id":"390501644112101376","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Giotrif (#afatinib) for non-small-cell #lung #cancer: http://t.co/fjqifNmn4W","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/fjqifNmn4W","expanded_url":"http://bit.ly/1fCB0bA","display_url":"bit.ly/1fCB0bA"}],"hashtags":[{"start":42,"end":50,"tag":"Giotrif"},{"start":52,"end":61,"tag":"afatinib"},{"start":82,"end":87,"tag":"lung"},{"start":88,"end":95,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-10-16T14:16:04.000Z","conversation_id":"390481272726102017","possibly_sensitive":false,"lang":"en","id":"390481272726102017","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our latest report on sales of veterinary antimicrobials is now available, covering 25 EU/EEA countries in 2011: http://t.co/BKkWEkwCOM","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/BKkWEkwCOM","expanded_url":"http://bit.ly/GPunDM","display_url":"bit.ly/GPunDM"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-16T08:42:03.000Z","conversation_id":"390397214305972226","possibly_sensitive":false,"lang":"en","id":"390397214305972226","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@cancereu We'll pass the message on.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"created_at":"2013-10-14T14:31:51.000Z","conversation_id":"389759765196189696","possibly_sensitive":false,"lang":"en","id":"389760468337696770","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389759765196189696"}],"in_reply_to_user_id":"140344419","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@cancereu We haven't suggested one for this workshop. Please feel free to use a hashtag of your choice.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"created_at":"2013-10-14T14:28:32.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","id":"389759633230798848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389758309231640576"}],"in_reply_to_user_id":"140344419","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Follow the workshop on preventing product shortages due to manufacturing and quality problems, live on our website: http://t.co/fm5KVrMvK0","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/fm5KVrMvK0","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-14T13:19:37.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","id":"389742290832334848","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Watch the live broadcast of our workshop on preventing product shortages due to manufacturing and quality problems: http://t.co/GDR1CXpHVQ","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/GDR1CXpHVQ","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-14T09:04:55.000Z","conversation_id":"389678190886924288","possibly_sensitive":false,"lang":"en","id":"389678190886924288","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the PRAC meeting highlights: http://t.co/K0BGqXJFGJ","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/K0BGqXJFGJ","expanded_url":"http://bit.ly/15YE1Q3","display_url":"bit.ly/15YE1Q3"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-11T11:13:20.000Z","conversation_id":"388623345287450624","possibly_sensitive":false,"lang":"en","id":"388623345287450624","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're hosting a workshop on prevention of product shortages due to manufacturing and quality problems on 14 October: http://t.co/2L38IQmcoP","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2L38IQmcoP","expanded_url":"http://bit.ly/1acjgwa","display_url":"bit.ly/1acjgwa"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-10T11:02:17.000Z","conversation_id":"388258176665399296","possibly_sensitive":false,"lang":"en","id":"388258176665399296","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"What does the #blacktriangle on medicines mean? Watch our video: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T08:20:27.000Z","conversation_id":"387130284593803264","possibly_sensitive":false,"lang":"en","id":"387130284593803264","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Watch our video on the #blacktriangle and additional monitoring of medicines: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":23,"end":37,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T11:10:00.000Z","conversation_id":"387172956381528064","possibly_sensitive":false,"lang":"en","id":"387172956381528064","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-10-07T10:00:29.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","id":"387155461805309952","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"387134868431179776"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're now publishing our recommendations based on the assessment of #safety #signals: http://t.co/4TcedOgAR9  #pharmacovigilance","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/4TcedOgAR9","expanded_url":"http://bit.ly/1ga3wzL","display_url":"bit.ly/1ga3wzL"}],"hashtags":[{"start":68,"end":75,"tag":"safety"},{"start":76,"end":84,"tag":"signals"},{"start":110,"end":128,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T08:21:11.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","id":"387130470867017728","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Find out what the #blacktriangle means and how additional monitoring works: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":18,"end":32,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-04T11:23:05.000Z","conversation_id":"386089083480457216","possibly_sensitive":false,"lang":"en","id":"386089083480457216","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website is down at the moment due to technical problems. We're working on getting it back up as soon as possible. Apologies.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-04T11:40:13.000Z","conversation_id":"386093396764262400","possibly_sensitive":false,"lang":"en","id":"386093396764262400","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The #blacktriangle is an invitation for patients and healthcare professionals to report suspected side effects: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":4,"end":18,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-04T08:25:38.000Z","conversation_id":"386044426146959360","possibly_sensitive":false,"lang":"en","id":"386044426146959360","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published the report and video from our workshop on #conflictsofinterests: http://t.co/yAXSlcN27o  #coiworkshop","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/yAXSlcN27o","expanded_url":"http://bit.ly/1730C94","display_url":"bit.ly/1730C94"}],"hashtags":[{"start":65,"end":86,"tag":"conflictsofinterests"},{"start":112,"end":124,"tag":"coiworkshop"}],"mentions":{},"annotations":{}},"created_at":"2013-10-03T08:34:35.000Z","conversation_id":"385684292044476416","possibly_sensitive":false,"lang":"en","id":"385684292044476416","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our video and factsheet explaining the #blacktriangle &amp; additional monitoring in all EU languages are now available: http://t.co/WeoH36QuED","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/WeoH36QuED","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":39,"end":53,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T11:01:16.000Z","conversation_id":"384996429652963328","possibly_sensitive":false,"lang":"en","id":"384996429652963328","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EPHA_EU The #blacktriangle is not a warning, but an invitation to report suspected side effects.","entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"blacktriangle"}],"mentions":[{"start":0,"end":8,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"created_at":"2013-10-01T10:13:46.000Z","conversation_id":"384971025286307840","possibly_sensitive":false,"lang":"en","id":"384984474796457984","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"384971025286307840"}],"in_reply_to_user_id":"184756856","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@ClinicaAmanda The #blacktriangle is only for medicines; a deliverable of the 2010 pharmacovigilance legislation: http://t.co/Mq1KF9kPri","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Mq1KF9kPri","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T10:32:11.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","id":"384989111255572480","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"384980031728279552"}],"in_reply_to_user_id":"183177433","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a video and factsheet in all EU languages explaining the #blacktriangle and additional monitoring: http://t.co/YWsuLDhWrE","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/YWsuLDhWrE","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":73,"end":87,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T08:50:39.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","id":"384963559614316544","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #advancedtherapies committee has issued its first recommendation for certification of non-clinical data: http://t.co/6NTwU4WFiR","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/6NTwU4WFiR","expanded_url":"http://bit.ly/1fqLhIw","display_url":"bit.ly/1fqLhIw"}],"hashtags":[{"start":4,"end":22,"tag":"advancedtherapies"}],"mentions":{},"annotations":{}},"created_at":"2013-09-27T08:18:57.000Z","conversation_id":"383506032338563072","possibly_sensitive":false,"lang":"en","id":"383506032338563072","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're holding a workshop on #biosimilars on 31 October. A few places are available: http://t.co/Wb5YqNPTTs","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Wb5YqNPTTs","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":28,"end":40,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-09-26T08:11:40.000Z","conversation_id":"383141810156998656","possibly_sensitive":false,"lang":"en","id":"383141810156998656","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Lemtrada (#alemtuzumab) for the treatment of #multiplesclerosis: http://t.co/ZbfHnyT0F9","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ZbfHnyT0F9","expanded_url":"http://bit.ly/1be3fwf","display_url":"bit.ly/1be3fwf"}],"hashtags":[{"start":42,"end":51,"tag":"Lemtrada"},{"start":53,"end":65,"tag":"alemtuzumab"},{"start":88,"end":106,"tag":"multiplesclerosis"}],"mentions":{},"annotations":{}},"created_at":"2013-09-26T08:40:10.000Z","conversation_id":"383148983629398016","possibly_sensitive":false,"lang":"en","id":"383148983629398016","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're organising a workshop on #biosimilars on 31 October: http://t.co/sTwbmf855w","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/sTwbmf855w","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":31,"end":43,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-09-25T16:20:36.000Z","conversation_id":"382902466805006336","possibly_sensitive":false,"lang":"en","id":"382902466805006336","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"hashtags":[{"start":97,"end":112,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-09-23T08:59:52.000Z","conversation_id":"382066775531065344","possibly_sensitive":false,"lang":"en","id":"382066775531065344","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: http://t.co/NVZGPQitu1","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/NVZGPQitu1","expanded_url":"http://bit.ly/18fpSwm","display_url":"bit.ly/18fpSwm"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-20T11:21:17.000Z","conversation_id":"381015199429689345","possibly_sensitive":false,"lang":"en","id":"381015199429689345","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@MarvinOLicious @fezziwig2008 We don't include new routes of administration in highlights. Please keep an eye on http://t.co/8mSUDahGIt.","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/8mSUDahGIt","expanded_url":"http://bit.ly/16dRdRD","display_url":"bit.ly/16dRdRD"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"MarvinOLicious","id":"595127053"},{"start":16,"end":29,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"created_at":"2013-09-20T11:50:26.000Z","conversation_id":"381022536055934976","possibly_sensitive":false,"lang":"en","id":"381022536055934976","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"595127053","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our websites and other online tools will be unavailable from 5.30pm tomorrow London time until Monday morning: http://t.co/WyC0u6Gyxb","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/WyC0u6Gyxb","expanded_url":"http://bit.ly/155UOjL","display_url":"bit.ly/155UOjL"}],"hashtags":{},"mentions":{},"annotations":[{"start":77,"end":82,"probability":0.9413,"type":"Place","normalized_text":"London"}]},"created_at":"2013-09-19T11:02:15.000Z","conversation_id":"380648022536753152","possibly_sensitive":false,"lang":"en","id":"380648022536753152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Tafinlar (#dabrafenib) for the treatment of #melanoma: http://t.co/yfpgCi1C39","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/yfpgCi1C39","expanded_url":"http://bit.ly/19glED1","display_url":"bit.ly/19glED1"}],"hashtags":[{"start":42,"end":51,"tag":"Tafinlar"},{"start":53,"end":64,"tag":"dabrafenib"},{"start":87,"end":96,"tag":"melanoma"}],"mentions":{},"annotations":{}},"created_at":"2013-09-19T08:57:30.000Z","conversation_id":"380616630759600128","possibly_sensitive":false,"lang":"en","id":"380616630759600128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published details on our new organisational structure: http://t.co/MIS1VfUoTd","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/MIS1VfUoTd","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-17T10:18:50.000Z","conversation_id":"379912320048037889","possibly_sensitive":false,"lang":"en","id":"379912320048037889","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just announced details of our new organisational structure: http://t.co/e3qjALiuwK","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/e3qjALiuwK","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-16T09:12:07.000Z","conversation_id":"379533142170017792","possibly_sensitive":false,"lang":"en","id":"379533142170017792","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@pharmatweat Please forward details of the problems to us at http://t.co/81mvfkEvbJ and we will look into it.","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"pharmatweat","id":"1725069487"}],"annotations":{}},"created_at":"2013-09-03T10:53:44.000Z","conversation_id":"374840221033975808","possibly_sensitive":false,"lang":"en","id":"374847673691803649","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374840221033975808"}],"in_reply_to_user_id":"1725069487","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Registration is open for a workshop on designation of #orphan medicines and grants: http://t.co/IJpoMiKcuZ","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/IJpoMiKcuZ","expanded_url":"http://bit.ly/19pHuoj","display_url":"bit.ly/19pHuoj"}],"hashtags":[{"start":54,"end":61,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2013-09-06T16:43:47.000Z","conversation_id":"376022929274077184","possibly_sensitive":false,"lang":"en","id":"376022929274077184","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Aubagio (#teriflunomide) for the treatment of #multiplesclerosis: http://t.co/bX84oiq936","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/bX84oiq936","expanded_url":"http://bit.ly/18HYvaY","display_url":"bit.ly/18HYvaY"}],"hashtags":[{"start":42,"end":50,"tag":"Aubagio"},{"start":52,"end":66,"tag":"teriflunomide"},{"start":89,"end":107,"tag":"multiplesclerosis"}],"mentions":{},"annotations":{}},"created_at":"2013-09-06T14:58:04.000Z","conversation_id":"375996325349040128","possibly_sensitive":false,"lang":"en","id":"375996325349040128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Pierre Chirac from @PrescrireMieux calls for EMA to only use experts with no links to industry: http://t.co/FlQL32MWTh #coiworkshop","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"hashtags":[{"start":119,"end":131,"tag":"coiworkshop"}],"mentions":[{"start":19,"end":34,"username":"PrescrireMieux","id":"247239882"}],"annotations":[{"start":0,"end":12,"probability":0.9867,"type":"Person","normalized_text":"Pierre Chirac"}]},"created_at":"2013-09-06T11:32:35.000Z","conversation_id":"375944616584830976","possibly_sensitive":false,"lang":"en","id":"375944616584830976","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EUombudsman Go to http://t.co/IO7nFwBCvs and click on 'multimedia' for broadcast and instructions for what to do if you're having problems.","entities":{"urls":[{"start":19,"end":41,"url":"http://t.co/IO7nFwBCvs","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"created_at":"2013-09-06T12:28:43.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","id":"375958739796623360","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375955342217056256"}],"in_reply_to_user_id":"873777758","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Lunch break now - workshop starting again at 2.00pm London time: http://t.co/FlQL32MWTh #coiworkshop","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"hashtags":[{"start":88,"end":100,"tag":"coiworkshop"}],"mentions":{},"annotations":[{"start":52,"end":57,"probability":0.7654,"type":"Place","normalized_text":"London"}]},"created_at":"2013-09-06T12:13:21.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","id":"375954872983490560","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the PRAC meeting highlights: 2013 http://t.co/8sHEWfcmhS","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/8sHEWfcmhS","expanded_url":"http://bit.ly/18z2J5R","display_url":"bit.ly/18z2J5R"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-06T11:06:44.000Z","conversation_id":"375938107369332736","possibly_sensitive":false,"lang":"en","id":"375938107369332736","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@HJF29088181 We're looking into it. Please bear with us.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"created_at":"2013-09-04T09:42:07.000Z","conversation_id":"375157376451489793","possibly_sensitive":false,"lang":"en","id":"375192039677509632","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375190558186041344"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The EPAR for #Lonquex (#lipegfilgrastim) for #neutropenia in adult #cancer patients is available on our website: http://t.co/55guqCvLOW","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/55guqCvLOW","expanded_url":"http://bit.ly/14fKBkv","display_url":"bit.ly/14fKBkv"}],"hashtags":[{"start":13,"end":21,"tag":"Lonquex"},{"start":23,"end":39,"tag":"lipegfilgrastim"},{"start":45,"end":57,"tag":"neutropenia"},{"start":67,"end":74,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-09-04T08:54:50.000Z","conversation_id":"375180140411498496","possibly_sensitive":false,"lang":"en","id":"375180140411498496","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: The #blacktriangle symbol does not mean that the use of these medicines is subject to greater risk.","entities":{"urls":{},"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-09-02T09:42:20.000Z","conversation_id":"374467317188796417","possibly_sensitive":false,"lang":"en","id":"374467317188796417","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 We will update our information on Herceptin after the Commission decision is granted. Keep an eye on http://t.co/VPOTJIMp13.","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/VPOTJIMp13","expanded_url":"http://bit.ly/1bofovI","display_url":"bit.ly/1bofovI"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"created_at":"2013-09-02T15:57:48.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","id":"374561807119425536","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374561391140962304"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 Please refer to the @EU_Commission for information on the marketing authorisation: http://t.co/VOX6tkW6Bm","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":34,"end":48,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-09-02T15:56:09.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","id":"374561391140962304","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374560385853956097"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @EP_Environment: New medicines to display #blacktriangle from September http://t.co/Cm9aZ8147t lead MEP @LindaMcAvanMEP","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/Cm9aZ8147t","expanded_url":"http://bit.ly/15aEYPg","display_url":"bit.ly/15aEYPg"}],"hashtags":[{"start":45,"end":59,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":107,"end":122,"username":"LindaMcAvanMEP","id":"166509226"}],"annotations":{}},"created_at":"2013-08-30T11:30:22.000Z","conversation_id":"373407343670992896","possibly_sensitive":false,"lang":"en","id":"373407343670992896","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 Once the @eu_commission has granted a positive opinion, the marketing-authorisation holder can start to market.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":23,"end":37,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-08-30T12:22:40.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","id":"373420505099161601","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373419694512148480"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 We aim to publish updates within 15 days of the decision from the @EU_Commission: http://t.co/MaxNF3ugp7","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/MaxNF3ugp7","expanded_url":"http://bit.ly/17r9vdH","display_url":"bit.ly/17r9vdH"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":80,"end":94,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-08-30T12:15:12.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","id":"373418626113888256","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373414548604481536"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Monthly report from the Committee for Medicinal Products for Human Use (July 2013): http://t.co/QIYj0YEKjH","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/QIYj0YEKjH","expanded_url":"http://bit.ly/1bW1T5J","display_url":"bit.ly/1bW1T5J"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2013-08-22T11:34:13.000Z","conversation_id":"370509205620654080","possibly_sensitive":false,"lang":"en","id":"370509205620654080","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"A public consultation is open on our draft Community #herbal monograph on #Arnica montana (Arnica flower): http://t.co/FfVL2gvB4r","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/FfVL2gvB4r","expanded_url":"http://bit.ly/16gs5T8","display_url":"bit.ly/16gs5T8"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":81,"tag":"Arnica"}],"mentions":{},"annotations":{}},"created_at":"2013-08-22T09:54:02.000Z","conversation_id":"370483995076984832","possibly_sensitive":false,"lang":"en","id":"370483995076984832","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Register now for our information day on using #MedDRA, including #medicationerrors, on 22 October: http://t.co/aVsafoAHRx","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/aVsafoAHRx","expanded_url":"http://bit.ly/14iub92","display_url":"bit.ly/14iub92"}],"hashtags":[{"start":46,"end":53,"tag":"MedDRA"},{"start":65,"end":82,"tag":"medicationerrors"}],"mentions":{},"annotations":{}},"created_at":"2013-08-21T11:01:18.000Z","conversation_id":"370138537544261632","possibly_sensitive":false,"lang":"en","id":"370138537544261632","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the first conclusions of parallel assessment of quality-by-design applications with @US_FDA: http://t.co/H21J68dRfK","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/H21J68dRfK","expanded_url":"http://bit.ly/13CzwJR","display_url":"bit.ly/13CzwJR"}],"hashtags":{},"mentions":[{"start":100,"end":107,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2013-08-20T14:10:52.000Z","conversation_id":"369823852404436994","possibly_sensitive":false,"lang":"en","id":"369823852404436994","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@StripSafely @webDM1 We do not deal with medical devices such as test strips: these are regulated at national level.http://t.co/v1ddkkIgB6","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/v1ddkkIgB6","expanded_url":"http://bit.ly/17XsIT4","display_url":"bit.ly/17XsIT4"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"StripSafely","id":"1496947920"},{"start":13,"end":20,"username":"webDM1","id":"758619698"}],"annotations":{}},"created_at":"2013-08-19T08:24:53.000Z","conversation_id":"368421127447539713","possibly_sensitive":false,"lang":"en","id":"369374395505995776","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"368436912203497472"}],"in_reply_to_user_id":"1496947920","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw Yes, orphan designations are only for medicines for diseases that are life-threatening or chronically debilitating.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-08-19T11:07:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"369415289110155264","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369414395077488640"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw Apologies, the correct link for the orphan designation is http://t.co/ybv9RSBgHs","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/ybv9RSBgHs","expanded_url":"http://bit.ly/1ajS6bP","display_url":"bit.ly/1ajS6bP"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-08-19T10:56:18.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"369412501634416640","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369411157016076288"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Imvanex, a vaccine to protect against #smallpox in adults: http://t.co/foVwlCYYSA","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/foVwlCYYSA","expanded_url":"http://bit.ly/1dcYfpJ","display_url":"bit.ly/1dcYfpJ"}],"hashtags":[{"start":42,"end":50,"tag":"Imvanex"},{"start":81,"end":90,"tag":"smallpox"}],"mentions":{},"annotations":{}},"created_at":"2013-08-16T12:32:11.000Z","conversation_id":"368349468036694016","possibly_sensitive":false,"lang":"en","id":"368349468036694016","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New dossier-submission requirements for active-substance master files (ASMFs) come into force on 1 September:  http://t.co/ckX3kxvOKY","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ckX3kxvOKY","expanded_url":"http://bit.ly/13ztmF3","display_url":"bit.ly/13ztmF3"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-08-14T08:54:36.000Z","conversation_id":"367569934844694528","possibly_sensitive":false,"lang":"en","id":"367569934844694528","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"The EPAR for #Pomalidomide Celgene for the treatment of #multiplemyeloma is now available on our website: http://t.co/rI8Zbj9xq3","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":13,"end":26,"tag":"Pomalidomide"},{"start":56,"end":72,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"created_at":"2013-08-14T08:14:05.000Z","conversation_id":"367559740010016768","possibly_sensitive":false,"lang":"en","id":"367559740010016768","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Pomalidomide Celgene for the treatment of #multiplemyeloma http://t.co/rI8Zbj9xq3","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":42,"end":55,"tag":"Pomalidomide"},{"start":85,"end":101,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T13:34:44.000Z","conversation_id":"367278045172080641","possibly_sensitive":false,"lang":"en","id":"367278045172080641","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Send us your comments on our inventory of #paediatric needs in #nephrourology: consultation open until 14 November: http://t.co/YR2ts17Q2P","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/YR2ts17Q2P","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":42,"end":53,"tag":"paediatric"},{"start":63,"end":77,"tag":"nephrourology"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T08:36:12.000Z","conversation_id":"367202918207733761","possibly_sensitive":false,"lang":"en","id":"367202918207733761","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two weeks to comment on our opinion on a new model of disease progression &amp; trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":100,"end":110,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T08:33:24.000Z","conversation_id":"367202214659358720","possibly_sensitive":false,"lang":"en","id":"367202214659358720","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our guideline on the pharmaceutical development of medicines for #paediatric use is available:http://t.co/rJ15XFJH72","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/rJ15XFJH72","expanded_url":"http://bit.ly/11OPlKp","display_url":"bit.ly/11OPlKp"}],"hashtags":[{"start":65,"end":76,"tag":"paediatric"}],"mentions":{},"annotations":{}},"created_at":"2013-08-08T14:28:56.000Z","conversation_id":"365479746554961921","possibly_sensitive":false,"lang":"en","id":"365479746554961921","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published guidance on the #validation process for initial marketing authorisations: http://t.co/sv8R6JkPA5","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/sv8R6JkPA5","expanded_url":"http://bit.ly/13eIszI","display_url":"bit.ly/13eIszI"}],"hashtags":[{"start":32,"end":43,"tag":"validation"}],"mentions":{},"annotations":{}},"created_at":"2013-08-05T10:19:00.000Z","conversation_id":"364329684139778048","possibly_sensitive":false,"lang":"en","id":"364329684139778048","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Send us your comments on our concept paper on development of product-specific guidance on #bioequivalence: http://t.co/eISk9bSd8U","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":90,"end":105,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-08-02T08:11:11.000Z","conversation_id":"363210354668474368","possibly_sensitive":false,"lang":"en","id":"363210354668474368","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our concept paper on development of product-specific guidance on #bioequivalence is open for consultation: http://t.co/eISk9bSd8U","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":65,"end":80,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-08-01T14:59:30.000Z","conversation_id":"362950721869590528","possibly_sensitive":false,"lang":"en","id":"362950721869590528","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a guideline on using starting materials and intermediates from different sources for biologicals: http://t.co/QphlXLE5el","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/QphlXLE5el","expanded_url":"http://bit.ly/18Rdqpp","display_url":"bit.ly/18Rdqpp"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-31T10:21:01.000Z","conversation_id":"362518252104073216","possibly_sensitive":false,"lang":"en","id":"362518252104073216","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete The longest in the link we supplied was NexoBrid - 210 active days + 463 clock stop = 673 days or about 22 months.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"created_at":"2013-07-30T11:11:53.000Z","conversation_id":"360726350052605952","possibly_sensitive":false,"lang":"en","id":"362168665245892608","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"362167070118526976"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide We expect to issue a recommendation on domperidone in December at the earliest: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-07-30T08:47:13.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","id":"362132260981440512","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"360700049375772672"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-07-29T10:49:34.000Z","conversation_id":"361800660603248640","possibly_sensitive":false,"lang":"en","id":"361800660603248640","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/qdFoA4IN6O","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/qdFoA4IN6O","expanded_url":"http://bit.ly/13gJEkI","display_url":"bit.ly/13gJEkI"}],"hashtags":[{"start":61,"end":74,"tag":"ketoconazole"}],"mentions":{},"annotations":{}},"created_at":"2013-07-29T09:29:41.000Z","conversation_id":"361780557295783937","possibly_sensitive":false,"lang":"en","id":"361780557295783937","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We published the CHMP meeting highlights on Friday: http://t.co/0yt85BB8Ef","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/0yt85BB8Ef","expanded_url":"http://bit.ly/1bUzNuf","display_url":"bit.ly/1bUzNuf"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-29T09:29:01.000Z","conversation_id":"361780390639312896","possibly_sensitive":false,"lang":"en","id":"361780390639312896","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We recommend changes to the use of #metoclopramide: http://t.co/mBUtjSDI6S","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/mBUtjSDI6S","expanded_url":"http://bit.ly/1dZrdXF","display_url":"bit.ly/1dZrdXF"}],"hashtags":[{"start":35,"end":50,"tag":"metoclopramide"}],"mentions":{},"annotations":{}},"created_at":"2013-07-26T09:17:34.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","id":"360690347334057984","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":4,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/iNybk9S0Vd","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/iNybk9S0Vd","expanded_url":"http://bit.ly/15PIQqa","display_url":"bit.ly/15PIQqa"}],"hashtags":[{"start":20,"end":24,"tag":"GLP"}],"mentions":{},"annotations":{}},"created_at":"2013-07-26T09:14:46.000Z","conversation_id":"360689641986338816","possibly_sensitive":false,"lang":"en","id":"360689641986338816","author_id":"116716199","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two more weeks to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-07-22T08:11:15.000Z","conversation_id":"359224104353660931","possibly_sensitive":false,"lang":"en","id":"359224104353660931","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC: one year of public health promotion and protection: http://t.co/80foENOv00","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/80foENOv00","expanded_url":"http://bit.ly/14mS686","display_url":"bit.ly/14mS686"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-19T15:59:36.000Z","conversation_id":"358254805031981057","possibly_sensitive":false,"lang":"en","id":"358254805031981057","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published our guideline on medicines for the treatment of urinary #incontinence: http://t.co/6xGm78C5Tx","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/6xGm78C5Tx","expanded_url":"http://bit.ly/15saNnQ","display_url":"bit.ly/15saNnQ"}],"hashtags":[{"start":77,"end":90,"tag":"incontinence"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T10:31:29.000Z","conversation_id":"358172232842887170","possibly_sensitive":false,"lang":"en","id":"358172232842887170","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've extended the public consultation on our inventory of #paediatric needs to 26 July - one week left to comment: http://t.co/DI2O8H4btl","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":59,"end":70,"tag":"paediatric"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:09:21.000Z","conversation_id":"358136462316806144","possibly_sensitive":false,"lang":"en","id":"358136462316806144","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Next week is the July #CHMP meeting. We're publishing the main outcomes on Friday: http://t.co/BVe20M2eXv","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/BVe20M2eXv","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":22,"end":27,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:12:38.000Z","conversation_id":"358137291010609152","possibly_sensitive":false,"lang":"en","id":"358137291010609152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"From 4 August, marketing-authorisation holders will need to use the updated application forms for variations: http://t.co/7eMVGXSiZi","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/7eMVGXSiZi","expanded_url":"http://bit.ly/18obr8n","display_url":"bit.ly/18obr8n"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:07:22.000Z","conversation_id":"358135964813635586","possibly_sensitive":false,"lang":"en","id":"358135964813635586","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"The website is live again now. Please bear with us while we continue to work on our technical problems.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-17T14:26:38.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","id":"357506635725406208","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"357502255412428802"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website is down again due to ongoing technical problems. We apologise for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-17T14:09:14.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","id":"357502255412428802","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"Our website is now back up and running. Apologies for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-16T10:56:56.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"357091472404774912","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356805472726163457"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website will be down until at least tomorrow morning because of ongoing technical problems. We apologise for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T16:00:28.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356805472726163457","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356766910630735872"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"We've had to take our website down temporarily while we try to resolve the problems we're having. Apologies for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T13:27:14.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356766910630735872","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356739492599701504"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're having some problems with documents published on our website. Please bear with us while we try to resolve the issue.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T11:38:17.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356739492599701504","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're organising webinars to train applicants on electronic submission of single-assessment #PSURs: http://t.co/CfzhJtroNL","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/CfzhJtroNL","expanded_url":"http://bit.ly/12ojoct","display_url":"bit.ly/12ojoct"}],"hashtags":[{"start":92,"end":98,"tag":"PSURs"}],"mentions":{},"annotations":{}},"created_at":"2013-07-11T10:24:11.000Z","conversation_id":"355271290992607232","possibly_sensitive":false,"lang":"en","id":"355271290992607232","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Information on safety monitoring of medicines is here: http://t.co/MpdmGvj0Ui.","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/MpdmGvj0Ui","expanded_url":"http://bit.ly/16tC1te","display_url":"bit.ly/16tC1te"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T10:15:58.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355269226325479426","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355267503389286400"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann If Stamaril is marketed in Greece, it will have a Greek marketing authorisation; not regulated centrally at EU level.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":19,"end":26,"probability":0.395,"type":"Person","normalized_text":"Stamaril"},{"start":43,"end":48,"probability":0.995,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T10:03:02.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355265970102738944","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355265419902320643"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Referrals are one-off. This one ended in July 2006.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:45:22.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355261524983549952","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355261359857991680"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann No, we do not deal with nationally authorised medicines unless referred to us. Please contact relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:33:59.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355258657795084288","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355258184644050945"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann No Greek authorisations for Stamaril were included in this referral in 2006.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":44,"end":51,"probability":0.3868,"type":"Person","normalized_text":"Stamaril"}]},"created_at":"2013-07-11T09:33:13.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355258468476788736","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355256131406405632"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann To get detailed information on the marketing authorisation granted in Greece, you will need to contact relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":86,"end":91,"probability":0.9942,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T09:27:30.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355257027993411584","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We only deal with centrally authorised medicines and referrals: http://t.co/U6hy4UKtZD.","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/U6hy4UKtZD","expanded_url":"http://bit.ly/18P5cgv","display_url":"bit.ly/18P5cgv"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:17:47.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355254581632049154","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We only deal with centrally authorised meds unless referred to us. Contact the Greek agency for info on Greek authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:02:17.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355250683731128321","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355249962784784385"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann The referral was in 2006; no authorisations in Greece to include. Contact the Greek agency for more info: relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":63,"end":68,"probability":0.9951,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T08:35:09.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355243854540177408","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355015922769068032"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Otherwise, try contacting the Greek medicines agency directly at relation@eof.gr for more info on the Greek authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-10T16:30:02.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355000975758606340","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355000370117869568"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@xOneStepBehind @WHO Try contacting your national regulator. If you're in Norway, email post@legemiddelverket.no http://t.co/gaXR2yqWLp","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/gaXR2yqWLp","expanded_url":"http://bit.ly/1531o5P","display_url":"bit.ly/1531o5P"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"annotations":[{"start":74,"end":79,"probability":0.9931,"type":"Place","normalized_text":"Norway"}]},"created_at":"2013-07-10T16:40:46.000Z","conversation_id":"354573717747142657","possibly_sensitive":false,"lang":"en","id":"355003675850190850","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"354573717747142657"}],"in_reply_to_user_id":"40722651","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Stamaril is not centrally authorised in the EU but we did recommend harmonised information in 2006: http://t.co/0NW5KHaluK","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/0NW5KHaluK","expanded_url":"http://bit.ly/15wqYlM","display_url":"bit.ly/15wqYlM"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":60,"end":61,"probability":0.3822,"type":"Organization","normalized_text":"EU"}]},"created_at":"2013-07-10T16:27:38.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355000370117869568","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"351645431878520835"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"European Medicines Agency creates Healthcare Professionals’ Working Party: http://t.co/y2H0FJKx6H","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/y2H0FJKx6H","expanded_url":"http://bit.ly/13IQndb","display_url":"bit.ly/13IQndb"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-09T14:24:35.000Z","conversation_id":"354607016880246785","possibly_sensitive":false,"lang":"en","id":"354607016880246785","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"},{"start":68,"end":76,"tag":"quality"}],"mentions":{},"annotations":{}},"created_at":"2013-07-05T14:49:27.000Z","conversation_id":"353163724019859457","possibly_sensitive":false,"lang":"en","id":"353163724019859457","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our draft concept paper on manufacture of the finished dosage form is open for consultation until 31 Dec 2013: http://t.co/NkVFxTBYin","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-04T14:50:28.000Z","conversation_id":"352801590698188800","possibly_sensitive":false,"lang":"en","id":"352801590698188800","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Concept paper on manufacture of the finished dosage form open for consultation: http://t.co/NkVFxTBYin","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-04T09:27:28.000Z","conversation_id":"352720304407187456","possibly_sensitive":false,"lang":"en","id":"352720304407187456","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"#Falsified medicines directive requires written confirmation for importation of active substances http://t.co/WRGW3Va8JC","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/WRGW3Va8JC","expanded_url":"http://bit.ly/1cM8jTx","display_url":"bit.ly/1cM8jTx"}],"hashtags":[{"start":0,"end":10,"tag":"Falsified"}],"mentions":{},"annotations":{}},"created_at":"2013-07-02T13:14:57.000Z","conversation_id":"352052775942762496","possibly_sensitive":false,"lang":"en","id":"352052775942762496","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We welcome #croatia to the European medicines network http://t.co/fw6EbbQd3a","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/fw6EbbQd3a","expanded_url":"http://bit.ly/11XW7KA","display_url":"bit.ly/11XW7KA"}],"hashtags":[{"start":11,"end":19,"tag":"croatia"}],"mentions":{},"annotations":{}},"created_at":"2013-07-01T10:31:01.000Z","conversation_id":"351649135897751554","possibly_sensitive":false,"lang":"en","id":"351649135897751554","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two more weeks to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":59,"end":68,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"created_at":"2013-07-01T10:33:40.000Z","conversation_id":"351649801722531841","possibly_sensitive":false,"lang":"en","id":"351649801722531841","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP highlights: http://t.co/8yFvm3eCLG","entities":{"urls":[{"start":42,"end":64,"url":"http://t.co/8yFvm3eCLG","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:47:47.000Z","conversation_id":"350581290778624000","possibly_sensitive":false,"lang":"en","id":"350581290778624000","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two days left to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"created_at":"2013-06-28T11:13:58.000Z","conversation_id":"350572777423634432","possibly_sensitive":false,"lang":"en","id":"350572777423634432","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Concept paper on statistical methodology for the comparative assessment of quality attributes open for consultation:  http://t.co/cPzrMeq9Ln","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T14:06:22.000Z","conversation_id":"350616162826059777","possibly_sensitive":false,"lang":"en","id":"350616162826059777","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/HqLWfluEcI","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/HqLWfluEcI","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":44,"end":63,"tag":"monoclonalantibody"},{"start":64,"end":76,"tag":"biosimilars"},{"start":79,"end":87,"tag":"Remsima"},{"start":92,"end":102,"tag":"Inflectra"}],"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:49:44.000Z","conversation_id":"350581781545762817","possibly_sensitive":false,"lang":"en","id":"350581781545762817","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Tomorrow some of our IT systems will be unavailable due to maintenance. We apologise for any inconvenience: http://t.co/zqcRWqsUAL","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/zqcRWqsUAL","expanded_url":"http://bit.ly/13d10Vh","display_url":"bit.ly/13d10Vh"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:10:24.000Z","conversation_id":"350571882807959554","possibly_sensitive":false,"lang":"en","id":"350571882807959554","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended new restrictions on use of medicines containing #ergot derivatives: http://t.co/1kU9OsO0Fq","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/1kU9OsO0Fq","expanded_url":"http://bit.ly/10oWW1x","display_url":"bit.ly/10oWW1x"}],"hashtags":[{"start":66,"end":72,"tag":"ergot"}],"mentions":{},"annotations":{}},"created_at":"2013-06-28T09:29:34.000Z","conversation_id":"350546504722812928","possibly_sensitive":false,"lang":"en","id":"350546504722812928","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@BushbyKate @paulinemacco We're working together with @EUnetHTA on this. More info here: http://t.co/LQnKlrypm5","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/LQnKlrypm5","expanded_url":"http://bit.ly/1226jAB","display_url":"bit.ly/1226jAB"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"BushbyKate","id":"1216228962"},{"start":12,"end":25,"username":"paulinemacco","id":"325032216"},{"start":54,"end":63,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-06-27T10:17:37.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","id":"350196209417322497","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"350195436017041408"}],"in_reply_to_user_id":"1216228962","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@paulinemacco @BushbyKate We don't deal with pricing or reimbursement - these are handled at a national level: http://t.co/Z7GrvbXFM6","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"paulinemacco","id":"325032216"},{"start":14,"end":25,"username":"BushbyKate","id":"1216228962"}],"annotations":{}},"created_at":"2013-06-27T10:12:17.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","id":"350194869676945408","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"350193398646448128"}],"in_reply_to_user_id":"325032216","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published guidance on how to submit single-assessment periodic safety update reports (#PSURs): http://t.co/46L8k5sqaK","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/46L8k5sqaK","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":[{"start":99,"end":105,"tag":"PSURs"}],"mentions":{},"annotations":{}},"created_at":"2013-06-25T08:41:26.000Z","conversation_id":"349447228785573888","possibly_sensitive":false,"lang":"en","id":"349447228785573888","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"@EU_Commission has published its report on 5 years of the #Paediatric Regulation: http://t.co/HhqmUB0bvt","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":[{"start":58,"end":69,"tag":"Paediatric"}],"mentions":[{"start":0,"end":14,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-06-25T08:40:19.000Z","conversation_id":"349446946383069185","possibly_sensitive":false,"lang":"en","id":"349446946383069185","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"157981564","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"European Commission has just published its report on Paediatric Regulation: http://t.co/HhqmUB0bvt","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":18,"probability":0.711,"type":"Organization","normalized_text":"European Commission"},{"start":53,"end":73,"probability":0.4186,"type":"Other","normalized_text":"Paediatric Regulation"}]},"created_at":"2013-06-24T13:11:14.000Z","conversation_id":"349152739596570624","possibly_sensitive":false,"lang":"en","id":"349152739596570624","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Information day on new good distribution practice for human medicines http://t.co/Ad9pXgz7SH","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Ad9pXgz7SH","expanded_url":"http://www.aemps.gob.es/eventosCongresos/inspe-Farma/2013/J_buena-practica-distribucion.htm","display_url":"aemps.gob.es/eventosCongres…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-20T13:33:57.000Z","conversation_id":"347708905595469824","possibly_sensitive":false,"lang":"en","id":"347708905595469824","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/g9RgK87jfl","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/g9RgK87jfl","expanded_url":"http://bit.ly/ZOnpVU","display_url":"bit.ly/ZOnpVU"}],"hashtags":[{"start":56,"end":67,"tag":"diclofenac"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T11:53:39.000Z","conversation_id":"345509336476418048","possibly_sensitive":false,"lang":"en","id":"345509336476418048","author_id":"116716199","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/BN5Y9E2RBG","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/BN5Y9E2RBG","expanded_url":"http://bit.ly/153cYMW","display_url":"bit.ly/153cYMW"}],"hashtags":[{"start":39,"end":47,"tag":"codeine"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T11:58:02.000Z","conversation_id":"345510439532261376","possibly_sensitive":false,"lang":"en","id":"345510439532261376","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends suspending marketing authorisations for infusion solutions containing #hydroxyethylstarch: http://t.co/1C4dAPuGrg","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/1C4dAPuGrg","expanded_url":"http://bit.ly/10hNhfb","display_url":"bit.ly/10hNhfb"}],"hashtags":[{"start":86,"end":105,"tag":"hydroxyethylstarch"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T12:01:11.000Z","conversation_id":"345511231257448448","possibly_sensitive":false,"lang":"en","id":"345511231257448448","author_id":"116716199","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @sanidadgob Reform of medicine laws will offer more safety to citizens &amp; eliminate falsified medicines http://t.co/RNssZcAMEv…","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/RNssZcAMEv","expanded_url":"http://msssi.es/gabinete/notas","display_url":"msssi.es/gabinete/notas"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"annotations":{}},"created_at":"2013-06-13T12:31:19.000Z","conversation_id":"345156426169200640","possibly_sensitive":false,"lang":"en","id":"345156426169200640","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're looking to #recruit a #scientist working in #quality of medicines. Apply by 12 July 2013: http://t.co/smbCJX2nuX #vacancy","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":28,"end":38,"tag":"scientist"},{"start":50,"end":58,"tag":"quality"},{"start":119,"end":127,"tag":"vacancy"}],"mentions":{},"annotations":{}},"created_at":"2013-06-12T15:47:08.000Z","conversation_id":"344843319605600256","possibly_sensitive":false,"lang":"en","id":"344843319605600256","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Problems with the supply of the medicine Epanutin (phenytoin) http://t.co/0w5TyABv65","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/0w5TyABv65","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/problemasSuministro/2013/NI-AEMPS_07-2013-epanutin.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-12T15:52:04.000Z","conversation_id":"344844560914059265","possibly_sensitive":false,"lang":"en","id":"344844560914059265","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a revised guideline on #biosimilars containing biotechnology-derived proteins for consultation: http://t.co/q4niOGAnDE","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/q4niOGAnDE","expanded_url":"http://bit.ly/15PEmjK","display_url":"bit.ly/15PEmjK"}],"hashtags":[{"start":39,"end":51,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-06-10T09:46:33.000Z","conversation_id":"344027796827426816","possibly_sensitive":false,"lang":"en","id":"344027796827426816","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Tetrazepam (Myolastan): suspension of marketing http://t.co/j6DMPwkovJ","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/j6DMPwkovJ","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_15-2013-myolastan.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-07T13:51:27.000Z","conversation_id":"343002267152171008","possibly_sensitive":false,"lang":"en","id":"343002267152171008","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We’ve met with @EUnetHTA to discuss how regulators and health-technology-assessment bodies can work together: http://t.co/Vmqe4IioAT","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/Vmqe4IioAT","expanded_url":"http://bit.ly/11J4l7U","display_url":"bit.ly/11J4l7U"}],"hashtags":{},"mentions":[{"start":15,"end":24,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-06-07T09:24:28.000Z","conversation_id":"342935076029485056","possibly_sensitive":false,"lang":"en","id":"342935076029485056","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Amendments to #pharmacovigilance legislation apply for centrally authorised medicines: new notification requirements: http://t.co/r6RbmSEiik","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-06-06T08:23:07.000Z","conversation_id":"342557249912311808","possibly_sensitive":false,"lang":"en","id":"342557249912311808","author_id":"116716199","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New notification requirements for companies now apply following amendments to the #pharmacovigilance legislation: http://t.co/r6RbmSEiik","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":82,"end":100,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-06-05T15:36:27.000Z","conversation_id":"342303913128632320","possibly_sensitive":false,"lang":"en","id":"342303913128632320","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We cannot see any emails from you in our press inbox. Please send your request to us again at press@ema.europa.eu.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-06-05T13:53:36.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","id":"342278031471149056","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"342273297259569153"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Legemiddelinfo: Patients can report side effects through pharmacies, via doctor or even here: http://t.co/NX3vO5qUir #PasSem13","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/NX3vO5qUir","expanded_url":"http://bit.ly/X9GBaY","display_url":"bit.ly/X9GBaY"}],"hashtags":[{"start":121,"end":130,"tag":"PasSem13"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"created_at":"2013-06-05T13:25:14.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","id":"342270891427782656","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our guideline on the use of #bovine #serum in the manufacture of human biological medicines is now available: http://t.co/bR86hsq6PB","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/bR86hsq6PB","expanded_url":"http://bit.ly/11oxOIj","display_url":"bit.ly/11oxOIj"}],"hashtags":[{"start":28,"end":35,"tag":"bovine"},{"start":36,"end":42,"tag":"serum"}],"mentions":{},"annotations":{}},"created_at":"2013-06-04T12:21:56.000Z","conversation_id":"341892572500873216","possibly_sensitive":false,"lang":"en","id":"341892572500873216","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Information on the revocation of marketing authorisations for products containing almitrine http://t.co/bJnWZDH5to","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/bJnWZDH5to","expanded_url":"http://tnij.org/vwwd","display_url":"tnij.org/vwwd"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-06-03T15:40:16.000Z","conversation_id":"341580097653981185","possibly_sensitive":false,"lang":"en","id":"341580097653981185","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Fiouw We're afraid we can't release more details while the evaluation is ongoing. We will publish the outcome as soon as it's complete.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-05-16T08:07:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"334943140853198848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334766728758308864"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Meeting highlights from the Committee for Medicinal Products for Human Use (#CHMP) 18-21 March 2013:  http://t.co/0xguMT80eZ","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/0xguMT80eZ","expanded_url":"http://bit.ly/XuKjxf","display_url":"bit.ly/XuKjxf"}],"hashtags":[{"start":76,"end":81,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-03-22T12:17:41.000Z","conversation_id":"315074803528765440","possibly_sensitive":false,"lang":"en","id":"315074803528765440","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Meeting highlights from April #CHMP meeting have now been published: http://t.co/R5jrTIX6A1","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/R5jrTIX6A1","expanded_url":"http://bit.ly/Y8Tjhj","display_url":"bit.ly/Y8Tjhj"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-04-26T11:12:40.000Z","conversation_id":"327742015964053504","possibly_sensitive":false,"lang":"en","id":"327742015964053504","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two more weeks to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy http://t.co/PGApjXG98G","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":117,"end":139,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"},{"start":69,"end":78,"tag":"vaccines"}],"mentions":{},"annotations":{}},"created_at":"2013-05-29T08:25:17.000Z","conversation_id":"339658692687454208","possibly_sensitive":false,"lang":"en","id":"339658692687454208","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're inviting comments on our guideline on the efficacy of #veterinary #antimicrobials. Deadline is 30/11/2013: http://t.co/06HsjEajNf","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/06HsjEajNf","expanded_url":"http://bit.ly/111YtX6","display_url":"bit.ly/111YtX6"}],"hashtags":[{"start":60,"end":71,"tag":"veterinary"},{"start":72,"end":87,"tag":"antimicrobials"}],"mentions":{},"annotations":{}},"created_at":"2013-05-29T08:59:17.000Z","conversation_id":"339667250107805696","possibly_sensitive":false,"lang":"en","id":"339667250107805696","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"To help deal with the harm caused by #medicationerrors in the EU, we've issued six key recommendations: http://t.co/vTmcvhNZMb","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/vTmcvhNZMb","expanded_url":"http://bit.ly/16Q91kA","display_url":"bit.ly/16Q91kA"}],"hashtags":[{"start":37,"end":54,"tag":"medicationerrors"}],"mentions":{},"annotations":[{"start":62,"end":63,"probability":0.344,"type":"Place","normalized_text":"EU"}]},"created_at":"2013-05-23T11:06:03.000Z","conversation_id":"337524821703397377","possibly_sensitive":false,"lang":"en","id":"337524821703397377","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"From March all applications for human medicines will need to use the #eSubmission Gateway or web client: http://t.co/YRzeY7uEBq","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/YRzeY7uEBq","expanded_url":"http://bit.ly/10LXhHt","display_url":"bit.ly/10LXhHt"}],"hashtags":[{"start":69,"end":81,"tag":"eSubmission"}],"mentions":{},"annotations":{}},"created_at":"2013-05-22T15:34:37.000Z","conversation_id":"337230023750737920","possibly_sensitive":false,"lang":"en","id":"337230023750737920","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #veterinary committee recommended the first vaccine for #footandmouth disease for authorisation last week: http://t.co/4O6hKdO0Af","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":60,"end":73,"tag":"footandmouth"}],"mentions":{},"annotations":{}},"created_at":"2013-05-21T08:13:06.000Z","conversation_id":"336756522304561152","possibly_sensitive":false,"lang":"en","id":"336756522304561152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We published the full highlights from our #pharmacovigilance committee last Friday: http://t.co/oJ4Nmm5nhY","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/oJ4Nmm5nhY","expanded_url":"http://bit.ly/16pwHMT","display_url":"bit.ly/16pwHMT"}],"hashtags":[{"start":42,"end":60,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-05-21T08:12:19.000Z","conversation_id":"336756326862577664","possibly_sensitive":false,"lang":"en","id":"336756326862577664","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've reiterated the PRAC's earlier recommendation on #Diane35 and its generics: http://t.co/6yLDCWGyAb","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/6yLDCWGyAb","expanded_url":"http://bit.ly/Z1MGOc","display_url":"bit.ly/Z1MGOc"}],"hashtags":[{"start":54,"end":62,"tag":"Diane35"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T20:12:37.000Z","conversation_id":"335488046277484544","possibly_sensitive":false,"lang":"en","id":"335488046277484544","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"EMA recommends first vaccine for foot-and-mouth disease for authorisation at EU level: http://t.co/4O6hKdO0Af","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.363,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-05-17T13:53:18.000Z","conversation_id":"335392584480468992","possibly_sensitive":false,"lang":"en","id":"335392584480468992","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends positive benefit/risk balance of #Diane 35 and generics in specific patient group http://t.co/nm2IYqoZNI","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/nm2IYqoZNI","expanded_url":"http://bit.ly/10CxqBy","display_url":"bit.ly/10CxqBy","status":429,"unwound_url":"https://www.ema.europa.eu/en/ema-redirect?redirect_type=jsp&curl=pages/news_and_events/news/2013/05/news_detail_001790.jsp&mid=WC0b01ac058004d5c1"}],"hashtags":[{"start":49,"end":55,"tag":"Diane"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T11:34:53.000Z","conversation_id":"335357753885331457","possibly_sensitive":false,"lang":"en","id":"335357753885331457","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're supporting International #ClinicalTrials Day on Monday: http://t.co/2GhdC2vNa1","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/2GhdC2vNa1","expanded_url":"http://bit.ly/10KaUYE","display_url":"bit.ly/10KaUYE"}],"hashtags":[{"start":31,"end":46,"tag":"ClinicalTrials"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T16:31:34.000Z","conversation_id":"335432413335416832","possibly_sensitive":false,"lang":"en","id":"335432413335416832","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Fiouw We are still evaluating Scenesse; it's not refused. We will publish the outcome once we've finished assessing: http://t.co/1MKhhUqcDx","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/1MKhhUqcDx","expanded_url":"http://bit.ly/16wqT3M","display_url":"bit.ly/16wqT3M"}],"hashtags":{},"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-05-14T08:38:40.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"334226243912359936","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"333531395681054720"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"RT @URPLWMiPB: Cases of necrotising fasciitis due to the use of Avastin (bevacizumab): http://t.co/4nHzMdqxC8 …","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4nHzMdqxC8","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/przypadki-martwiczego-zapalenia-powiezi-w-zwiazku-z-zastosowaniem-produktu-avastin-bewacyzumab","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-05-15T10:55:25.000Z","conversation_id":"334623043517304832","possibly_sensitive":false,"lang":"en","id":"334623043517304832","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@URPLWMiPB The link in your tweet isn't working! @FrancoisMaignen","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"URPLWMiPB","id":"556679074"},{"start":49,"end":65,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"created_at":"2013-05-14T09:44:53.000Z","conversation_id":"334216509482213377","possibly_sensitive":false,"lang":"en","id":"334242906154098688","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334216509482213377"}],"in_reply_to_user_id":"556679074","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FrancoisMaignen Thanks. We've let them know.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":16,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"created_at":"2013-05-14T09:45:51.000Z","conversation_id":"334223216191082496","possibly_sensitive":false,"lang":"en","id":"334243151164346369","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334241896278941696"}],"in_reply_to_user_id":"769373400","attachments":{"media_keys":{}}}],"places":[{"name":"Harrow","full_name":"Harrow, England","id":"8907ab3ca1490878","country_code":"GB","country":"Verenigd Koninkrijk","place_type":"city","geo":{"type":"Feature","bbox":[-0.404,51.5531,-0.2701,51.6406],"properties":{}}},{"name":"Oslo","full_name":"Oslo, Norge","id":"e42ed02b50d62e29","country_code":"NO","country":"Noorwegen","place_type":"city","geo":{"type":"Feature","bbox":[10.4915,59.8098,10.9516,60.135],"properties":{}}},{"name":"Lucena","full_name":"Lucena, España","id":"9c61116b741a2d09","country_code":"ES","country":"Spanje","place_type":"city","geo":{"type":"Feature","bbox":[-4.6836,37.2457,-4.4169,37.4637],"properties":{}}}]}
